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ABSTRACT 
 
Cynthia M. Visness 
 
CYNTHIA VISNESS:  The Association of Overweight with Allergy and Asthma in Children: 
Findings from the National Health and Nutrition Examination Survey  
(NHANES) 1999-2006 
(Under the direction of Dr. Julie L. Daniels) 
 
 
Obesity and asthma prevalence have both risen among children over the last several 
decades, and research efforts increasingly suggest that obesity is associated with asthma. 
Atopy is a strong risk factor for asthma, but previous literature on the relationship between 
obesity and atopy has been inconsistent. In addition, some, but not all, studies have shown 
that the effect of obesity on asthma is stronger among non-atopic individuals than among 
those with atopy. Systemic inflammation may be a factor in the relationship between obesity 
and asthma. Breastfeeding may potentially protect against obesity, atopy, and asthma.  
This dissertation used National Health and Nutrition Examination and Survey 
(NHANES) data from 1999-2006 to examine the relationship between obesity and asthma 
among U.S. children age 2-19. Data from 2005-2006, which include assays for total and 
allergen-specific IgE, were used to explore the relationship of obesity with IgE levels, atopy, 
and allergy symptoms, and also to stratify the obesity-asthma analysis by atopic status.  The 
protective effect of breastfeeding was investigated using data for children age 1-6.  
Obese children were more likely to report having current asthma than children of 
normal weight (OR: 1.68, 95% CI: 1.33, 2.12). The association did not differ by gender, but 
was stronger among non-atopic children than among children with at least 1 positive specific 
 iv
IgE result (OR: 2.46, 95% CI: 1.21, 5.02 vs. OR: 1.34, 95% CI: 0.70, 2.57; interaction p-
value 0.09). Total IgE levels increased with BMI in a dose response manner and the odds of 
having at least one positive specific IgE were elevated among obese children compared to 
normal weight children (OR: 1.35; 95% CI: 1.04-1.76). C-reactive protein levels were 
associated with both atopy and asthma, and may indicate a role for systemic inflammation 
for both outcomes. Breastfeeding was found to protect against obesity and asthma, but not 
atopy. The protective effect of breastfeeding against asthma was not modified by obesity or 
by atopy.  
An increased risk of allergic disease and asthma may not be the most consequential 
health risk faced by overweight children. Nonetheless, it provides additional motivation for 
undertaking the difficult challenge to reduce childhood obesity. 
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Chapter I.  Introduction and Specific Aims 
 
 
The adiposity of the American population has been growing steadily. This is true both 
for adults and children, and it is also the case in Canada, Australia, Europe, and throughout 
the developed countries of the world. This increase has been most apparent since about 
1980. Before that time, only about 5% of US children age 6-11 were considered overweight; 
by 2004 that had climbed to nearly 19%.1 
 Asthma has also been on the rise in recent decades. From 1980 to 1995, the period 
of steepest increase, the prevalence of asthma among children 0-17 years of age increased 
from 3.6% to 7.5%. In 2005, 8.9% of children were reported to have current asthma, which 
would total 6.5 million American children.2 The increase in asthma has been steepest in 
disadvantaged populations in the United States, the same populations that have seen the 
steepest increases in overweight. Despite copious research, the cause or causes for the 
increase in asthma prevalence are unknown. 
Studies over the last fifteen years have suggested that obesity is related to asthma.3-
5 At least 30 cross-sectional and 13 prospective studies have been reported between 1999 
and 2006, with nearly all of them showing a positive association between obesity and 
asthma.3-5 Both asthma and obesity appear to be associated with inflammation, as indicated 
by levels of inflammatory markers such as leptin and C-reactive protein. Thus, inflammation 
due to obesity may lead to airway inflammation and asthma.  
 Allergic disease has also been on the rise in recent decades. In the U.S. from 
the period 1976-1980 to 1988-1994, the prevalence of skin test reactivity to 6 common 
allergens increased from 22% to 42%.6 Increases in atopy have also been observed in the 
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U.K. and Europe.7-9 Asthma and allergy/atopy often go hand in hand, but it is not clear 
whether obesity may be related to atopy. Some researchers have also shown obesity to be 
related to allergy symptoms or to higher serum IgE levels (a marker for atopy),10-12 while 
others have not.13-15 While there is certainly a large allergic component to asthma, recent 
research estimates that only about 40% of asthma in the U.S. is attributable to atopy.16 It is 
possible that obesity-related asthma and atopic asthma have different etiologies, which has 
implications for treatment and prevention.17 
A new allergy module was added to the 2005-2006 National Health and Nutrition 
Examination Survey (NHANES). This module included survey questions about allergy 
symptoms, total and specific serum IgE measurements, and environmental measures of 
dust allergen and endotoxin. This is the largest dataset of serum IgE levels that has ever 
been collected, and it comes from a sample that is generalizable to the entire population of 
the United States. This dataset affords a new opportunity to explore the question of the 
relationship between obesity and allergy/atopy, and to investigate whether atopic status 
modifies the relationship between obesity and asthma in children. 
The current research project will examine the relationship between 
obesity/overweight and asthma and allergy/atopy in U.S. children ages 2-19 using data from 
the National Health and Nutrition Examination Survey (NHANES). The specific aims of this 
project are: 
1. To determine if there is a relationship between overweight and total and specific IgE 
levels and allergic symptom outcomes among U.S. children ages 2-19. 
2. To examine the effect of overweight on asthma outcomes among children 2-19 in a 
nationally representative sample of U.S. children from 1999-2006, and to use the 
2005-2006 data to examine the hypothesis that the effect of overweight on asthma is 
different depending on whether the child also is atopic.  
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3. To examine whether the relationship between overweight and asthma is modified by 
infant feeding method or by atopy.  
  
Chapter II.  Literature Review 
 
A.  Background and Significance of the Contemporaneous Increases in Obesity and 
Asthma in Children 
A.1.  The Growing Problem of Childhood Obesity 
Obesity in children is usually defined as being above the 95th percentile in body mass 
index (kg/m2) for their age. Before 1980, when these standards were developed, by 
definition only 5% of US children age 6-11 were considered obese; by 2004 that had 
climbed to nearly 19%.1 One of the leading health indicators for the Healthy People 2010 
objectives is to reduce obesity among U.S. children and adolescents aged 6-19 back down 
to 5%.18  
A combination of behavioral and environmental factors is to blame for this increase in 
overweight. The U.S. population in general is eating more food – eating more meals away 
from home, eating larger portions, and consuming more sugar-sweetened drinks.19, 20 In 
addition, the prevalence of snacking among U.S. children has significantly increased from 
1977 to 1996, with a higher proportion of energy and a higher proportion of energy from fat 
coming from snacks than from regular meals.21 At the same time, the number of children 
getting regular physical exercise is declining,22, 23 and children are spending more time in 
sedentary activities such as television watching and using the computer.24 The issue of 
childhood obesity has risen to the level of being called an “epidemic,”25, 26 and schools and 
other organizations around the country are taking steps to improve the situation, such as 
eliminating sugary soft drinks from school vending machines in middle and high schools and 
mandating daily physical education or recess in elementary schools.27  
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Obesity in childhood can lead to a lifetime of health consequences. Obese children 
are more likely to become obese adults,28, 29 and obesity in adults is associated with 
numerous health problems, such as cardiovascular disease and diabetes. And, rather than 
waiting until adulthood to manifest themselves, these sequelae of obesity are being seen 
increasingly in children. In the Bogalusa Heart Study more than half of the overweight 
schoolchildren had at least one cardiovascular risk factor.30 Type II (adult onset) diabetes 
used to be a rare occurrence in children, but is now increasingly common,31 and it has also 
been shown that childhood overweight is associated with obesity and insulin resistance in 
young adulthood.32 More and more children are coming to the attention of health 
professionals with metabolic syndrome – a precursor to diabetes.33, 34 The American 
Diabetes Association estimates that 1 in 6 overweight adolescents has pre-diabetes.35  
In addition, a wide variety of other health conditions have been associated with 
childhood obesity, such as liver steatosis, cholelithiasis, menstrual abnormalities, polycystic 
ovary syndrome, and sleep apnea.36 Mental health consequences for obese children should 
also not be trivialized.37, 38 Another important health problem that appears to be related to 
obesity in children, and will be the focus of this project, is asthma.  
A.2.  The Growing Problem of Childhood Asthma 
Asthma is the most common chronic illness in childhood and is characterized by 
variable airflow obstruction with airway hyper-responsiveness. Asthma is responsible for 
more missed school days among children than any other chronic illness.39 According to The 
National Health Interview Survey, 12.1% of U.S. children have had a physician diagnosis of 
asthma at some time in their lives, and 5.8% have had an asthma attack in the past 12 
months.40 Asthma is a multifactorial disease that has been associated with genetic, 
environmental, race/ethnicity, poverty, urbanization, psychosocial, and infectious factors.41  
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Asthma symptoms are caused by inflammation of the airways, and the inflammation 
is chronic. It can be treated with anti-inflammatory medication such as inhaled steroids, but it 
never goes away. It can cause difficulty breathing, wheezing, chronic coughing, and often 
shortness of breath or rapid breathing; however each asthmatic individual can have a 
different symptomatology. This can make asthma diagnosis difficult.42  
Asthma is especially difficult to diagnose in children. Although the inflammation is chronic, 
symptoms may be intermittent. Additionally, many young children develop wheezy or noisy 
breathing when they have a viral illness, but they do not go to develop asthma. The Tucson 
Children’s Respiratory Study identified several different phenotypes of childhood 
wheezing.43 One group, transient wheezers, appear to simply have smaller airways and low 
levels of lung function in early life. They may have isolated episodes of wheeze in early 
childhood, particularly during respiratory illnesses, but stop wheezing after age 3. As many 
as 80% of children who wheeze in the first year of life belong to this group.44 Among children 
who continue to wheeze after age 3, about 40% are non-atopic and may have reduced lung 
function subsequent to lower respiratory infections, particularly with RSV. 
The majority (60%) of the children that wheezed beyond age 3 were atopic.43 Atopy 
is a very important risk factor for asthma in young children, and the prevalence of atopy is 
also increasing in the U.S. popluation.6  
Allergic diseases and allergic asthma are caused by exaggerated Th2-biased 
immune responses. In the allergic response, allergens presented by antigen presenting cells 
activate T helper (Th) cells that lead to the production of cytokines that further regulate the 
production of IgE (Figure 1). This is commonly called the “allergic cascade.”45  
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Figure 1.  Role of T helper (Th) cells and cytokines in immune function. 
 
Figure reproduced from BD Biosciences. Th1 and Th2 Balance, Regulation, and Involvement in Disease. 
http://www.bdbiosciences.com/discovery_labware/products/display_product.php?keyID=108 
 
Tolerance to allergens is a mechanism that normally prevents this allergic response, 
but in allergic individuals this tolerance is poor or non-existent for reasons that are unclear. 
Another subset of T-helper cells, T-regulatory cells, act to suppress (or regulate) both Th1 
and Th2 cytokine production. Some have proposed that it is a defect, probably genetic, in 
this regulatory function that causes the Th2-skewed immune response seen in allergy.46, 47  
Still, there is continued debate over whether allergic diseases and asthma are caused by 
this lack of T-regulatory cell development, the loss of tolerance to environmental allergens 
through some as yet unknown mechanism, or the over-development of allergen-specific Th2 
cells.48 
Prescott et al. demonstrate that virtually all newborn infants display Th-2 skewed 
responses to common environmental allergens, in particular high levels of IL-10.49 Most 
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children “outgrow” this response in the first years of life, and develop a Th1-Th2 balance. 
This is thought to be brought about by encountering infectious agents during early childhood 
and mounting the appropriate Th1 response to those infections.49, 50 Repeated infectious 
encounters educate the immune system to behave appropriately. In children predisposed to 
allergy, however, this process is thwarted, and the child continues to mount a Th2 response 
to foreign bodies that the non-allergic child’s immune system simply ignores.51 Why and how 
this happens in some children and not in others is not well understood at this time. 
Children at genetic risk for allergic disease have been noted to have a weaker IFN-γ 
response.52 Holt suggests that genetic risk for asthma is associated with a diminished 
capacity to produce IFN-γ, the primary Th-1 cytokine, during fetal and early postnatal life.53, 
54 Others have found that detectable cord blood IFN-γ is associated with lower risk for 
allergy/asthma at age 655 and that lower IFN-γ responses are associated with atopic disease 
at age 2.56  However new research has been showing increased IFN-γ in asthmatic 
individuals under certain conditions.57 These findings suggest that, even though it is a Th1 
cytokine, IFN-γ may also contribute to chronic inflammation and may associated with 
asthma.46  
B.  The Effect of Obesity on Asthma in Children 
B.1.  General Evidence 
Awareness in the research community regarding the concomitant increases in 
obesity and in asthma led to a new field of research on the relationship between the two. A 
number of the early studies regarding weight looked at birthweight and its effect on later 
asthma. One of these was reported in 1990 and examined the effect of high birthweight 
(≥3.8 kg) on physician-diagnosed asthma at age 6 months to 11 years. No relationship was 
found.58 A series of further studies also using birthweight as a predictor of asthma also failed 
to find a significant effect.59-61 Shaheen et al. reported on a British birth cohort study started 
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in 1970 that BMI measured at 10 years of age was not related to self-reported asthma or 
wheeze in adulthood.62  
However, a 1983 population study of 72,284 adults in Italy showed an increased risk 
for asthma with high BMI.63 Further large cross-sectional studies also demonstrated 
increased risks, though in some studies these findings were only significant in women.62, 64 
In a U.S. study among 39,637 participants of a military managed care program, a very 
distinct dose response was seen for higher risks of asthma with increasing BMI (BMI > 25 
OR=1.2, BMI > 30 OR=1.7, BMI > 35 OR=2.3, BMI > 40 OR=2.8).65  
Camargo, et al. analyzed prospective data from the Nurses Health Study (over 
85,000 adult female subjects) using self-reported height and weight to calculate BMI and 
self-reported physician-diagnosed asthma after 4 years of follow-up as the outcome. A risk 
ratio for asthma of 1.6 was seen for women with a BMI over 25 and 2.7 for those with a BMI 
over 30.66  
Since these early reports, further studies have been done, which have been 
extensively reviewed.4, 5, 67 At least 30 cross-sectional and 13 prospective studies were 
reported between 1999 and 2006, with nearly all of them showing a positive association 
between obesity and asthma.5 In a 2003 study Chen et al. found obesity (BMI ≥ 30) to be 
associated with diagnosed asthma among Canadian women, but not men.68 Guerra et al. 
found a relationship for both men and women in the U.S.69 In a follow-up study of NHANES 
I, a moderately increased risk for the development of asthma was found for adults obese at 
baseline.70 
The scientific community is generally in agreement that there is a strong association 
between obesity and asthma in adults.4 Prospective studies suggest that obesity precedes 
asthma development, providing support for the idea that obesity may be causally related to 
asthma.  
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Evidence has been more inconsistent for children, hampered in part by different age 
ranges being examined, differing definitions of overweight and obesity, and different 
morbidity endpoints being used. The differing age ranges included can affect the likelihood 
of a child having previously received an asthma diagnosis. Chinn and Rona found that 5-6 
year-old obese children in the U.K. had an increased risk of developing asthma over 4 years 
of follow-up.71  Gilliland et al. found a significant relationship between overweight and 
asthma among boys, but not girls,72 while Gold et al. found a relationship only among girls.73 
Castro-Rodriguez et al. reported from the Tucson Chidren’s Respiratory Study that obesity 
among girls at age 11 was associated with frequent wheeze at age 13.74 No associations 
were seen among boys or for overweight at age 6 with later asthma. While this study has a 
relatively large sample size (N=448) there is a fairly low prevalence of asthma (~10%), 
leading to wide confidence intervals, particularly as the analyses are stratified by sex. The 
OR for frequent wheeze at age 13 among girls who became overweight or obese during 
puberty (changed categories between age 6 and 11) was 4.8 with a 95% CI of 1.2-18.8.  
An interesting meta-analysis of longitudinal studies examining the effect of high 
weight in childhood on the subsequent development of asthma found that in early studies 
(published before 2000) overweight was associated with a decreased risk of asthma, 
whereas all studies published since 2001 showed a statistically significant increased risk of 
asthma among heavier children, and that the strength of the relationship appeared to 
increase over time. This meta-analysis concluded that high body weight in middle childhood 
resulted in a relative risk of 1.5 for subsequent asthma and a 6.6% population attributable 
risk for asthma due to overweight.75 
B.2.  Gender Differences 
Many, though not all, of the studies have examined the obesity/asthma relationship 
separately for males and females. Most of these have found greater effects in females, 
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though a significant gender interaction effect did not always exist. Only 3 cross-sectional 
studies found greater effects in males.70, 72, 76  
One possible reason for these differences is that the most commonly used measure 
of obesity or overweight, BMI, is not a direct measure of adiposity. As an index of obesity, it 
may perform better for one sex than for another. A male at the same BMI as a female, even 
at a BMI of 30 which indicates obesity, may have more muscle mass and less body fat.5 In 
children, differences in the age in which peak lung growth and puberty occur (earlier for 
girls) may also influence these findings of gender differences.73  
There is additionally some evidence that these gender differences could be related to 
female hormones. Castro-Rodriquez et al. found the strongest effects of obesity on asthma 
among girls that started puberty before age 11, compared to those with later pubertal 
development (definition of “puberty” not given by the authors),74 and Varraso et al. found that 
BMI was more strongly related to asthma severity among girls with early menarche.77 
Nevertheless Chinn states in 2006 that the weight of the evidence does not support gender 
differences in children or adolescents.67 
B.3.  Possible Biological Mechanisms  
The first studies to note a relationship between obesity and asthma were cross-
sectional and thus unable to address the question of the direction of causality. It does seem 
plausible that asthma symptoms might lead adults and children to be less physically active, 
which could lead to weight gain. However, all of the 13 prospective studies were able to 
show that obesity preceded asthma, thus discounting this premise.5 Mechanisms that have 
been proposed to explain the relationship between obesity and the development of asthma 
include airway inflammation, mechanical factors, decreased physical activity, and changes 
in diet.  
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B.3.1.  Systemic Inflammation and Airway Inflammation 
Obesity is a chronic inflammatory state characterized by increased levels of 
inflammatory cytokines and other markers, such as leptin and C-reactive protein.78, 79 High 
leptin levels are associated with increased body fat mass.80, 81 Leptin also stimulates the 
release of the pro-inflammatory cytokines IL-6 and TNF-alpha82, 83 and also the Th1 
cytokine, IFN-gamma 84. Obesity is therefore categorized as an inflammatory state,85 and 
obesity seems to be driving inflammation that is associated with other inflammatory diseases 
such as cardiovascular disease.86 Because asthma is also characterized as an inflammatory 
disease, 87 many researchers feel that leptin may be the mediating mechanism between 
obesity and asthma, or may be a proximate determinant of both.78, 88 Additionally, Matsuda 
et al. found an association between leptin and another appetite-modulating hormone, 
ghrelin, and total IgE levels, indicating a link between obesity-related inflammation and 
allergy.88 
Hancox et al. found significantly reduced lung function (FEV1) to be associated with 
elevated C-reactive protein levels,89 indicating systemic inflammation, and C-reactive protein 
has also been shown to be related to obesity in children.90 Still in the Hancox study, the 
relationship between inflammation and lung function was not mediated by smoking, asthma, 
or obesity. Conversely, Ford et al. found that BMI significantly attenuated the odds ratio for 
elevated CRP in asthmatic U.S. adults.91 Similarly, Butland et al. examined the effect of CRP 
levels on asthma and found that CRP was related to  asthma only among non-atopics, and 
that the association became non-significant when controlling for BMI, suggesting that CRP 
may be on the causal pathway between obesity and asthma.92 
Additionally, inflammation specific to the airway has not been demonstrated to be 
higher in obese individuals. Four published studies in children that examined the relationship 
between BMI and exhaled nitric oxide (eNO), a marker of airway inflammation, did not find 
an association.93-96 Unpublished analyses in inner-city children age12-20 also did not show a 
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relationship between BMI and eNO (Kattan, personal communication). In a recent study of 
patients age 15-73, there was a negative association between BMI and eNO.97 Using 
bioelectrical impedance to measure the percentage of body fat, McLachlan et al. found that 
while body fat was associated with asthma in women (but not men), this was not mediated 
by airway inflammation as indicated by eNO measurements.98  
There was also no association seen in a recent study between BMI and airway 
inflammation as measured by sputum cell counts.99 Assuming these markers are good 
surrogates for airway inflammation, as is claimed, there is no convincing evidence that 
systemic inflammation due to obesity (as measured by leptin and C-reactive protein) results 
in airway inflammation.  
B.3.2.  Mechanical Factors 
A high percentage of body fat seems to be related to decreased ventilatory 
function.100, 101 Shortness of breath can result from excess weight compressing the chest 
wall.102 Obesity has also been shown to be related to reduced lung volumes in adults103 and 
with lower forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) in 
children.100  
The tidal action of breathing is different for obese individuals, who breathe faster but 
with smaller tidal volumes compared to lean individuals.104 This can result in a compromised 
bronchodilating mechanism and can lead to increased airway hyper-responsiveness.  
Airway size has been shown to be related to asthma. Babies born prematurely have 
smaller airways which can result in a type of pediatric asthma that is often outgrown as the 
children get older. Boys, who are more likely to have asthma in childhood than girls, are also 
more likely to outgrow their asthma during puberty, as their airway caliber gets larger.105 
B.3.3.  Physical Activity 
For those with asthma, exercise can bring on bronchospasm. Obese individuals may 
also become breathless during vigorous physical exertion. A low level of physical activity is 
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likely to be associated with weight gain or overweight, and children with asthma were found 
to have lower levels of physical activity, measured using an “Actiwatch”.106 Epstein et al. 
found that asthma and physical activity level were independently related to obesity in an 
analysis of NHANES III data.107 A number of prospective studies have found that BMI was 
associated with an increased risk of asthma even when controlling for the level of physical 
activity.66, 108, 109  
In addition, reduced physical activity, whether as a cause or effect of obesity, may 
result in a reduction of deep spontaneous breathing. Normal breathing forces the extension 
of airway smooth muscle and has a strong bronchodilatory mechanism.110 The shallower 
breaths taken by obese individuals due to the mechanical factors detailed above, may 
hinder this process, which could lead to increased airway hyper-responsiveness.111   
Several prospective interventions have shown improvements in lung function among 
asthmatic patients enrolled in exercise programs.112-114 However, it was reported in an 
analysis of NHANES III survey data that time spent exercising or watching TV was not 
related to asthma.115 To date, there has only been one prospective study of the effect of 
physical activity on the development of asthma. Rasmussen et al. showed that low physical 
fitness at age 9 was significantly associated with the development of asthma in 
adolescence.116 
Physical activity is difficult to measure, especially in children and especially over 
time, which is likely why it has not been researched more fully. Lucas and Platts-Mills 
suggest that physical activity may emerge as a stronger determinant of asthma when better 
monitoring techniques are developed and used.111 
B.3.4.  Diet 
Dietary studies are notoriously difficult and, while diet is clearly closely associated to 
weight, little research has been done on the relationship between diet and asthma. Most of 
this research has focused on early life intake of (or prenatal exposure to) certain nutrients 
 15
and their effect on allergic disease. For example, recent studies in two different populations, 
one in Boston117 and one in Scotland118 found that higher maternal intake of Vitamin D 
during pregnancy is associated with a decreased risk for wheezing illnesses in early 
childhood. In an interesting twist, an examination of vitamin supplementation in Swedish 
newborns found that infants given vitamins A and D in water-soluble form were twice as 
likely to develop asthma and allergies than infants given vitamins in peanut oil.119 While it is 
not entirely clear whether the vitamins are responsible for the effect, or the method of 
delivery of the vitamins, some researchers are convinced that vitamin supplementation has 
the potential to significantly reduce the incidence of asthma.120, 121  
Dietary antioxidants have also been examined for their effect on allergic disease. 
Seaton et al. found that low intake of vitamins E and C were both risk factors for wheezy 
illness in adults.122 In young children, Martindale et al. report that maternal vitamin E intake 
during pregnancy was associated with less wheeze in the child’s second year of life, but that 
vitamin C intake was associated with a higher incidence of “ever wheeze” and with 
eczema.123 Litonjua et al. found higher levels of maternal intake of vitamin E and zinc during 
pregnancy to be associated with a lower risk for wheeze in the first 2 years.124  
Intake of omega-3 polyunsaturated fatty acids have also been hypothesized to be 
related to allergic disease development in early childhood.125 A fish oil supplementation 
intervention in infants showed a reduction in wheeze at age 18 months, but no difference in 
IgE levels.126 Another study providing fish oil supplements to pregnant women found a 
significant difference in neonatal Th2 cytokine production between the intervention and 
control groups, including lower levels of IL-13 in cord blood. Also, infants in the 
supplementation group were less likely to be sensitized to egg at one year of age.127 
However, in an observational analysis of data from the Childhood Asthma Prevention Study, 
plasma levels of omega-3 and omega-6 fatty acids, measured at 18 months, 3 years, and 5 
years, were not associated with wheeze, eczema, or atopy at 5 years of age.128 
 16
In addition to specific components of diet, some research has shown total energy 
intake to be related to asthmatic symptoms. A study of alternate day calorie restriction was 
successful in improving asthma symptoms and pulmonary function among 9 overweight 
asthma patients. Markers of oxidative stress and inflammation were also decreased.129 The 
patients also lost weight. These results, and those of others who have shown improvement 
in asthma after bariatric surgery,130-132 suggest that dietary interventions may have a 
beneficial effect on overweight individuals with asthma, but do not explain whether high-
calorie diets are associated with asthma in the population in general.  
Total calorie intake can be considered to be on the causal pathway to obesity. In 
order to confound the relationship between obesity and asthma, total calorie intake would 
have to have a direct effect on asthma, independent of resultant weight and obesity-induced 
inflammation. If a specific component of diet, such as fatty acids, anti-oxidants, or vitamins 
were to act as a confounder, those would need to be independently associated with obesity. 
Some recent studies suggest that this might be the case, at least for vitamin D. Obese 
individuals have been shown to have vitamin D deficiency not explained by calcium/vitamin 
D intake or sunlight exposure,133 and pre-pregnancy obesity has been found to be 
associated with lower vitamin D levels in pregnant mothers and neonates.134 Vitamin D 
levels have also been shown to be low in obese children and adolescents.135 
B.3.5.  Infant Feeding 
One major exception to the paucity of research on dietary influences, is the 
examination the relationship of infant feeding method to both obesity and to allergic disease 
and asthma. Copious research has been done in both areas, especially the latter, with the 
general consensus being that breastfeeding is protective against both obesity and against 
asthma and atopy. 
A large survey of more than 15,000 children in the Growing Up Today Study 
concluded that children who were fed exclusively or mostly breastmilk during the first 6 
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months of life were less likely to be overweight (≥95th percentile of BMI for age) at age 9 to 
14 (OR=0.78, 95% CI: 0.66, 0.91).136 These findings were adjusted for current energy 
intake, time watching television, physical activity, mother’s BMI, age, sex and sexual 
maturity. An analysis of NHANES III data found a reduced risk of being at risk for overweight 
(≥85th percentile of BMI for age) at age 5 for children who were ever breastfed compared to 
those not breastfed (OR=0.63, 95% CI: 0.41, 0.96), but no significant risk of being 
overweight (≥95th percentile).137 The authors found that the strongest predictor of a child’s 
overweight status was the mother’s weight, and suggest that current diet and lifestyles 
factors are more important than breastfeeding in preventing childhood overweight.  
Much research has been done over the past several decades on the effect of 
breastfeeding on allergic diseases and asthma, and much of it has shown that breastfeeding 
reduces the risk of developing asthma or allergic disease.138 However, conflicting findings 
have also been reported.139, 140 The general consensus in the medical community is that 
breastfeeding reduces the risk of allergic disease, and some have put forth breastfeeding 
promotion as a method of primary prevention for asthma.141, 142  
Findings regarding the effect of breastfeeding on allergies and asthma are 
sometimes different depending on the mother’s asthma or allergy status. A study in Sweden 
found that breastfeeding (for 3-4 months or 5 or more months) was protective against 
asthma (at 4 years of age) among all mothers, and among those without asthma 
themselves, but that it was not protective among asthmatic mothers (OR 1.04, 95% CI: 0.35-
3.09).142 Another study from the Netherlands found that breastfeeding duration was 
associated with a reduced risk of recurrent wheeze independent of maternal asthma or 
allergy, but was associated with a lower risk of eczema during the first 2 years of life only 
among children whose mothers did not have allergies or asthma.143 A recent analysis of a 
large birth cohort with objective outcomes for atopy and bronchial hyperresponsiveness 
found that breastfeeding was protective against wheeze in early childhood, but the 
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protective effect was not evident against atopy or asthma in older children.144 This study also 
found that maternal allergy was an important confounder of the relationship between 
breastfeeding and atopy. 
A recent review summarized literature from 1966-2001 on the effect of infant feeding 
on “later atopic manifestations” and concluded that the weight of the evidence suggests 
breastfeeding reduces the risk of atopic disease.138 In contrast to the report above, they also 
reported that this association may be stronger among children with atopic heredity.  
Two research studies have looked specifically at the interaction of overweight and 
breastfeeding to the development of asthma. In a nested case-control study, Mai et al. found 
an increased risk of asthma among children with a short duration of exclusive breastfeeding 
(< 12 weeks) who were also overweight (BMI ≥ 85th percentile for age and sex) at age 8 to 
10 years. Neither of these exposures was associated with asthma in the absence of the 
other.145 In this nested cast-control study, all respondents to a survey on child health who 
reported asthma were compared to a randomly selected group of respondents without 
asthma. The children were subsequently examined by a physician to confirm asthma and to 
measure height and weight. Breastfeeding information was collected by questionnaire. Skin 
prick testing for allergy was done, and a stronger effect of breastfeeding and overweight was 
found for atopic asthma than for non-atopic asthma. This analysis was somewhat unusual 
though, in that both the atopic asthmatics and non-atopic asthmatics were compared to the 
same reference group of non-asthmatics.145 
In a birth cohort study, Oddy et al. determined that there was no interaction, and the 
duration of exclusive breastfeeding and BMI (≥85th percentile) were independent predictors 
of the development of asthma in 2,195 Australian children by age 6 years.146 This analysis 
used a propensity score for BMI to adjust for confounding and fractional polynomials to allow 
curves to be fit for the separate effects of BMI and duration of breastfeeding. This 
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sophisticated analysis controlled each variable for the other in separate models, but the 
interaction effect between BMI and breastfeeding was not examined.146 
Clearly, there are complex relationships between maternal diet during the prenatal 
period, breastfeeding, later diet, weight, and allergy that have an impact on the development 
of asthma.  
B.4.  Allergic vs. non-allergic asthma 
It remains unclear through what sort of mechanism obesity and asthma may be 
related. As noted above, both asthma and obesity are associated with inflammation, as 
indicated by higher levels of serum leptin78, 147 and CRP.79, 90 Inflammation due to obesity 
may be a factor in the development of asthma.  
The relationship between obesity and atopy has been less often examined, but a few 
studies have shown obesity to be related to allergy or higher IgE levels,10-12 while others 
have not.13-15 Asthma is often considered to be an allergic disease, and while there is 
certainly a large allergic component to asthma, recent research estimates that only about 
50% of asthma in the U.S. is attributable to atopy.16  
Two recent studies in adults have examined exactly the question of whether obesity 
is more strongly related to non-atopic than to atopic asthma. In an Australian study of 4,060 
men and women, an increased risk for asthma was found for those with central obesity 
(measured by waist circumference and waist/hip ratio) who were non-atopic.148 In a cross-
sectional survey of more than 86,000 Canadian adults, BMI was associated with asthma in 
both allergic and non-allergic women, but the odds ratio was stronger in non-allergic women 
(1.85 vs. 1.21).15 In men, the corresponding odds ratios were 1.30 and 1.18, with only the 
relationship in non-allergic men being significant. The authors note that women have a 
greater prevalence of non-allergic asthma than men (at least in this Canadian population) 
and that this may account for the stronger obesity-asthma relationship seen in many studies.  
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In a study using NHANES III data, both the prevalence of asthma and of atopy rose 
significantly with increasing quartiles of BMI among children age 4-17. Atopy in this study 
was defined as being a positive response to at least one allergen measured using skin prick 
testing. After adjustment for confounding, however, only the relationship with asthma 
remained significant. BMI was also not related to serum eosinophil counts, a marker for 
allergy.115 The effects were not modified by sex or ethnic group. The authors propose that 
the obesity effect on asthma is mediated by mechanical properties associated with obesity 
or with systemic inflammation rather than by allergic inflammation.  
 
  
Chapter III.  Research Aims and Hypothesis 
 
 
Heavier individuals seem more likely to have asthma, prospective studies suggest 
that overweight and obesity precede the development of asthma, gender differences have 
been observed for the relationship between obesity and asthma (usually, but not always, 
being found to be stronger for women than for men), and it is not known what sort of 
mechanism drives the relationship between obesity and asthma (though speculation leans 
toward an inflammatory mechanism rather than an allergic one). 
Although a lot of work has previously been done in this area, there are still some 
unanswered questions. Perhaps the most important is whether obesity is related to 
atopy/allergy or operates through an entirely different inflammatory pathway to influence the 
development of asthma. Because the recent allergy module of the NHANES contains a 
large IgE panel, including total IgE, for a large number of children it provides a new and 
exciting opportunity to examine exactly this question.   
Many previous studies, including previous work in NHANES6, 115 have defined atopy 
based on skin prick tests. This evaluation is always limited by the number of tests 
performed. NHANES III performed skin prick tests for 10 allergens. The allergens chosen 
(Alternaria, rye grass, ragweed, Russian thistle, white oak, cat, German cockroach, dust 
mites, and peanuts) reflect some of the most common allergies in the U.S., but certainly 
some participants could have been allergic to something that was not tested. Specific IgE 
levels have this same limitation, but total IgE provides a measure of the complete allergic 
propensity of the individual.  
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In addition, NHANES III only skin tested children age 6 and above, whereas 
NHANES 2005-2006 has IgE levels for children starting at age 1. This will allow examination 
of effects at younger ages, and also allow for an examination of any modification of the 
effect of overweight on atopy by infant feeding.  
In the causal diagram in Figure 2, I suggest that overweight can operate through two 
different pathways in its effect on asthma -- one pathway via inflammation and the other via 
atopy. This arrow for atopy is drawn with a dashed line because it is unclear whether this 
effect exists. Infant feeding method, diet in general, and physical activity are shown to be 
influencing overweight status. Socio-demographic factors, such as the age, education, and 
race of the mother are shown to be influencing infant feeding method. The mother’s 
asthma/allergy status is also shown to be a factor in the infant feeding decision.  Smoking is 
shown to be related to infant feeding and to respiratory infections, and also to have a direct 
effect on asthma. Genetic factors influence the mother’s asthma/allergy status, and are also 
shown to have a direct effect on asthma and atopy in the child. Diet is theorized to have a 
direct effect on atopy, but only through this indirect pathway on asthma; while physical 
activity is theorized to have an effect on asthma, but not atopy. Infant feeding is shown to 
have an effect on asthma through the atopic pathway, and also shown to be mediated by 
respiratory infections. Respiratory infections can lead to atopy by affecting immune system 
experience and function, and can directly cause asthma through insult to the child’s 
developing lungs.  
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The recent allergy module of the 2005-2006 NHANES contains allergy symptom 
measures and IgE levels for 3,387 children and young adults age 2 to 19. This large dataset 
of serum allergy markers is the largest ever collected on children. These data provide an 
excellent opportunity to look for evidence that overweight in children is related to allergy. 
The present analysis examines the effect of childhood overweight on allergy and asthma 
using data from the United States National Health and Nutrition and Examination Survey.  
This project will examine the relationship between obesity/overweight and asthma 
and allergy in U.S. children ages 2-19 using data from the National Health and Nutrition 
Examination Survey (NHANES). The specific aims are: 
1. To determine if there is a relationship between overweight and total and specific IgE 
levels and allergic symptom outcomes among U.S. children ages 2-19. 
2. To examine the effect of overweight on asthma outcomes among children 2-19 in a 
nationally representative sample of U.S. children from 1999-2006, and to use the 
2005-2006 data to examine the hypothesis that the effect of overweight on asthma is 
different depending on whether the child also is atopic.  
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3. To examine whether the relationship between overweight and asthma is modified by 
infant feeding method or by atopy.  
4.  
  
Chapter IV.  Methods 
 
A.  The National Health and Nutrition and Examination Survey 
 
These questions were explored using data from the US National Health and Nutrition 
Examination Survey (NHANES) collected from 1999 through 2006. The NHANES is a 
nationally representative survey conducted periodically in the United States, and the 
resulting data are publicly available. The first NHANES was conducted in 1971-1975. 
NHANES II and NHANES III were conducted in 1976-1980 and 1988-1994, respectively, 
with each round becoming progressively more comprehensive. Since 1999, NHANES has 
taken a somewhat different approach, with smaller numbers of persons surveyed in two-year 
cycles, but maintaining general consistency in data collection across cycles, so that datasets 
can be combined to explore many questions. In these recent surveys, all data is collected 
directly into electronic media, decreasing the amount of time needed to release the cleaned 
datasets to the public. The primary objectives of NHANES are to estimate the national 
prevalence of certain diseases and their risk factors, and to monitor changes in these over 
time. There is a special emphasis on the health effects of diet and nutrition. 
B.  Study Population 
 
The target population of NHANES is the civilian, non-institutionalized population of 
the US. Each survey round has typically oversampled persons believed to be at increased 
health risk – low-income persons, adolescents age 12-19, persons age 60+, African 
Americans and Mexican Americans. Weights are supplied with the public use dataset so 
that estimates can be produced that reflect the US population distribution and can be 
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considered to be nationally representative. Table 1 shows the population age 2-19 by age 
group, race/ethnicity, and survey round that completed the medical examination. 
 
Table 1.  Distribution of NHANES 1999-2006 sample of persons age 2-19 who attended the 
medical examination. 
 Age Group Total 
1999-2000 2-5 6-10 11-14 15-19  
Mexican American 275 355 478 601 1709 
Other Hispanic 45 44 48 68 205 
Non-Hispanic White 206 193 230 278 907 
Non-Hispanic Black 203 258 330 362 1153 
Other/Multiracial 39 29 34 67 169 
Total 768 879 1120 1376 4143 
2001-2002      
Mexican American 254 277 338 472 1341 
Other Hispanic 60 44 47 72 223 
Non-Hispanic White 314 292 335 443 1384 
Non-Hispanic Black 270 334 376 442 1422 
Other/Multiracial 53 46 42 60 201 
Total 951 993 1138 1489 4571 
2003-2004      
Mexican American 242 247 312 422 1223 
Other Hispanic 44 24 34 41 143 
Non-Hispanic White 259 218 264 391 1132 
Non-Hispanic Black 266 296 361 499 1422 
Other/Multiracial 54 47 46 38 185 
Total 865 832 1017 1391 4105 
2005-2006      
Mexican American 356 315 328 449 1448 
Other Hispanic 54 27 25 40 146 
Non-Hispanic White 271 256 231 372 1130 
Non-Hispanic Black 268 265 338 481 1352 
Other/Multiracial 59 70 51 65 245 
Total 1008 933 973 1407 4321 
      
 
The NHANES uses a stratified, multi-stage probability sampling design. The stages 
of sampling are 1) Primary Sampling Unit (PSU) which is usually a county or block of 
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contiguous (low-population) counties; 2) segments within PSUs (blocks or clusters of 
households); 3) households within segments; 4) one or more participants within households. 
Eligible persons age 16 or over are interviewed directly, while interviews for those under 16 
are done with a proxy. All persons who complete the household interview are invited to 
participate in the Medical Examination component of NHANES. Most of the health 
examinations are conducted in mobile examination centers – trailers outfitted with all the 
necessary examination equipment. Over the 4 rounds of NHANES from 1999-2006, 17,140 
children and adolescents age 2-19 completed both the interview portion of the survey and 
the physical examination.  
All of the NHANES data that is not collected at the medical examination is collected 
by questionnaire. For children under age 16, the questionnaire information is collected from 
a proxy respondent, typically a parent. The medical examination data includes 
anthropometric measurements, a DXA scan, and laboratory data from assays done on blood 
drawn at the visit. Other medical information, including medical histories and symptom 
information are collected during an interview.  
Specific questionnaires and medical components of the NHANES vary by age and 
survey round. Data availability for the three main components of these analyses are listed 
below. Details regarding the variables used are available in Table 2. 
C.  Data Availability 
C.1.  Asthma Outcomes 
All participants, one year of age or older, in all cycles, were administered the Medical 
Conditions questionnaire which asks if the sample person has ever been told by a health 
professional that they have asthma. For those with such doctor-diagnosed asthma, there is 
further information on age (in years) of diagnosis of asthma, current asthma, experience of 
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asthma attacks in the past 12 months, and emergency room visits for asthma in the past 12 
months.   
The Respiratory Health and Disease questionnaire collects information on all 
participants over age 1 on wheezing symptoms and health care and medication use for 
wheezing attacks. Sample persons age 6 and over are asked how much time they missed 
from work or school due to wheezing.  
C.2.  Allergy Outcomes 
The questionnaire that was added to the NHANES for Allergic Diseases Module in 
the 2005-2006 cycle asks about previous diagnoses of hay fever, eczema, and allergies. For 
those reporting a diagnosis, further questions are asked regarding age at diagnosis and 
occurrence of symptoms over the past year. This analysis uses current symptoms – those 
occurring in the previous 12 months. 
Participants aged 1 year and older were eligible for total and allergen-specific serum 
IgE testing. Blood samples were drawn and processed in the Mobile Examination Center 
and shipped to a laboratory where they were analyzed for total and allergen-specific IgE 
using the Pharmacia Diagnostics ImmunoCAP 1000 System (Kalamazoo, Michigan).  A 
detailed description of the laboratory method can be found at NHANES 2005-2006 web 
page (http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/al_ige_d.pdf). Total IgE is 
available for 3,482 (81%) of the children age 2-19. Because smaller quantities of serum 
were available for young children, the number and type of allergen-specific IgE tests 
performed varied by age.  Children aged 1 to 5 years were tested for total IgE as well as 
specific IgE to dust mite (D. farinae and D.  pteronyssinus), cat, dog, cockroach, alternaria, 
peanut, egg, and milk. Sample persons age 6 and above also have specific IgE 
measurements for ragweed, ryegrass, bermuda, white oak, birch, shellfish, aspergillus, 
thistle, mouse, and rat.   
 29
Atopy has been defined as the genetic propensity to develop immunoglobulin E (IgE) 
antibodies in response to exposure to allergen;149 allergic hypersensitivity that affects 
different parts of the body that do not come in contact with allergens, substances that trigger 
the body's allergic reaction;150 and a genetic predisposition toward the development of 
immediate hypersensitivity reactions against common environmental antigens, most 
commonly manifested as allergic rhinitis but also as bronchial asthma, atopic dermatitis, or 
food allergy.151 The common features of these definitions are 1) production of IgE 
antibodies, and 2) that the IgE is produced in response to an allergen. Following these 
definitions, atopy has been defined in these analyses as a positive response (≥ 0.35 kU/L) to 
at least one of the allergens tested. In order to be included in the analyses for atopy, the 
individual had to have information for the full panel of allergens (9 allergens for those under 
age 6, and 19 for those age 6-19). Atopy information is available for 3,387 children (82%) in 
this age range. 
C.3.  Weight and Body Measurements 
All participants who attended the medical examination had their weight and height 
measured, which is then used to calculate Body Mass Index (BMI) as weight in kilograms 
divided by height in meters squared.  
In adults, a person with a BMI over 25 is considered overweight and a person with a 
BMI over 30 is considered obese. These values cannot be used to characterize overweight 
in children however, as normal BMI values are generally much lower and change with age. 
The BMI curve typically follows a J-shape, hitting a low point at around 5 or 6 years of age 
and then steadily increasing until children attain their adult height. This change in BMI in 
children is termed the “adiposity rebound.”152 Thus, in children BMI is typically compared to 
normal curves (stratified by sex) and calculated as a percentile for age. Previous rounds of 
NHANES, combined with other datasets, have been used to create growth curves for US 
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children age 2-20, and the CDC recommends using the percentile of BMI for age to 
characterize overweight in children.153 Children at the 85th percentile of BMI for age are 
considered overweight and those at or above the 95th percentile are considered obese.154  
C.4.  Infant feeding 
Infant feeding information was collected in the NHANES for all children age 6 and 
under at the time of the survey. All of the infant feeding data is collected by self-report. The 
proxy respondent, typically the mother, is asked whether the child was ever breastfed or fed 
breastmilk, and if so, when other foods or liquids (other than water) were introduced and 
when breastfeeding stopped completely. Although self-report data, potentially looking back 
over 5 years, for breastfeeding history are not ideal, self-report has been shown to be a valid 
and reliable estimate for breastfeeding initiation and duration.155 The reliability of recall 
regarding exclusivity of breastfeeding has been shown to be less satisfactory.156 
C.5.  Potential confounders and other variables 
The potential for confounding was examined for sex, race/ethnicity, age of the child, 
household income and, where possible, education of the family head (this variable is only 
available in 2005-2006 data). In analyses using several rounds of NHANES data, survey 
round was also adjusted. 
Birthweight was also considered as a potential modifier and as a confounder, as 
lower birthweight has been shown to be associated with higher percent body fat in 
childhood157 and with childhood asthma.158 As the risk of low birthweight on asthma may be 
due to early insults to the developing lung subsequent to prematurity, effect measure 
modification was examined first. No effect measure modification was observed, so low 
birthweight children were retained in the analyses and birthweight was considered as a 
confounder only.  
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 Two other potentially important confounders for which there is data in the NHANES 
are diet and physical activity. Both are obviously highly associated with weight. For all 
children ages 2-19 (only up to age 15 in 1999-2002) there are questions regarding the 
number of hours spent watching TV/videos and spent on the computer. These were 
examined as confounders. In addition, there is a question asking how many times per week 
the child engages in vigorous physical activity. For children ages 12-15 there are more 
detailed questions about the types of physical activity they participate in, such as sports or 
running, bicycling, playing Frisbee, and long list of other activities. For this analysis, the 
number of times vigorous activities were reported were summed and recalculated as a 
weekly rather than a monthly total to make this information comparable to that for the 
younger children.   
Lastly, NHANES laboratory files do not contain information about serum leptin; 
however, serum levels of C-reactive protein, another inflammatory marker, are available. If 
asthma is related to obesity through an inflammatory pathway, C-reactive protein may be on 
the causal pathway between obesity and asthma, or it may be a marker for systemic 
inflammation that is part of the causal pathway. This may be best tested in this cross-
sectional data by examining whether BMI confounds the relationship of CRP to atopy and 
asthma. 
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Table 2.  NHANES variables for the examination of obesity and asthma/allergy. 
 
Variable Source Details Coding Available in Years Available for Age 
Exposure Variables  
Body Mass 
Index 
Medical Exam 
– measured 
weight and 
height 
Weight/Height2 Dichotomized as 
<>95th percentile for 
age and sex; 
Also continuous z-
score 
1999-2006 Measurements for 
all ages 2+ 
months. BMI z-
scores for age 2-
20. 
Outcome Variables 
Current asthma Survey Do you still have asthma? 
(Only asked when affirmative 
answer to ever having a 
diagnosis of asthma) 
Dichotomous 1999-2006 Age 1+ 
Asthma attack Survey During the past 12 months, 
have you had an episode of 
asthma or an asthma attack? 
Dichotomous 1999-2006 Age 1+ 
ED visit for 
asthma 
Survey During the past 12 months, 
have you had to visit an 
emergency room or urgent 
care center because of 
asthma? 
Dichotomous 1999-2006 Age 1+ 
Wheeze Survey In the past 12 months have 
you had wheezing or 
whistling in your chest?  
Dichotomous 1999-2006 Age 1+ 
Medical visits 
for wheezing 
Survey In the past 12 months how 
many times have you gone to 
the doctor’s office or the 
hospital emergency room for 
one or more of these attacks 
of wheezing or whistling? 
Dichotomized to any 
vs. none 
1999-2006 Age 1+ 
Missed school 
or work due to 
wheezing 
Survey During the past 12 months, 
how many days of work or 
school did you miss due to 
wheezing or whistling? 
Dichotomized to any 
vs. none 
1999-2006 Age 6-69 
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Allergy 
symptoms 
Survey During the past 12 months, 
have you had any allergy 
symptoms or an allergy 
attack? 
Dichotomous 2005-2006 Age 1+ 
Hay fever 
symptoms 
Survey During the past 12 months 
have you had an episode of 
hay fever? 
Dichotomous 2005-2006 Age 1+ 
Eczema Survey During the past 12 months 
have you had an episode of 
eczema? 
Dichotomous 2005-2006 Age 1+ 
Total IgE Laboratory  Dichotomized <>100 
kU/L 
2005-2006 Age 1+ 
Specific IgE Laboratory D. farinae (dust mite) 
D. pteronyssinus (dust mite) 
Cat 
Dog 
Cockroach 
Alternaria (mold) 
Peanut 
Egg 
Milk 
Ragweed 
Ryegrass 
Bermuda 
White oak 
Birch 
Shellfish 
Aspergillus (mold) 
Thistle 
Mouse 
Rat 
Dichotomized <>0.35 
kU/L for each 
allergen 
 
Also as yes/no vars: 
 
Pos response to any 
allergen 
 
Pos response to any 
indoor allergen 
 
Pos response to any 
outdoor allergen 
 
Pos response to any 
food allergen 
2005-2006 Age 1+ 
  “ 
  “ 
  “ 
  “ 
  “ 
  “ 
  “ 
  “ 
Age 6+ 
  “ 
  “ 
  “ 
  “ 
  “ 
  “ 
  “ 
  “ 
  “ 
Potential Modifiers and Confounders 
Ever breastfed Survey Was [child] ever fed 
breastmilk? 
Dichotomous 1999-2006 Age 0-6 
Duration of Survey How old was [child] when Dichotomized to <> 4 1999-2006 Age 0-6 
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exclusive 
breastfeeding 
he/she was first fed 
something other than 
breastmilk or water? 
months 
Duration of any 
breastfeeding 
Survey How old was [child] when 
he/she completely stopped 
breastfeeding or being fed 
breastmilk? 
Dichotomized to <> 4 
months 
1999-2006 Age 0-6 
Race/ethnicity Survey Recoded by NHANES: 
Non-hispanic white 
Non-hispanic black 
Mexican American 
Other Hispanic 
Other, including multi-racial 
Categorical 1999-2006 All ages 
Household 
income 
Survey Reported as a range value in 
dollars; recoded by NHANES 
Categorical 1999-2006 All ages 
Poverty Income 
Ratio 
Survey Recoded income based on 
household size and the 
corresponding poverty 
threshold 
Continuous 
Range: 0-5 
1999-2006 All ages 
Education of 
household 
head 
Survey What is the highest grade or 
level of school you completed 
or the highest degree you 
have received? 
Categorical: 
Less than HS 
HS, incl. GED 
More than HS 
2005-2006 All ages 
Birthweight Survey How much did [child] weigh at 
birth? 
Continuous 1999-2006 Age 0-15 
Low birthweight Survey Did [child] weigh more than 
5.5 lbs or less than 5.5 lbs? 
(asked of those who could 
not provide an actual weight) 
Dichotomous 1999-2006 Age 0-15 
Household 
smoking 
Survey Does anyone who lives here 
smoke cigarettes, cigars, or 
pipes anywhere inside this 
home? 
Dichotomous 1999-2006 All ages 
ETS exposure Laboratory Serum cotinine  Continuous or 
dichotomize <> 30 
1999-2006 Age 3+ 
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Physical 
activity 
Survey Over the past 30 days, on 
average how many hours per 
day did you sit and watch TV 
or videos? 
Categorical: 
None 
< 1 hour 
1, 2, 3, 4, 5 hours or 
more 
1999-2002 
2003-2006 
Age 2-15 
Age 2+ 
Physical 
activity 
Survey Over the past 30 days, on 
average how many hours per 
day did you use a computer 
or play computer games? 
Categorical: 
None 
< 1 hour 
1, 2, 3, 4, 5 hours or 
more 
1999-2002 
2003-2006 
Age 2-15 
Age 2+ 
Physical 
activity 
Survey How many times per week do 
you play or exercise enough 
to make you sweat and 
breathe hard? 
Continuous 1999-2006 Age 2+ 
Vitamin D Laboratory  Continuous 2000-2002 
2003-2006 
Age 6+ 
Age 1+ 
Vitamin C Laboratory  Continuous 2003-2006 Age 6+ 
Vitamin E Laboratory  Continuous 1999-2002 
2003-2006 
Age 3+ 
Age 6+ 
Vitamin A Laboratory  Continuous 1999-2002 
2003-2006 
Age 3+ 
Age 6+ 
Carotenoids Laboratory  Continuous 1999-2002 
2003-2006 
Age 3+ 
Age 6+ 
C-reactive 
protein 
Laboratory  Continuous 1999-2002 
2003-2006 
Age 3+ 
Age 1+ 
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D.  Statistical Methods and Data Analysis 
D.1.  Sample Size and Power 
For Aim 1, which uses only the last round of the survey, there are 4,111 children age 
2-19 normal weight or above with allergy symptom data. Assuming that even 1 in 6 children 
are overweight (remembering that national prevalence is now 19%1), and the baseline risk of 
atopy is 50%,6 I have 99% power for overall analyses, and 96% power for analyses stratified 
by gender, to detect a risk ratio for overweight of 1.2. There are somewhat fewer 
observations for analysis of atopy (3,387), but there is still 92% power to detect a risk ratio 
of 1.2.  
Aim 2 uses the entire database of children surveyed since 1999 (16,074 children age 
2-19) to look at the effect of obesity on current asthma. Using the same assumption about 
obesity prevalence and assuming that the baseline risk for asthma is 8%,159 I have 85% 
power to detect a risk ratio for overweight of 1.2 in overall analysis and 88% power to detect 
a risk ratio of 1.3 in analyses stratified by gender  
The second part of Aim 2 stratifies the analysis above by atopy. Decomposing the 
tables in Arbes et al.16 gives a risk for asthma of 7.5% among atopic individuals and of 2.5% 
among non-atopic individuals. Assuming that half of the 3,387 children are allergic and 1 in 
6 are overweight, as above, I have 90% power to detect a risk ratio of 1.75 in the atopic 
children, but only 80% power to detect a risk ratio of 2.2 in the non-atopic children.  
Aim 3 is underpowered, especially for the atopy outcome. But Aim 3 is a secondary 
aim, and is being examined to see if there is any signal that the effect of breastfeeding on 
asthma may be mediated by effects on obesity or atopy.   
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D.2.  Overview of Analytic Approach 
The analysis of the relationship between obesity and asthma has three pieces. The 
first piece of this analysis used only data from the recent 2005-2006 NHANES survey and 
examined the relationship between overweight and allergic outcomes, including total and 
specific IgE levels. Specific variables used for exposure and outcome are discussed below. 
The second analysis began by using all four recent rounds of the NHANES survey 
(1999-2006) to look at the effect of overweight on report of current asthma. This analysis 
was then further refined to look at the effect of overweight on atopic vs. non-atopic asthma. 
Because this refinement required the IgE data, it again used only the 2005-2006 data.  
The third analysis examined infant feeding and used a somewhat different sample – 
children age 1-6 – because infant feeding information is only available up to age 6. This 
analysis focused on the protective effects of breastfeeding against obesity, atopy, and 
asthma and effect measure modification of the obesity-asthma relationship by obesity and 
by atopy. 
The NHANES sample was selected using a known sampling probability for each 
sample person. When the correct sample weights are applied, results can be considered to 
be representative of the U.S. population. In addition, the stratified, multi-stage probability 
sampling design requires special techniques or software to obtain correct variances and 
confidence intervals. All analyses were done with either SAS survey procedures or with 
SUDAAN, both of which can account for the survey design. 
D.3.  Detailed Statistical Methods  
Aim 1: Overweight children age 2-19 are more likely than normal weight children to have 
total and specific IgE levels indicating atopy and are more likely to report allergy symptoms, 
hay fever and eczema. 
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Because underweight has been associated with increased risk for allergic disease,160 
we excluded 144 children who were less than the 5th percentile of BMI for their age and sex 
(3.4%). Of the 4,125 children and adolescents above this cut-off, 4,111 have data on allergy 
symptoms and 3,387 have data for atopy. 
The effect of weight in two categories, overweight and obese, on total IgE was 
calculated as the ratio of the geometric means. Total IgE has a skewed distribution, so the 
variable was logged and the geometric means calculated. The geometric mean ratio is 
simply the difference on a log scale. In addition, the continuous dose response between BMI 
percentile-for-age and total IgE levels was examined. The effect of the weight categories on 
the prevalence odds of atopy was examined using logistic regression. Atopy was defined as 
a positive test (≥ 0.35 kU/L) to any of the allergens tested. In order to be included in the 
analyses for atopy, the individual had to have information for the full panel of allergens (9 
allergens for those under age 6, and 19 for those age 6-19).  In addition, dichotomous 
variables were defined for a) a positive test to any food allergen, b) a positive test to any 
inhalant allergen, c) a positive test to any perennial allergen, and d) a positive test to any 
seasonal allergen. Each allergen-specific IgE was also examined individually for its 
relationship to atopy. 
Logistic regression was also used to look at the relationship of overweight and obese 
categories on allergic outcomes among the 4,111 children with symptom data. The primary 
outcome was the occurrence of allergy symptoms or attacks in the past year (yes/no). The 
occurrence of hay fever and eczema were also examined (also as yes/no variables).  
 
Aim 2; Hypothesis 1:  Overweight children age 2-19 are more likely than normal weight 
children to have asthma. 
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The effect of overweight and obesity on current asthma and the other outcomes, as 
defined above, was examined using a logistic regression model. Results are presented for 
16,074 children for whom current asthma status is available in the complete 1999-2006 
dataset. This analysis excluded 581 children (3.5%) that were less than the 5th percentile for 
their age and sex. The association of continuous BMI percentile-for-age with current asthma 
was also examined using logistic regression, with a 1-standard-deviation increase in the BMI 
z-score as the exposure. Results were plotted using a scatterplot smoothing technique.161  
Potential modification of the effect of overweight on asthma was examined for sex 
and for age and race/ethnicity, separately for boys and girls. A p-value for the interaction 
term < 0.15 was considered evidence of interaction. No effect measure modification was 
observed for these factors. 
 
Aim 2; Hypothesis 2:  The effect of overweight on asthma among children age 2-19 is 
different depending on whether the child also is atopic.  
 Atopic asthma was defined as an affirmative report of current asthma in 
conjunction with atopy, defined as any positive allergen-specific IgE result. Non-atopic 
asthma was defined as an affirmative report of current asthma with no positive IgE tests. 
Effect modification was examined in a logistic regression model stratified by atopy for the 
2005-2006 dataset (3,387 children with atopy information).  A p-value < 0.15 was 
considered evidence of effect modification. 
 
Aim 3. The relationship between breastfeeding and asthma is modified by overweight and/or 
atopy.  
Breastfeeding may protect against overweight, atopy and asthma . These effects 
may be independent, or there may be a synergistic effect such that the effects of 
breastfeeding and overweight on asthma may be more than additive. This examination for 
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asthma was done on a subsample of the population, because breastfeeding information is 
only available for children up to age 6.  
Because BMI percentile-for-age values begin at age 2, this analysis included 
examination of weight-for-length percentiles. Weight-for-length is recommended for 
assessing obesity in children under age 2 and in preschool children, with the 95% percentile 
being the criterion for obesity.154 For 2-6 year-olds, both weight-for-length and BMI-for-age 
were calculated and the obesity classifications were compared for each year of age. For 2-
year-olds there were more missing values for BMI-for-age than for weight-for-length, which 
is due to fewer 2-year-olds having their standing height measured. Thus, weight-for-length 
was used to determine obesity in the 1- and 2-year-olds, and BMI-for-age was used for the 
3-6 year-olds.  
In addition to categorizing children as having ever been breastfed (yes/no), the 
effects of exclusivity and duration of breastfeeding were also examined, dichotomized at 4 
months in order to compare with previous NHANES work.115  
D.4.  Examination of Effect Measure Modification and Confounding 
Gender differences are important in the literature on obesity and asthma. Thus, 
stratified models were run by sex for both the atopy and asthma outcomes. Except for total 
IgE, important effect modification was not seen, and therefore the stratified tables were 
presented in supplemental data, rather than in the main papers.  
The second hypothesis of Aim 2 involved directly testing for evidence of effect 
measure modification. The question of interest is whether there is a true biological difference 
between two groups of children, e.g. atopic vs. non-atopic. Rothman suggests that such a 
biological effect is best tested as an additive interaction, rather than multiplicative.162, p. 339 
Although analyses for the published manuscripts included only an interaction term in the 
logistic model and testing for the significance of its estimate, I also performed a stratified 
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analysis to test the difference between effects using the interaction contrast ratio (ICR)162, p. 
339 specifically for separate and combined effects of atopy and obesity on current asthma. 
The ICR can be considered to be the “relative excess risk for interaction”. If it is greater than 
1, there is an effect on the outcome for both exposures considered simultaneously that is 
greater than the sum of the effect of each individual exposure.  
Model covariates were selected by examining their univariate associations with the 
exposure and outcome variables. In addition, substantive knowledge and consideration of 
the conceptual diagram were used to select confounders. For models using the allergy 
outcomes, the selected confounders were age of the child, race/ethnicity, sex, the Poverty 
Income Ratio, and household smoking. The Poverty Income Ratio was chosen for use over 
the education of the household head because its associations were stronger, and only one 
SES confounder was considered necessary based on consideration of the conceptual 
framework. Household smoking was chosen over maternal smoking during pregnancy 
because information on smoking during pregnancy was only available for subjects up to age 
15. Again, one smoking variable was considered sufficient. Results for simple age-adjusted 
and fully-adjusted models are shown. 
The models using the asthma and wheeze outcomes used the same set of 
confounders with the addition of the level of vigorous physical activity and adjustment for 
survey round. The breastfeeding models were adjusted for age, sex, race/ethnicity, maternal 
smoking during pregnancy, low birthweight, poverty income ratio and survey round (except 
in models using the atopy variable).  
 
  
 
Chapter V.  Results 
 A.  Manuscript 1:  Association of Obesity with IgE and Allergy Symptoms in Children 
and Adolescents: Results from NHANES 2005-2006 
 
A.1.  Introduction 
The adoposity of the U.S. population has been growing steadily. This is true both for 
adults and children, and it is also the case throughout the developed countries of the world. 
This increase has been most apparent since about 1980. Before that time, only about 5% of 
U.S. children age 6-11 were considered overweight; by 2004 that rate had climbed to nearly 
19%.1 
 Allergic disease has also been on the rise in recent decades. In the U.S. from the 
period 1976-1980 to 1988-1994, the prevalence of skin test reactivity to 6 common allergens 
increased from 22% to 42%.6  Increases in atopy have also been observed in the U.K. and 
Europe.7-9  
Some researchers have shown obesity to be related to allergy symptoms or to higher 
serum IgE levels (a marker for atopy),10-12 while others have not.13-15 In an earlier study using 
NHANES III data, neither the prevalence of atopy (defined by skin test) nor serum eosinophil 
counts (another marker for allergy) were significantly related to increasing quartiles of body 
mass index (BMI) among children age 4-17 in adjusted models.115 No IgE data were 
available in NHANES III.  
Recent research suggests that systemic inflammation, as measured by C-reactive 
protein (CRP) levels, may be important in the relationship between obesity and asthma.92 C-
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reactive protein is a marker for systemic inflammation and is often very high in overweight 
individuals. Differences in CRP levels by atopic status have not been previously examined. 
If CRP is associated with atopy as well, that would suggest a common pathway for the effect 
of overweight on allergic disease and asthma.   
This analysis explores the complex relationships between obesity, serum IgE, and 
allergy symptoms, and examines how CRP plays a role in these relationships, using data 
from the National Health and Nutrition Examination Survey (NHANES) 2005-2006.  
A.2.  Methods 
A.2.1.  Study Population 
The NHANES is a nationally representative survey conducted periodically to assess 
the health and nutritional status of adults and children in the United States. The primary 
purpose of NHANES is to determine the prevalence of major diseases and risk factors for 
those diseases.163 Details of the plan and operation of NHANES may be found online at 
http://www.cdc.gov/nchs/nhanes.htm. Written informed consent was obtained for all 
subjects.    
The NHANES uses a stratified, multi-stage probability sampling design. The stages 
of sampling are 1) Primary Sampling Unit (PSU) which is usually a county or block of 
contiguous (low-population) counties; 2) segments within PSUs (blocks or clusters of 
households); 3) households within segments; 4) one or more participants within households. 
Eligible persons age 16 or older are interviewed directly, while interviews for those under 
age 16 are done with a proxy. All persons who complete the household interview are invited 
to participate in the Medical Examination component of NHANES.  
The target population of NHANES is the civilian, non-institutionalized population of 
the U.S. The NHANES uses a stratified, multi-stage probability sampling design with 
oversampling of persons believed to be at increased health risk. Weights are supplied with 
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the public use dataset so that estimates can be produced that reflect the U.S. population 
distribution and can be considered to be nationally representative. In the 2005-2006 
NHANES, 4,321 children age 2-19 completed both the interview and the medical 
examination components, and 4,269 children had their height and weight measured.  
A.2.2  Allergy Outcomes 
Allergy was determined in two ways: questionnaire about symptoms and serum IgE 
levels. The questionnaire that was added to NHANES in the 2005-2006 cycle asks 
individuals to report previous diagnoses of hay fever, eczema, and allergies. For those 
reporting a diagnosis, further questions are asked regarding age at diagnosis and 
occurrence of symptoms over the past year. This analysis uses current symptoms – those 
occurring in the previous 12 months.  
Participants aged 1 year and older were tested for total and allergen-specific serum 
IgE using the Pharmacia Diagnostics ImmunoCAP 1000 System (Kalamazoo, Michigan).  A 
detailed description of the laboratory method can be found at NHANES 2005-2006 web 
page (http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/al_ige_d.pdf). Total IgE is 
available for 3,617 (84%) of the children age 2-19. Because smaller quantities of serum 
were available for young children, the number and type of allergen-specific IgE tests 
performed varied by age.  Children age 1 to 5 were tested for total IgE and specific IgE to 
dust mite (D. farinae and D.  pteronyssinus), cat, dog, cockroach, Alternaria, peanut, egg, 
and milk. Children and young adults age 6 and above also have specific IgE measurements 
for ragweed, ryegrass, bermuda, white oak, birch, shrimp, Aspergillus, thistle, mouse, and 
rat.  
We definied atopy as a positive response (≥ 0.35 kU/L) to at least one of the 
allergens tested. Analysis of atopy included only individuals with information for the full 
panel of allergens (9 allergens for those under age 6, and 19 for those age 6-19). Of the 
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4,321 children with a physical exam, 703 (16.3%) did not have enough blood for specific IgE 
testing, and 100 (2.3%) did not have a full panel.  
A.2.3.  Weight Measurements 
All participants who attended the medical examination had their weight and height 
measured following a standard protocol. Body mass index (BMI) was calculated as weight in 
kilograms divided by height in meters squared. Sex-specific BMI percentile-for-age was 
calculated using the Centers for Disease Control and Prevention 2000 reference 
standards.153 Children between the 5th and 85th percentile of BMI-for-age were considered to 
be normal weight, those between the 85th and 95th percentile were considered overweight, 
and those at or above the 95th percentile were considered obese, as recommended by the 
American Medical Association.154 
A.2.4.  Other Measures 
The age, sex, and race/ethnicity of the child, as reported in the personal interview, 
were examined as potential confounders and effect modifiers. As measures of socio-
economic status (SES), the highest education level obtained by the household reference 
person (typically the household head) and quartiles of the poverty income ratio (PIR) were 
also examined for their relationship to overweight and atopy. The PIR is the relationship of 
family income to the poverty threshold based on family size and composition.164  
Other potential confounders considered were current household smoking (yes/no), 
maternal smoking during pregnancy (yes/no), birthweight (low birthweight vs. not), and 
several physical activity measures. All children were asked the average number of hours per 
day they spent either watching television or using a computer. For children age 2-11, the 
proxy respondent answered one question about how many times per week the child played 
or exercised enough to sweat or breathe hard. Children age 12-19 answered more detailed 
questions about the specific activities that qualified as moderate or vigorous activity and the 
number of times they did those activities in the past month. For this analysis, the number of 
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times vigorous activities were reported were summed and recalculated as a weekly rather 
than a monthly total to make this information comparable to that for the younger children.  
A.2.5  Statistical Analyses 
Because underweight has been associated with increased risk for allergic disease,160 
we excluded 144 children who were less than the 5th percentile of BMI for their age and sex 
(3.4%). Of the 4,125 children and adolescents above this cut-off, 4,111 have data on allergy 
symptoms and 3,387 have data for atopy. 
The association of overweight with geometric mean total IgE was estimated using 
the ratio of the geometric means in a linear regression model. Logistic regression was used 
to determine the prevalence odds ratio for weight category in relation to atopy, a positive 
test to any food allergen, a positive test to any inhalant allergen (the non-food allergens), a 
positive test to any perennial allergen (dust mite, cockroach, mold, cat, dog, rat, mouse), a 
positive test to any seasonal allergen (trees and grasses), and to the allergic symptom 
outcomes:  the occurrence of allergy symptoms or attacks in the past year (yes/no), the 
occurrence of hay fever symptoms in the past year (yes/no), and eczema (itchy rash coming 
and going for at least 6 months in the past year) (yes/no). In addition, weight was examined 
in relation to each allergen individually. 
The association between continuous BMI percentile-for-age and total IgE was 
examined using linear regression. Data were plotted using a scatterplot smoothing 
technique.161   
Potential modification of the effect of overweight on atopy and allergic outcomes was 
examined for sex, age, and race/ethnicity. A p-value for the interaction term < 0.15 was 
considered evidence of interaction. Stratified models were used to explore associations 
where evidence for interaction was found.  
The potential for confounding was first examined by looking at the strength of the 
univariate associations between potential available confounders and the exposure and the 
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outcome. Age, sex, race/ethnicity, poverty income ratio, and household smoking were 
retained in the adjusted models based on these associations and findings from previous 
studies. Results for both simple age-adjusted and fully adjusted models are shown. C-
reactive protein was found to be associated with both weight and atopy, but cannot be 
treated as a confounder in this relationship as it may be on the causal pathway. Instead, a 
model that assessed the relationship between CRP and atopy and potential confounding by 
BMI examined this possiblility. 
All analyses were performed using the survey sampling weights and SAS survey 
sampling procedures to adjust for the NHANES complex sampling design (Version 9.1.3, 
Cary, NC). Figures were generated using the R system for statistical computing (version 
2.7.0), which also can account for the sampling design.161 
A.3.  Results 
Table 3 shows the distribution of the allergic outcomes in the NHANES 2005-2006 
population age 2-19 by demographic characteristics and other potential confounding 
variables. Total IgE increased with age and was higher among boys. By race/ethnicity, IgE 
was highest in non-Hispanic blacks and lowest in non-Hispanic whites. Total IgE was higher 
with a lower poverty income ratio. There is also a strong relationship between CRP levels 
and total IgE. Total IgE was not related to smoking, birthweight, or physical activity.  
The proportion classified as atopic based on at least one positive allergen-specific 
IgE result follows a similar pattern, with boys being more likely than girls to be atopic and 
non-Hispanic blacks and Mexican-Americans being more likely than non-Hispanic whites to 
be atopic. Children whose mothers smoked during pregnancy were less likely to be atopic 
than children of non-smoking mothers. Atopy was also related to the child’s CRP level.  
Odds of current allergy symptoms are increased at older ages, but reduced for 
Mexican Americans. Children whose household reference person had less than a high 
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school education and for those in the lowest quartile of poverty income ratio also had a 
reduced odds of recent allergy symptoms. Otherwise, report of recent allergy symptoms was 
not highly associated with any of the socio-demographic characteristics. Maternal smoking 
during pregnancy is related to higher odds for allergy symptoms. 
The relationships of the same characteristics to obesity are shown in Table 4. 
Overweight was associated with older age, being non-Hispanic black or Hispanic, lower 
education, smoking, and lower physical activity levels, especially the number of hours of 
television watching. As expected, there is a strong relationship of obesity with CRP levels. 
The correlation between the continuous BMI z-score and the log 10 CRP level is 0.39 (95% 
CI: 0.37, 0.41).  
Table 5 shows the age-adjusted and fully adjusted association of the overweight 
categories with total IgE; atopy; allergy to foods and inhalant allergens; and reported allergy 
symptoms, hay fever, and eczema. Both weight categories were associated with higher total 
IgE in both models. Being in the obese category was associated with higher odds of atopy 
and food allergy, and odds for children in the overweight category were also somewhat 
elevated. Odds for a positive test to inhalant allergens, allergy symptoms, hay fever, and 
itchy rash were not different by weight category in adjusted models. Results for inhalant 
allergens did not differ between perennial and seasonal allergens (data not shown).  
With the exception of total IgE, significant gender differences were not observed; 
however, data are presented by sex in Table 6 in the online supplement.  
Each individual allergen-specific IgE test was also examined using the same 
modeling process (in unadjusted models only). Because of small number of positive results 
for some of the allergens, a number of the estimates are imprecise, and their clinical 
significance is unknown. These data are available in Table 7. 
Figure 3 shows the relationship between continuous BMI percentile-for-age and total 
IgE, stratified by sex. There is a significant linear trend (for a 1 standard deviation increase 
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in the BMI z-score on the log-10 value of total IgE) that is stronger for girls (slope=0.104, 
95% CI: 0.064-0.143, p<0.001) than for boys (slope=0.042, 95% CI: 0.010-0.075, p=0.02) 
(p-value for interaction=0.04).  
Race/ethnicity modified the relationship between overweight and atopy in girls (see 
Table 8). Figure 4 displays the percent of atopy among girls by ethnicity and weight 
category. The association of obesity with atopy was only significant among non-Hispanic 
white and non-Hispanic black girls.  
To examine whether CRP (i.e. systemic inflammation) might be on the causal 
pathway between obesity and atopy, we examined whether CRP was related to total IgE 
with and without adjustment for BMI (Table 9). CRP and total IgE were correlated in age-
adjusted analysis. Further adjustment for race, SES, and smoking attenuated the 
relationship. Adjusting for BMI in addition to socio-demographic factors decreased the model 
estimate by 31% (12% in boys and 70% in girls). Thus, the relationship of CRP to total IgE 
was confounded by BMI.  
A.4.  Discussion 
We found a relationship between overweight and atopy in this population of 
American children age 2-19. This relationship has been observed before, but not 
consistently. Huang et al. found that Taiwanese teenage girls in the highest quintile of BMI 
were more likely to be atopic than girls in the middle 3 quintiles (OR 1.77, 95% CI: 1.15, 
2.73).10 Xu et al. found atopy to be associated with current BMI among Finnish adults.12 
Schachter et al. combined data from 7 epidemiological studies in Australian children and 
found that BMI was associated with atopic status among girls only.11 In all of these studies, 
prick skin tests were used rather than allergen-specific serum IgE. In contrast, the European 
Community Respiratory Health Survey used allergen-specific IgE to define atopy and did not 
find a relationship with BMI among young adults.13  
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Previous work using NHANES III data did not find a significant relationship between 
overweight and atopy in children age 4-17.115 Apart from the different age range, the major 
difference between the studies was that the earlier work used quartiles of BMI rather than 
percentiles of BMI-for-age. In order to relate the present findings more directly to this 
previous work, we analyzed the 2005-2006 data using quartiles of BMI. While we found a 
dose-response for total IgE across quartiles, we observed no relationship with atopy. While 
these models using quartiles of BMI were adjusted for age and sex, the method differs 
substantially from the recommended transformation of BMI to a percentile based on the 
CDC sex-specific growth curves of BMI-for-age.153, 154 The implication is that the CDC 
percentiles and categories of overweight and obese for children are more informative than 
simple BMI for children, and that perhaps, had the NHANES III data been analyzed in this 
manner, the findings might have been more like those presented here.  
For most of the outcomes, the associations were stronger for the obese weight 
category than the overweight category, providing evidence of a dose-response for weight. 
The analysis of continuous BMI with total IgE supports the idea that increased weight is 
associated with increased allergic predisposition.  
Effect modification by sex was observed for total IgE but not the other allergic 
outcomes. Total IgE was elevated for girls (but not boys) in the overweight category, 
whereas it was elevated for boys (but not girls) in the obese category. In addition, the 
relationship of BMI examined as a continuous variable with total IgE was stronger in girls 
than in boys. In girls, the effect on atopy was present among non-Hispanic white and black 
girls, but not Mexican American girls. The mechanism for this difference among racial/ethnic 
groups remains enigmatic, especially given that obesity and atopy were strongly associated 
among Mexican-American boys.  
One limitation of this analysis is that it used BMI to characterize obesity, which is not 
a direct measure of fatness and may misclassify some children, particularly adolescent 
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males, who can be heavier than average due to a larger bone structure or more muscle 
mass.165 Nevertheless, BMI has been shown to correlate well with other measures of 
adiposity. Mei et al. compared BMI to dual x-ray absorbtiometry (DXA) in a pooled dataset of 
3 studies in children and found correlations that ranged from 0.78 to 0.88, and that the area 
under the receiving operating characteristics curve was 0.952.166 DXA to directly measure 
percent body fat was performed in the 2005-2006 NHANES, but those data are not yet 
publically available.  
Odds ratios, as presented in this study, always overestimate the true relative risk, but 
are a reasonably good estimate for rare outcomes.162 Because the prevalence of atopy is 
high in U.S. children (46%), the estimated odds ratio is considerably farther from the null 
than the relative risk. Nonetheless, reported p-values and confidence intervals remain valid. 
Logistic regression was used, however, because the software packages employed to handle 
the complex survey design do not offer a binomial regression alternative.   
The relationship between CRP levels and atopy has not been previously examined. 
Because we found a relationship between CRP levels and atopy in this study, we therefore 
examined whether there was any evidence that inflammation (CRP) could be on the 
pathway between obesity and atopy. As it is inappropriate to control for such an 
intermediate variable as a confounder,162 we tested whether the intermediate (CRP) was 
related to total IgE and whether that relationship was confounded by BMI. We found that 
CRP was positively correlated to total IgE, and that confounding of this relationship by BMI 
was indeed present. This suggests that there could indeed be an inflammatory component 
to the association between BMI and atopy.  
Importantly, because these NHANES data come from a cross-sectional survey, it is 
not possible to assign causality to these associations. In order to understand the true causal 
mechanisms that underlie the relationships between adiposity and development and 
manifestation of atopy and allergic symptoms, it will be necessary to examine inter-
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relationships among overweight, systemic inflammation, atopy, and asthma in a prospective 
fashion.  
NHANES 2005-06 is the largest dataset of serum IgE levels that has ever been 
collected, and it comes from a sample that is generalizable to the population of the U.S. The 
NHANES employs standardized data collection methods, with strict quality control, and 
contains a wealth of data regarding every study subject. Our analysis, using an objective 
assessment of atopy, shows that overweight in children is associated with allergic 
predisposition. Childhood obesity may be the most important health issue facing U.S. 
children today. While an increase in allergy may not be the most consequential health risk 
faced by overweight children, it does provide additional motivation for undertaking the 
difficult challenge to reduce childhood obesity. 
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Table 3. Distribution of total serum IgE, atopy, and recent allergy symptoms by population characteristics, NHANES 2005-2006, 
children age 2-19.  
 
Subject Characteristics N % 
Geometric 
mean total 
IgE (SE) p-value* 
Percent 
(SE)  
atopic† OR (95% CI) 
Percent 
(SE) with  
allergy 
symptoms  OR (95% CI) 
         
Overall 4111  50.4    (2.5)  46.4    (0.9)  18.7    (1.4)  
Age         
2-5 918 21.0  35.2    (3.9) <0.0001 37.5    (2.1) 1.00 14.8    (2.1) 1.00 
6-10 904 28.4  52.9    (3.7)  46.3    (2.5) 1.44 (1.02-2.02) 20.8    (2.3) 1.51 (1.01-2.23)
11-14 929 21.6  50.6    (4.0)  45.2    (2.1) 1.38 (1.07-1.77) 17.4    (1.9) 1.21 (0.81-1.81)
15-19 1360 29.0  59.2    (6.3)  52.1    (2.4) 1.82 (1.32-2.49) 20.6    (2.2) 1.49 (1.09-2.04)
Sex         
Male 2031 51.0  60.8    (3.7) 0.0002 49.4    (1.7) 1.29 (1.09-1.52) 19.1    (1.9) 1.05 (0.82-1.35)
Female 2080 49.0  41.4    (2.7)  43.2    (1.1) 1.00 18.4    (1.6) 1.00 
Race-ethnicity         
Non-Hispanic white 1074 59.6  41.4    (3.0) <0.0001 42.2    (1.5) 1.00 21.8    (2.4) 1.00 
Non-Hispanic black 1291 14.9  83.9    (5.9)  62.2    (1.8) 2.26 (1.82-2.79) 17.5    (1.7) 0.76 (0.50-1.16)
Mexican American 1371 13.3  55.6    (3.2)  47.4    (1.7) 1.23 (1.01-1.51) 10.7    (0.9) 0.43 (0.30-0.63)
Other 375 12.2  66.6    (8.7)  47.6    (3.7) 1.24 (0.90-1.72) 14.0    (2.4) 0.58 (0.34-0.98)
Education (family 
referent)  
 
 
 
    
< 12th grade 1280 18.9  62.6    (4.9) 0.02 46.7    (2.2) 0.99 (0.84-1.17) 9.3     (1.4) 0.38 (0.23-0.62)
12th grade/GED 930 24.7  45.4    (4.6)  46.2    (1.6) 0.97 (0.77-1.22) 19.5    (1.8) 0.88 (0.63-1.24)
> 12th grade 1722 52.9  49.0    (3.4)  46.9    (1.7) 1.00 21.5    (2.2) 1.00 
Poverty Income Ratio 
(quartiles)  
       
1st 1474 24.2  62.9    (3.1) 0.003 49.0    (1.8) 1.11 (0.88-1.39) 13.7    (1.2) 0.52 (0.39-0.69)
2nd 1064 24.2  51.3    (6.0)  44.9    (2.2) 0.94 (0.68-1.29) 19.1    (2.2) 0.77 (0.53-1.12)
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Subject Characteristics N % 
Geometric 
mean total 
IgE (SE) p-value* 
Percent 
(SE)  
atopic† OR (95% CI) 
Percent 
(SE) with  
allergy 
symptoms  OR (95% CI) 
         
3rd 755 24.2  45.4    (3.2)  45.5    (2.1) 0.96 (0.78-1.19) 18.5    (2.5) 0.74 (0.52-1.07)
4th 617 24.1  43.5    (3.2)  46.5    (2.6) 1.00 23.4    (3.0) 1.00 
Missing/unknown 201   3.3  54.0    (9.5)  43.2    (6.0)  19.8    (3.4)  
Any smokers in 
household  
 
 
 
    
Yes 667 16.3 53.5    (5.6) 0.61 44.3    (3.1) 0.90 (0.64-1.25) 20.4    (1.7) 1.13 (0.91-1.40)
No 3398 83.7 49.9    (3.0)  47.0    (1.4) 1.00 18.5    (1.5) 1.00 
Mother smoked during 
pregnancy‡  
 
 
 
    
Yes 436 18.0 50.1    (2.6) 0.74 39.2    (2.7) 0.75 (0.59-0.96) 21.1    (1.9) 1.27 (1.00-1.62)
No 2555 82.0 47.9    (2.6)  46.1    (1.1) 1.00 17.3    (1.6) 1.00 
Birthweight‡         
<2500 g 278 8.0 49.0    (6.3) 0.87 41.4    (3.9) 0.86 (0.60-1.24) 12.9    (2.6) 0.65 (0.37-1.13)
≥2500 g 2692 92.0 48.0    (2.5)  45.2    (1.2) 1.00 18.6    (1.7) 1.00 
Physical Activity         
 0-3 times/wk 1454 32.9  48.2    (4.4) 0.33  45.9    (1.7) 0.85 (0.65-1.10) 19.5    (1.7) 1.08 (0.83-1.40)
 4-6 times/wk 730 19.0  49.8    (5.1)   48.2    (2.4) 0.93 (0.71-1.21) 19.7    (2.0) 1.09 (0.89-1.34)
 7 times/wk 1100 17.9  49.7    (4.9)   43.6    (2.1) 0.77 (0.61-0.97) 17.9    (2.4) 0.98 (0.66-1.43)
 8+ times/wk 752 18.3  57.1    (5.8)   50.1    (2.4) 1.00 18.3    (2.1) 1.00 
Average hours of 
TV/videos  
       
 0 hours/day 531 15.5  49.6    (5.1) 0.29  49.9    (2.5) 1.00 19.0    (2.5) 1.00 
 1-2 hours/day 2002 54.9  47.0    (2.7)   45.2    (1.4) 0.83 (0.66-1.04) 18.4    (2.1) 0.96 (0.66-1.40)
 3+ hours/day 1508 29.7  58.2    (5.2)   46.9    (2.5) 0.89 (0.67-1.16) 19.8    (1.8) 1.05 (0.80-1.39)
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Subject Characteristics N % 
Geometric 
mean total 
IgE (SE) p-value* 
Percent 
(SE)  
atopic† OR (95% CI) 
Percent 
(SE) with  
allergy 
symptoms  OR (95% CI) 
         
Average hours of 
computer use  
       
 0 hours/day 1300 36.6  50.1    (2.8) 0.89  46.0    (1.8) 1.00 20.0    (2.0) 1.00 
 1-2 hours/day 1155 29.9  52.2    (4.0)   46.8    (1.7) 1.03 (0.82-1.29) 20.2    (2.3) 1.01 (0.72-1.42)
 3+ hours/day 1581 33.5  49.6    (3.9)   46.6    (1.5) 1.02 (0.90-1.17) 16.4    (2.0) 0.78 (0.53-1.16)
C-reactive protein§         
Not detectable 860 23.9  42.2    (2.6) 0.0008  42.8    (1.9) 1.00 17.1    (2.3) 1.00 
0.02 – 0.04 g/dL 834 20.8  49.2    (4.7)   42.5    (2.7) 0.99 (0.79-1.24) 18.1    (2.9) 1.07 (0.67-1.69)
0.04 – 0.14 mg/dL 804 18.7  55.0    (3.2)   51.7    (2.6) 1.43 (1.07-1.92) 18.5    (2.1) 1.10 (0.73-1.65)
>0.14 mg/dL 888 19.1  62.5    (5.9)   50.8    (2.4) 1.38 (1.11-1.72) 20.7    (2.3) 1.26 (0.93-1.72)
Missing/unknown 725 17.6  30.6    (8.0) --  35.6    (6.0) -- 19.8    (2.1) -- 
         
 
* Test for linear trend. 
† Atopy defined as at least one positive allergen-specific IgE result. 
‡ Only available for subjects up to age 15. 
§ Values represent tertiles above detection. 
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Table 4. Distribution of overweight by population characteristics, NHANES 2005-2006, children and young adults age 2-19. 
 
Subject Characteristics N 
Percent (SE) 
overweight OR (95% CI) 
Percent (SE) 
obese OR (95% CI) 
     
Overall 4111 14.2   (0.9)  16.6    (1.3)  
Age      
2-5 918 10.7    (1.7) 1.00 11.0    (1.5) 1.00 
6-10 904 12.9    (2.1) 1.32 (0.79-2.21) 15.7    (2.1) 1.56 (0.96-2.55) 
11-14 929 16.0    (2.2) 1.86 (1.24-2.78) 21.3    (3.4) 2.40 (1.51-3.83) 
15-19  1360 16.6    (1.4) 1.85 (1.32-2.59) 18.0    (2.0) 1.95 (1.30-2.92)  
Sex      
Male 2031 14.2    (1.2) 1.02 (0.87-1.21) 17.2    (1.4) 1.10 (0.94-1.30) 
Female 2080 14.1    (0.9) 1.00 15.9    (1.4) 1.00 
Race-ethnicity      
Non-Hispanic white 1074 14.3    (1.3) 1.00 14.1    (1.7) 1.00 
Non-Hispanic black 1291 14.2    (1.1) 1.12 (0.85-1.48) 21.9    (1.6) 1.74 (1.24-2.46) 
Mexican American 1371 16.1    (0.8) 1.34 (1.06-1.70) 23.7    (1.8) 2.00 (1.48-2.72) 
Other 375 11.4    (1.9) 0.78 (0.52-1.16) 14.4    (2.3) 0.99 (0.62-1.58) 
Education (family referent)      
< 12th grade 1280 15.3    (1.9) 1.28 (0.94-1.76) 19.5    (1.4) 1.50 (1.22-1.85) 
12th grade/GED 930 14.9    (1.7) 1.24 (0.86-1.79) 19.2    (1.9) 1.46 (1.15-1.86) 
> 12th grade 1722 13.2    (1.1) 1.00 14.4    (1.5) 1.00 
Poverty Index (quartiles)      
1st 1474 15.0    (1.6) 1.30 (0.87-1.95) 20.4    (1.8) 1.80 (1.31-2.47) 
2nd 1064 13.5    (1.2) 1.11 (0.85-1.46) 18.3    (1.5) 1.53 (0.94-2.50) 
3rd 755 14.9    (2.5) 1.18 (0.75-1.86) 14.2    (2.5) 1.15 (0.69-1.90) 
4th 617 13.1    (1.3) 1.00 13.0    (2.2) 1.00 
Missing/unknown 201 16.0    (2.4)  20.0    (4.2)  
Any smokers in household      
Yes 667 15.2    (2.2) 1.17 (0.88-1.56) 20.0    (2.4) 1.36 (0.97-1.89) 
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Subject Characteristics N 
Percent (SE) 
overweight OR (95% CI) 
Percent (SE) 
obese OR (95% CI) 
     
No 3398 14.0    (0.9) 1.00 15.9    (1.4) 1.00 
Mother smoked during      
Yes 436 13.3    (1.2) 1.04 (0.78-1.39) 19.6    (2.4) 1.39 (1.00-1.92) 
No 2555 13.6    (1.1) 1.00 15.0    (1.5) 1.00 
Birthweight      
<2500 g 278 12.0    (3.8) 0.82 (0.43-1.56) 13.0    (3.3) 0.75 (0.45-1.24) 
≥2500 g 2692 13.6    (0.8) 1.00 16.1    (1.4) 1.00 
Physical Activity      
 0-3 times/wk 1454 13.7    (1.3) 0.81 (0.62-1.04) 21.3    (1.6) 1.57 (1.12-2.20) 
 4-6 times/wk 730 14.3    (1.4) 0.78 (0.50-1.21) 15.0    (2.2) 1.02 (0.75-1.38) 
 7 times/wk 1100 12.3    (2.1) 0.64 (0.37-1.11) 14.1    (1.4) 0.92 (0.56-1.51) 
 8+ times/wk 752 17.8    (2.4) 1.00 14.2    (2.7) 1.00 
Average hours of TV/videos      
 0 hours/day 531 12.4    (2.5) 1.00 8.6    (1.4) 1.00 
 1-2 hours/day 2002 14.2    (1.1) 1.28 (0.79-2.09) 15.6    (1.4) 2.03 (1.37-3.02) 
 3+ hours/day 1508 14.9    (1.2) 1.52 (0.94-2.45) 22.8    (2.5) 3.35 (2.09-5.37) 
Average hours of computer      
 0 hours/day 1300 13.3    (1.4) 1.00 16.1    (1.8) 1.00 
 1-2 hours/day 1155 16.3    (1.7) 1.32 (0.92-1.90) 18.1    (1.9) 1.21 (0.90-1.62) 
 3+ hours/day 1581 13.1    (1.4) 0.98 (0.70-1.35) 15.8    (1.3) 0.98 (0.78-1.26) 
C-reactive protein*      
Not detectable 860 7.9    (0.9) 1.00 1.8    (0.5) 1.00 
0.02 – 0.04 g/dL 834 14.2    (1.3) 2.19 (1.60-3.00) 11.9    (1.9) 8.14 (5.36-12.4) 
0.04 – 0.14 mg/dL 804 19.3    (1.7) 3.82 (2.94-4.97) 23.1    (2.1) 20.2 (10.8-37.9) 
>0.14 mg/dL 888 18.4    (2.6) 4.66 (3.23-6.73) 36.5    (3.4) 40.9 (26.4-63.3) 
Missing/unknown 725 12.5    (1.7)  13.8    (2.2)  
 
* Values represent tertiles above detection. 
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Table 5. Allergic outcomes by weight category (BMI percentile for age), NHANES 2005-
2006, children and young adults age 2-19. 
 
Allergy Outcome 
Measure 
(SE) 
Ratio* (95% CI) 
Unadjusted 
Model† 
Ratio* (95% CI) 
Adjusted  
Model‡ 
    
Total IgE (geometric mean kU/L)    
Normal weight 45.7    (2.6)  1.00 1.00 
Overweight 57.8    (5.1) 1.22 (0.99-1.51) 1.25 (1.02-1.54) 
Obese 66.6    (5.8) 1.40 (1.19-1.66) 1.31 (1.10-1.57) 
Any positive specific IgE result (%)
Normal weight 44.5    (1.3) 1.00 1.00 
Overweight 48.9    (2.6) 1.14 (0.91-1.44) 1.16 (0.93-1.45) 
Obese 51.8    (2.1) 1.28 (1.05-1.58) 1.26 (1.03-1.55) 
Any positive food IgE result (%)    
Normal weight 21.1    (0.9) 1.00 1.00 
Overweight 24.4    (2.0) 1.26 (0.99-1.60) 1.27 (0.98-1.65) 
Obese 29.2    (2.2) 1.61 (1.30-1.98) 1.59 (1.28-1.98) 
Any positive inhalant IgE result (%)    
Normal weight 39.2    (1.4) 1.00 1.00 
Overweight 42.7    (3.2) 1.05 (0.80-1.37) 1.08 (0.83-1.42) 
Obese 45.6    (2.7) 1.18 (0.95-1.48) 1.17 (0.91-1.50) 
Allergy symptoms in previous year (%)    
Normal weight 19.3    (1.5) 1.00 1.00 
Overweight 18.1    (2.0) 0.90 (0.73-1.10) 0.96 (0.77-1.20) 
Obese 17.0    (1.7) 0.83 (0.68-1.02) 0.90 (0.74-1.10) 
Hay fever in previous year (%)    
Normal weight 2.9    (0.7) 1.00 1.00 
Overweight 2.0    (0.9) 0.66 (0.24-1.81) 0.68 (0.23-1.99) 
Obese 3.5    (0.8) 1.19 (0.61-2.32) 1.37 (0.71-2.62) 
Itchy rash in previous year (%)    
Normal weight 6.0    (0.7) 1.00 1.00 
Overweight 8.3    (1.7) 1.50 (0.79-2.85) 1.58 (0.82-3.05) 
Obese 7.9    (1.7) 1.43 (0.96-2.13) 1.50 (0.96-2.32) 
    
 
* The effect measure for total IgE is the geometric mean ratio. The effect measure for all 
percents is an odds ratio.  
 
† Model adjusted for age only. 
 
‡ Model adjusted for age, race, sex, poverty income ratio, and household smoking. 
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Table 6. Allergic outcomes by weight category (BMI percentile for age) and gender, NHANES 2005-2006, children and young adults 
age 2-19. 
 
 Boys (N=2,031) Girls (N=2,080)  
Allergy Outcome 
Measure  
(SE) 
Ratio* (95% CI) 
Unadjusted Model†
Ratio* (95% CI) 
Adjusted Model‡ 
Measure 
 (SE) 
Ratio* (95% CI) 
Unadjusted Model†
Ratio* (95% CI) 
Adjusted Model‡ 
Inter-action
p-value 
        
Total IgE (geometric mean kU/L)        
Normal weight 56.4    (4.2) 1.00 1.00 36.6    (2.3) 1.00 1.00 0.02 
Overweight 57.7    (4.6) 1.02 (0.80-1.29) 1.02 (0.78-1.34) 58.0    (7.8) 1.45 (1.12-1.87) 1.47 (1.16-1.86)  
Obese 84.3   (10.9) 1.47 (1.16-1.86) 1.42 (1.12-1.80) 50.8    (6.9) 1.30 (1.00-1.70) 1.19 (0.89-1.57)  
Any positive specific IgE result (%)       
Normal weight 48.3    (2.2) 1.00 1.00 40.5    (1.2) 1.00 1.00 0.54 
Overweight 50.8    (3.5) 1.08 (0.78-1.48) 1.10 (0.80-1.52) 47.0    (3.5) 1.25 (0.90-1.72) 1.21 (0.86-1.71)  
Obese 52.5    (4.1) 1.12 (0.78-1.61) 1.20 (0.89-1.63) 50.9    (2.3) 1.48 (1.22-1.79) 1.32 (1.06-1.64)  
Any positive food IgE result (%)        
Normal weight 24.3    (1.8) 1.00 1.00 17.8    (0.8) 1.00 1.00 0.62 
Overweight 26.1    (3.4) 1.12 (0.79-1.60) 1.13 (0.80-1.62) 22.7    (2.8) 1.45 (1.01-2.08) 1.44 (0.97-2.12)  
Obese 31.7    (3.6) 1.50 (1.12-2.03) 1.60 (1.16-2.23) 26.2    (2.2) 1.73 (1.38-2.16) 1.56 (1.20-2.03)  
Any positive inhalant IgE result (%)       
Normal weight 43.0    (2.5) 1.00 1.00 35.1    (1.3) 1.00 1.00 0.45 
Overweight 44.3    (4.8) 1.00 (0.64-1.56) 1.01 (0.65-1.57) 41.1    (3.3) 1.14 (0.85-1.51) 1.14 (0.83-1.56)  
Obese 45.5    (4.6) 0.99 (0.67-1.48) 1.04 (0.72-1.52) 45.7    (2.5) 1.43 (1.18-1.74) 1.29 (1.01-1.63)  
Allergy symptoms in previous year (%)       
Normal weight 20.0    (2.1) 1.00 1.00 18.6    (1.6) 1.00 1.00 0.71 
Overweight 17.1    (2.5) 0.83 (0.58-1.18) 0.85 (0.58-1.23) 19.2    (3.2) 0.94 (0.63-1.41) 1.05 (0.66-1.68)  
Obese 17.4    (2.7) 0.85 (0.60-1.20) 0.90 (0.65-1.25) 16.7    (3.0) 0.82 (0.54-1.25) 0.90 (0.57-1.43)  
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 Boys (N=2,031) Girls (N=2,080)  
Allergy Outcome 
Measure  
(SE) 
Ratio* (95% CI) 
Unadjusted Model†
Ratio* (95% CI) 
Adjusted Model‡ 
Measure 
 (SE) 
Ratio* (95% CI) 
Unadjusted Model†
Ratio* (95% CI) 
Adjusted Model‡ 
Inter-action
p-value 
        
Hay fever in previous year (%)        
Normal weight 2.5    (0.7) 1.00 1.00 3.4    (1.4) 1.00 1.00 0.73 
Overweight 1.3    (1.2) 0.52 (0.05-4.99) 0.53 (0.05-5.40) 2.7    (1.3) 0.78 (0.21-2.84) 0.82 (0.20-3.41)  
Obese 2.3    (0.5) 0.92 (0.42-2.01) 0.95 (0.41-2.20) 4.8    (1.5) 1.43 (0.54-3.79) 1.74 (0.67-4.49)  
Itchy rash in previous year (%)        
Normal weight 6.0    (1.0) 1.00 1.00 5.9    (0.8) 1.00 1.00 0.02 
Overweight 4.4    (1.8) 0.77 (0.27-2.20) 0.82 (0.28-2.36) 12.3    (2.1) 2.28 (1.29-4.03) 2.35 (1.30-4.25)  
Obese 8.4    (2.5) 1.60 (0.93-2.75) 1.88 (1.02-3.45) 7.4    (1.7) 1.28 (0.70-2.34) 1.18 (0.62-2.27)  
        
        
 
* The effect measure for total IgE is the geometric mean ratio. The effect measure for all percents is an odds ratio.  
† Model adjusted for age only. 
‡ Model adjusted for age, race, sex, poverty income ratio, and household smoking. 
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Table 7. Positive specific IgE tests by weight category, NHANES 2005-2006, children and young adults age 2-19, overall and by 
gender. 
 
Specific IgE Results 
Normal 
weight 
(reference) Overweight OR (95% CI) Obese OR (95% CI) 
      
Overall       
Percent positive: D. Farinae 17.5    (1.0) 19.6    (2.3) 1.15 (0.86-1.55) 22.3    (2.6) 1.36 (1.04-1.77) 
Percent positive: D. Pteronyssinus 17.4    (0.9) 20.3    (1.9) 1.21 (0.96-1.53) 22.7    (2.3) 1.40 (1.09-1.90) 
Percent positive: Cat 12.1    (1.3) 12.5    (1.8) 1.03 (0.74-1.44) 13.4    (2.1) 1.12 (0.79-1.60) 
Percent positive: Dog 13.9    (0.9) 14.0    (2.1) 1.00 (0.72-1.39) 15.8    (2.6) 1.16 (0.84-1.60) 
Percent positive: Cockroach 8.5    (0.8) 7.2    (1.5) 0.83 (0.53-1.31) 16.2    (1.7) 2.08 (1.56-2.77) 
Percent positive: Alternaria 11.6    (1.4) 10.4    (1.7) 0.88 (0.61-1.27) 10.9    (1.7) 0.93 (0.70-1.24) 
Percent positive: Peanut 9.6    (1.1) 8.4    (1.5) 0.86 (0.55-1.35) 11.8    (1.7) 1.25 (0.83-1.89) 
Percent positive: Egg 5.2    (0.6) 8.7    (1.5) 1.73 (1.13-2.63) 4.7    (1.1) 0.90 (0.54-1.47) 
Percent positive: Milk 10.0    (0.9) 12.3    (2.0) 1.27 (0.98-1.65) 12.0    (1.4) 1.24 (0.95-1.61) 
Percent positive: Ragweed 15.6    (1.8) 15.2    (2.0) 0.97 (0.67-1.40) 22.1    (2.6) 1.54 (1.13-2.08) 
Percent positive: Rye grass 21.6    (1.7) 19.2    (1.6) 0.86 (0.64-1.16) 25.1    (2.1) 1.22 (0.96-1.55) 
Percent positive: Bermuda grass 17.1    (1.9) 17.5    (2.6) 1.02 (0.68-1.55) 20.5    (1.9) 1.25 (0.93-1.68) 
Percent positive: Oak 14.8    (1.5) 12.2    (1.9) 0.80 (0.52-1.22) 17.6    (1.9) 1.23 (0.92-1.64) 
Percent positive: Birch 12.9    (1.0) 10.2    (1.5) 0.77 (0.50-1.18) 14.9    (2.3) 1.18 (0.83-1.68) 
Percent positive: Shellfish 5.1    (0.5) 5.2    (1.7) 1.02 (0.55-1.88) 10.6    (1.3) 2.18 (1.76-2.70) 
Percent positive: Aspergillus 9.6    (1.4) 6.9    (1.6) 0.70 (0.49-1.01) 8.4    (1.2) 0.87 (0.53-1.43) 
Percent positive: Thistle 13.3    (1.6) 10.0    (1.6) 0.72 (0.51-1.04) 14.8    (1.8) 1.13 (0.75-1.72) 
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Specific IgE Results 
Normal 
weight 
(reference) Overweight OR (95% CI) Obese OR (95% CI) 
      
Percent positive: Mouse 1.1    (0.2) 1.9    (0.7) 1.69 (0.67-4.29) 2.6    (0.7) 2.36 (1.11-5.01) 
Percent positive: Rat 1.0    (0.3) 0.8    (0.4) 0.77 (0.23-2.59) 2.1    (0.6) 2.14 (0.94-4.86) 
      
Boys      
Percent positive: D. Farinae 19.4    (1.6) 21.1    (3.2) 1.11 (0.75-1.64) 24.8    (3.9) 1.37 (0.88-2.13) 
Percent positive: D. Pteronyssinus 18.2    (1.6) 22.2    (2.6) 1.28 (0.88-1.87) 25.0    (3.4) 1.50 (0.99-2.27) 
Percent positive: Cat 14.8    (2.0) 16.2    (3.3) 1.11 (0.67-1.85) 16.9    (3.1) 1.17 (0.70-1.95) 
Percent positive: Dog 18.4    (1.9) 18.3    (3.6) 0.99 (0.58-1.70) 17.3    (2.6) 0.93 (0.56-1.52) 
Percent positive: Cockroach 11.2    (1.2) 7.9    (2.0) 0.68 (0.40-1.16) 17.7    (2.8) 1.70 (1.09-2.66) 
Percent positive: Alternaria 14.6    (2.3) 7.1    (1.8) 0.45 (0.25-0.80) 12.2    (2.6) 0.81 (0.53-1.23) 
Percent positive: Peanut 12.7    (1.9) 9.7    (2.9) 0.74 (0.37-1.48) 13.6    (2.4) 1.09 (0.65-1.82) 
Percent positive: Egg 5.4    (1.0) 10.5    (2.7) 2.04 (1.00-4.20) 6.1    (1.5) 1.12 (0.70-1.80) 
Percent positive: Milk 11.5    (1.1) 12.9    (3.4) 1.14 (0.68-1.92) 13.6    (2.6) 1.21 (0.79-1.86) 
Percent positive: Ragweed 19.2    (2.4) 15.1    (3.4) 0.75 (0.41-1.38) 26.0    (5.3) 1.48 (0.97-2.26) 
Percent positive: Rye grass 27.2    (2.5) 20.5    (4.1) 0.69 (0.40-1.18) 26.8    (3.3) 0.98 (0.65-1.46) 
Percent positive: Bermuda grass 21.2    (2.9) 18.2    (4.6) 0.83 (0.42-1.62) 22.8    (3.2) 1.10 (0.70-1.72) 
Percent positive: Oak 18.6    (2.4) 15.7    (3.6) 0.81 (0.43-1.54) 19.2    (3.7) 1.04 (0.70-1.54) 
Percent positive: Birch 16.6    (1.8) 13.4    (3.1) 0.78 (0.40-1.52) 17.0    (4.4) 1.03 (0.61-1.75) 
Percent positive: Shellfish 5.7    (0.9) 4.3    (1.8) 0.74 (0.31-1.79) 10.9    (2.0) 2.02 (1.32-3.07) 
Percent positive: Aspergillus 12.7    (2.3) 5.7    (1.6) 0.41 (0.22-0.79) 9.9    (2.4) 0.75 (0.37-1.52) 
Percent positive: Thistle 17.0    (2.0) 9.5    (1.9) 0.51 (0.29-0.91) 15.9    (2.9) 0.93 (0.56-1.54) 
 63 
Specific IgE Results 
Normal 
weight 
(reference) Overweight OR (95% CI) Obese OR (95% CI) 
      
Percent positive: Mouse 1.1    (0.3) 1.9    (1.0) 1.77 (0.46-6.72) 2.6    (1.0) 2.44 (0.87-6.83) 
Percent positive: Rat 1.2    (0.3) 1.4    (0.8) 1.21 (0.28-5.31) 2.3    (0.9) 2.03 (0.65-6.34) 
      
      
Girls      
Percent positive: D. Farinae 15.4    (1.2) 18.2    (2.3) 1.22 (0.86-1.74) 19.5    (1.9) 1.33 (1.10-1.61) 
Percent positive: D. Pteronyssinus 16.5    (0.9) 18.4    (2.5) 1.14 (0.81-1.61) 20.1    (2.1) 1.28 (1.02-1.60) 
Percent positive: Cat 9.4    (0.9) 8.9    (1.4) 0.95 (0.63-1.42) 9.5    (2.2) 1.02 (0.66-1.56) 
Percent positive: Dog 9.3    (1.2) 9.7    (1.9) 1.05 (0.67-1.66) 14.2    (2.1) 1.61 (1.20-2.16) 
Percent positive: Cockroach 5.7    (0.9) 6.5    (1.5) 1.14 (0.67-1.95) 14.6    (1.3) 2.81 (1.98-4.00) 
Percent positive: Alternaria 8.4    (1.0) 13.5    (2.4) 1.71 (1.11-2.63) 9.3    (1.6) 1.13 (0.72-1.77) 
Percent positive: Peanut 6.5    (0.6) 7.2    (1.6) 1.12 (0.68-1.82) 9.7    (1.9) 1.55 (0.93-2.58) 
Percent positive: Egg 5.0    (0.6) 6.8    (2.1) 1.40 (0.75-2.64) 3.1    (1.4) 0.61 (0.23-1.64) 
Percent positive: Milk 8.4    (1.0) 11.8    (2.3) 1.47 (0.91-2.36) 10.3    (1.6) 1.25 (0.81-1.92) 
Percent positive: Ragweed 11.9    (1.7) 15.2    (2.8) 1.34 (0.89-2.01) 17.7    (2.9) 1.60 (1.10-2.32) 
Percent positive: Rye grass 15.7    (1.9) 18.0    (2.1) 1.18 (0.91-1.53) 23.1    (3.0) 1.62 (1.22-2.13) 
Percent positive: Bermuda grass 12.9    (1.6) 16.8    (2.9) 1.36 (0.92-2.03) 17.9    (2.4) 1.48 (1.10-1.98) 
Percent positive: Oak 10.8    (0.8) 8.9    (1.6) 0.81 (0.55-1.19) 15.7    (2.8) 1.54 (0.95-2.50) 
Percent positive: Birch 9.0    (1.1) 7.3    (1.7) 0.80 (0.50-1.27) 12.4    (2.8) 1.43 (0.85-2.41) 
Percent positive: Shellfish 4.5    (0.7) 6.1    (2.1) 1.36 (0.66-2.81) 10.2    (1.9) 2.39 (1.60-3.56) 
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Specific IgE Results 
Normal 
weight 
(reference) Overweight OR (95% CI) Obese OR (95% CI) 
      
Percent positive: Aspergillus 6.3    (1.0) 8.0    (2.4) 1.30 (0.76-2.22) 6.7     (1.4) 1.08 (0.62-1.88) 
Percent positive: Thistle 9.4    (1.5) 10.4    (3.0) 1.12 (0.67-1.86) 13.5    (2.7) 1.50 (0.90-2.50) 
Percent positive: Mouse 1.2    (0.4) 1.9    (1.1) 1.62 (0.40-6.62) 2.6    (0.9) 2.28 (0.94-5.48) 
Percent positive: Rat 0.8    (0.4) 0.2    (0.2) 0.23 (0.02-2.03) 1.8    (0.9) 2.26 (1.16-4.42) 
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Table 8.  Odds ratios by age group and ethnicity for the association between BMI and atopy, overall and stratified by sex. 
 
Stratum Overall P-value† Males P-value† Females P-value† 
       
Atopy (≥ 1 positive specific IgE)       
       
All subjects  --     
Overweight 1.23 (0.98 - 1.54)  1.16 (0.86 - 1.57)  1.31 (0.96 - 1.79) 0.55 
Obese 1.35 (1.09 - 1.65)  1.18 (0.81 - 1.74)  1.54 (1.27 - 1.86) 0.27 
       
Age       
Overweight vs. normal  0.87  0.90  0.91 
2-5 1.53 (0.75 - 3.12)   1.27 (0.57 - 2.84)  1.96 (0.63 - 6.17)  
6-10 1.17 (0.59 - 2.31)   1.26 (0.60 - 2.64)  1.08 (0.37 - 3.17)  
11-14 1.00 (0.56 - 1.77)   0.90 (0.51 - 1.59)   1.13 (0.52 - 2.44)  
15-19 1.21 (0.82 – 1.78)   1.18 (0.49 - 2.85)  1.34 (0.79 - 2.25)  
Obese vs. normal  0.13  0.08  0.67 
2-5 2.58 (1.45 - 4.60)  4.74 (1.46 - 15.4)  1.39 (0.55 - 3.53)  
6-10 1.03 (0.63 - 1.69)  0.82 (0.39 - 1.70)  1.35 (0.67 - 2.73)  
11-14 1.20 (0.82 - 1.77)  1.12 (0.49 - 2.54)  1.35 (0.96 - 1.88)  
15-19 1.28 (0.88 – 1.88)  0.88 (0.45 - 1.72)  1.94 (1.23 - 3.07)  
Race Ethnicity       
Overweight vs. normal  0.75  0.28  0.82 
Non-Hispanic White  1.29 (0.97 - 1.72)  1.24 (0.86 - 1.80)  1.39 (0.82 - 2.37)  
Non-Hispanic Black  0.98 (0.68 - 1.43)  0.77 (0.59 - 1.02)  1.23 (0.63 - 2.40)  
Mexican American  1.09 (0.70 - 1.70)  1.06 (0.58 - 1.96)  1.11 (0.71 - 1.74)  
Other  1.36 (0.45 - 4.11)  1.43 (0.26 - 7.81)  1.23 (0.36 - 4.16)  
Obese vs. normal  0.76  0.16  0.0004 
Non-Hispanic White  1.28 (0.94 - 1.74)  0.98 (0.56 - 1.73)  1.73 (1.22 - 2.46)  
Non-Hispanic Black  1.41 (1.06 - 1.87)  1.01 (0.64 - 1.58)  1.85 (1.37 - 2.50)  
Mexican American  1.38 (1.07 - 1.78)  1.64 (1.12 - 2.41)  1.09 (0.81 - 1.47)  
Other  1.00 (0.50 - 2.00)  1.73 (1.00 - 2.97)  0.41 (0.16 - 1.04)  
† P-value testing that the association between weight category and outcome (atopy or allergy symptoms) differs across categories
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Table 9. Increase in log 10 total IgE for a log 10 increase in C-reactive protein, unadjusted and adjusted models,  
NHANES 2005-2006, children age 2-19. 
 
 Model 1* Model 2† Model 3‡ Percent 
 Estimate 95% CI Estimate 95% CI Estimate 95% CI Change§ 
        
Overall 0.087 0.036-0.137 0.084 0.032-0.136 0.058 -0.009-0.124 31% 
        
Boys 0.090 0.007-0.172 0.095 0.007-0.183 0.084 -0.010-0.177 12% 
        
Girls 0.091 0.032-0.149 0.066 -0.001-0.133 0.020 -0.070-0.110 70% 
         
 
*Model adjusting for age only. 
†Model adjusting for survey round, age, race, poverty income ratio, and household smoking. 
‡Model adjusting for survey round, age, race, poverty income ratio, household smoking, and BMI z-score. 
§Percent change in model coefficient between Model 2 and Model 3. 
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Figure 3.  Association between BMI percentile-for-age and total IgE by sex, NHANES 2005-2006, children age 2-19. The shaded 
region represents the 95% confidence limits of the data. The black lines represent observations and show where the data lie on the 
BMI distribution. The x axis is plotted as the z-score for BMI-for-age and labeled with the transformation of z-scores to percentiles.  
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Figure 4.  Prevalence of atopy by race and weight status among girls NHANES 2005-2006, 
children age 2-19. The dots reflect the mean prevalence of atopy and the bars represent the 
95% confidence interval. 
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B.  Manuscript 2:  The Association of Obesity with Atopic and Non-Atopic Asthma in 
Children and Adolescents: Results from NHANES 1999-2006 
B.1.  Introduction 
Obesity and asthma prevalence have increased over the last several decades,1, 159 
and studies over the last fifteen years have suggested that obesity is related to asthma.3-5 At 
least 30 cross-sectional and 13 prospective studies have been published between 1999 and 
2006, with nearly all of them showing a positive association between obesity and asthma.5 A 
few of these included children, but the majority were conducted in adults.  
Evidence for an obesity effect in children has been less consistent than that in adults, 
hampered in part by different age ranges examined, different definitions of overweight and 
obesity, and different morbidity endpoints.167 A recent meta-analysis found that the strength 
of the relationship between obesity and asthma in children appeared to be increasing over 
time.75 The authors determined the overall effect of high body weight in childhood was 
associated with a relative risk of 1.5 for subsequent asthma and reported a 6.6% population 
attributable risk for asthma due to being overweight 75 
Several studies have found that obesity was more strongly related to non-atopic than 
to atopic asthma in adults.15, 148 In the National Health and Nutrition Examination Survey 
(NHANES) III dataset, obesity was related to childhood asthma, but only weakly and non-
significantly related to atopy as assessed by skin prick tests.115 No difference was observed 
in the relationship between obesity and asthma by atopic status. This study analyzed BMI by 
quartiles, rather than using the currently-recommended percentiles of BMI-for-age as 
calculated by the Centers for Disease Control.153, 154The authors proposed that the obesity 
effect on asthma was mediated by mechanical properties associated with obesity or with 
systemic inflammation rather than by allergic inflammation but did not examine markers of 
systemic inflammation.  
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C-reactive protein (CRP) is a marker for systemic inflammation and is often very high 
in overweight individuals. Butland et al. found that CRP was related to asthma only among 
non-atopics, and that the association became non-significant when controlling for BMI, 
suggesting that CRP may be on the causal pathway between obesity and asthma.92 
While atopy is a very strong risk factor for asthma, recent research estimates that 
only about 40% of asthma in the U.S. is attributable to atopy.16 It is possible that obesity-
related asthma and atopic asthma have different etiologies, which has implications for 
treatment and prevention of allergic diseases and asthma in children.17  
We examined the association between obesity and asthma in a representative 
sample of U.S. children and young adults. We used allergen-specific serum IgE results to 
distinguish atopic and non-atopic children. We investigated the possibility of an inflammatory 
pathway for the obesity-asthma relationship by examining confounding of the CRP-asthma 
relationship by BMI, following previous work in adults.92  
B.2.  Methods 
B.2.1  Study Population 
The NHANES is a nationally representative survey conducted periodically to assess 
the health and nutritional status of adults and children in the U.S. The primary purpose of 
NHANES is to determine the prevalence of major diseases and risk factors for those 
diseases.163 Details of the plan and operation of NHANES may be found online at 
http://www.cdc.gov/nchs/nhanes.htm.     
The NHANES used a stratified, multi-stage probability sampling design. The stages 
of sampling are 1) Primary Sampling Unit (PSU) which is usually a county or block of 
contiguous (low-population) counties; 2) segments within PSUs (blocks or clusters of 
households); 3) households within segments; 4) one or more participants within households. 
Eligible persons age 16 or older were interviewed directly, while interviews for those under 
 71
age 16 were done with a proxy. All persons who completed the household interview were 
invited to participate in the Medical Examination component of NHANES. The study 
protocols were IRB-approved and all participants (or their parent/guardian) gave written 
informed consent. 
The target population of NHANES is the civilian, non-institutionalized population of 
the U.S. Each survey round oversampled persons believed to be at increased health risk – 
low-income persons, adolescents age 12-19, persons age 60+, African Americans and 
Mexican Americans. Weights are supplied with the public use dataset so that estimates can 
be produced that reflect the U.S. population distribution and can be considered to be 
nationally representative. In the combined 1999-2006 NHANES, 17,140 children age 2-19 
completed both the interview portion of the survey and the medical examination, and 16,717 
children had their height and weight measured.  
B.2.2.  Asthma Outcomes 
All participants age 1 year and older were asked (by proxy if under age 16) whether 
a doctor or other health professional had ever said they had asthma. Those who answered 
‘yes’ were asked a series of additional questions, including whether they still had asthma, 
whether they had experienced an asthma attack in the past year, and whether they had 
been to the emergency department for asthma in the past year. For the purposes of these 
analyses, all those who reported never having asthma were coded as giving ‘no’ responses 
to the subsequent questions. The primary outcome for these analyses is a report of current 
asthma (those with an asthma diagnosis who report still having asthma). 
A separate set of questions were asked about wheezing. Wheeze outcomes used in 
these analyses include a report of wheeze in the past year (yes/no), medical visit for wheeze 
in the past year (yes/no) and missing school or work due to wheeze in the past year 
(yes/no). Again, those who reported no wheezing in the past year were coded as having ‘no’ 
responses to the remaining wheeze questions. 
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B.2.3.  Atopy 
Participants of the 2005-2006 survey age 1 year and older were tested for total and 
allergen-specific serum IgE using the Pharmacia Diagnostics ImmunoCAP 1000 System 
(Kalamazoo, Michigan).  A detailed description of the laboratory method can be found at 
NHANES 2005-2006 web page 
(http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/al_ige_d.pdf). Because smaller 
quantities of serum were available for young children, the number and type of allergen-
specific IgE tests performed varied by age. Children age 1 to 5 years were tested for total 
IgE as well as specific IgE to dust mite (D. farinae and D.  pteronyssinus), cat, dog, 
cockroach, Alternaria, peanut, egg, and milk. Children and young adults age 6 and above 
also have specific IgE measurements for ragweed, ryegrass, bermuda, white oak, birch, 
shrimp, Aspergillus, thistle, mouse, and rat. 
Atopy was defined in these analyses as a positive specific IgE response (≥ 0.35 
kU/L) to at least one of the allergens tested. In order to be included in the analyses that 
stratify by atopic status, the individual had to have information for the full panel of allergens 
(9 allergens for those under age 6, and 19 for those age 6-19).168 
B.2.4.  Weight Measurements 
All participants who attended the medical examination had their weight and height 
measured following a standard protocol. Body Mass Index (BMI) was calculated as weight in 
kilograms divided by height in meters squared. Sex-specific BMI percentile-for-age was 
calculated using the Centers for Disease Control and Prevention 2000 reference 
standards.153 Children between the 5th and 85th percentile of BMI-for-age are considered to 
be normal weight, those between the 85th and 95th percentile are considered overweight, 
and those at or above the 95th percentile are considered obese, as recommended by the 
American Medical Association.154 
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B.2.5.  Other Measures 
The age, sex, and race/ethnicity of the child were examined as potential confounders 
and effect modifiers. As a measure of SES, quartiles of the poverty income ratio (PIR) were 
also examined for their relationship to overweight and asthma. The PIR is the relationship of 
family income to the family’s appropriate poverty threshold based on family size and 
composition.164 Ratios below 1 are below the poverty threshold.  
Other potential confounders considered were current household smoking (yes/no), 
maternal smoking during pregnancy (yes/no), birthweight (low birthweight vs. not), and 
several physical activity measures. All children were asked the average number of hours per 
day they spent either watching television or using a computer. For children age 2-11, the 
proxy respondent answered one question about how many times per week the child played 
or exercised enough to sweat or breathe hard. Children age 12-19 answered more detailed 
questions about the specific activities they did that qualified as moderate or vigorous activity 
and the number of times they did those activities in the past month. For this analysis, the 
number of times vigorous activities were reported were summed and recalculated as a 
weekly rather than a monthly total to make this information comparable to that for the 
younger children.  
B.2.6.  Statistical Analyses 
Because underweight has been associated with increased risk for asthma,160, 169 this 
analysis excluded 581 children (3.5%) that were less than the 5th percentile for their age and 
sex. The effect of overweight and obesity on current asthma and the other outcomes, as 
defined above, was examined using a logistic regression model. Results are presented for 
16,074 children for whom current asthma status is available in the complete 1999-2006 
dataset, and stratified by atopy for the 2005-2006 dataset (3,387 children with atopy 
information).   
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The association of continuous BMI percentile-for-age with current asthma was also 
examined using logistic regression, with a 1-standard-deviation increase in the BMI z-score 
as the exposure. Results were plotted using a scatterplot smoothing technique.161  
Potential modification of the effect of overweight on asthma was examined for sex 
and for age and race/ethnicity, separately for boys and girls. A p-value for the interaction 
term < 0.15 was considered evidence of interaction. No effect measure modification was 
observed for these factors (Table 10). 
The potential for confounding was first examined by looking at the magnitude of the 
univariate associations between potential available confounders and the exposure and the 
outcome. Survey year, age, race/ethnicity, poverty income ratio, household smoking, and 
level of physical activity were related to both the exposure and the outcome and were 
retained in the adjusted models. Results for both simple age-adjusted and fully adjusted 
models are shown.  
All analyses were performed using the survey sampling weights and SAS survey 
sampling procedures to adjust for the NHANES complex sampling design (Version 9.1.3, 
Cary, NC). Figures were generated using the R system for statistical computing (version 
2.7.0), which also can account for the sampling design.161 
B.3.  Results 
Table 11 shows the prevalence of current asthma and of medical visits for wheezing 
among the population of children and young adults age 2-19 in the four rounds of NHANES 
from 1999-2006. Nearly 10% of the subjects reported current asthma. Seven percent 
reported a medical visit for wheeze in the past year. Current asthma was somewhat more 
prevalent in 2005-2006, though the difference is not large. Medical visits for wheeze were 
more common in the 2003-06 period than in the preceding 4 years. Age did not appear to be 
strongly related to asthma, but medical visits for wheeze were more common in the 2-5 year 
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old children. More boys than girls reported current asthma. Compared to non-Hispanic 
whites, non-Hispanic blacks reported more asthma and visits for wheezing, whereas 
Mexican Americans reported less asthma and fewer visits for wheezing. In-utero exposure 
to tobacco smoke was associated with wheezing requiring a medical visit, and low 
birthweight and elevated CRP were associated with a higher prevalence of asthma. Neither 
asthma nor medical visits for wheeze were strongly associated with the physical activity 
variables.   
The relationships of the same characteristics to overweight were also examined 
(Table 12). Fifteen percent of the population met the criteria for overweight, and 16.2% were 
obese. Overweight and obesity were somewhat less common in 2005-2006 than in 2003-
2004 (percent obese 16.5% vs. 17.4%). Higher weight was associated with being male, 
being non-Hispanic black or Mexican American, lower PIR (less income), smoking, low 
birthweight, and decreased physical activity levels, especially with the number of hours of 
television watching. There was a strong relationship between obesity and CRP levels. The 
correlation between the continuous BMI z-score and the log 10 CRP level was 0.41 (95% 
CI: 0.39-0.44).  
Table 13 shows the age-adjusted and fully adjusted association of the overweight 
categories with current asthma, and several other asthma-related outcomes occurring in the 
past year  (asthma attack, emergency department visit for asthma, wheeze, medical visits 
for wheeze, and missed school or work due to wheezing). Obese children had 1.68 higher 
odds of having current asthma (95% CI: 1.33, 2.12) and 1.97 higher odds of having 
experienced an asthma attack in the previous year (95% CI: 1.66, 2.34) than normal weight 
children. Odds for all of the asthma-related outcomes are elevated for both categories of 
overweight, although the confidence intervals are wider for the emergency department visit 
outcome. Stronger estimates were observed for obese than for overweight categories for 
 76
every outcome, providing evidence of a dose-response effect for BMI. In general, 
adjustment for confounding did not have a large effect on the odds ratios. 
Effect modification by sex was not observed for these outcomes, but data stratified 
by sex are provided in Table 14. 
Table 15 shows the same set of asthma outcomes as predicted by weight category, 
but stratified by atopic status for the 2005-2006 survey years when specific IgE data were 
available. The prevalence of all of the asthma-related outcomes was higher for the atopic 
children. However, the obesity association was stronger among the non-atopic children, with 
important interaction effects (p < 0.15) seen for all outcomes except asthma attack and 
medical visits for wheeze. Very few emergency department visits were reported in this 
smaller population, so the data are not shown. Among non-atopic subjects, those in the 
obese category were more than twice as likely to have current asthma (OR 2.46, 95% CI: 
1.21, 5.02), an asthma attack (OR 2.45, 95% CI: 1.31, 4.58), or wheezing (OR 2.20, 95% CI: 
1.15, 4.22) in the previous year than those of normal weight youth. In contrast, there was no 
appreciable association between overweight or obesity and asthma among atopic subjects.  
Figure 5 shows the relationship between continuous BMI percentile-for-age and the 
probability of current asthma, stratified by atopic status. The relationship between 
continuous BMI and asthma was stronger among the non-atopic subjects. For each 1-
standard deviation increase in the BMI z-score the odds for asthma were increased 1.52 
times (95% CI: 1.14, 2.04) among the non-atopic youth , but only 1.13 times among atopic 
youth (95% CI: 0.91, 1.41)(interaction p-value=0.04).  
In a logistic regression model examining the association between CRP and current 
asthma, separately for atopic and non-atopic children, increased CRP (a 1-log increase) 
was associated with an increased odds of having asthma among non-atopic children (OR 
1.47; 95% CI: 1.17, 1.84), but not among atopic children (OR 0.97; 95% CI: 0.65, 1.44). 
Among the non-atopic children, adjustment for age, race, sex, household smoking, PIR, and 
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physical activity did not affect the odds ratio; whereas further adjustment for BMI attenuated 
the OR to 1.17 (95% CI: 0.80, 1.72). This demonstrates that the relationship of CRP to 
current asthma among these non-atopic children is confounded by BMI.  
B.4.  Discussion 
This analysis from a representative survey of U.S. children shows that being 
overweight or obese is associated with an increased likelihood of reporting current asthma. 
The association with BMI was uniformly stronger for the obese category than for the 
overweight category. We also demonstrated that the continuous BMI z-score was 
associated in a dose-response fashion with the odds of reporting asthma. In addition we 
were able to objectively classify subjects in NHANES 2005-2006 as atopic or non-atopic 
based on allergen-specific IgE tests. This analysis revealed that the association of 
overweight and obesity with asthma was stronger among the non-atopic children. 
These findings differ from those using NHANES III data, which did not find a 
difference between atopic and non-atopic children.115 The studies differ in their definition of 
obesity (quartiles vs. the AMA-recommended ranges) and in the manner of assessing atopy 
(skin prick tests vs. specific IgE tests). The earlier study did find a strong relationship 
between obesity and asthma, especially for highest quartile of obesity, but reported that 
there was no effect modification by atopic status. Stratified data were not presented, 
however, and lack of effect modification was not defined. 
However, our findings are similar to studies in adults that found obesity to be more 
strongly related to non-atopic than to atopic asthma. In an Australian study of 4,060 men 
and women, an increased risk for asthma was found for those with central obesity 
(measured by waist circumference and waist/hip ratio) who were non-atopic.148 In a cross-
sectional survey of more than 86,000 Canadian adults, overweight was associated with 
 78
asthma in both allergic and non-allergic women, but the odds ratio was stronger in non-
allergic women, whereas in men only the relationship in non-allergic men was significant.15  
Several previous studies have found the effect of obesity on asthma to differ by 
gender in children. Gilliland et al. found a significant relationship between overweight and 
asthma among boys, but not girls,72 while Gold et al. found a relationship only among girls.73 
Castro-Rodriguez et al. reported from the Tucson Chidren’s Respiratory Study that obesity 
among girls at age 11 was associated with frequent wheeze at age 13.74 The authors 
suggest that these gender differences may be due to female hormones. Indeed, the 
strongest effects of obesity on asthma were among girls that started puberty before age 11, 
compared to those with later pubertal development.74  Varraso et al. also found that BMI was 
more strongly related to asthma severity among girls with early menarche.77 The present 
analyses, with a large and representative sample of children and adolescents, did not find 
evidence of effect measure modification by gender.  
Previous studies suggest that systemic inflammation is a potential mechanism 
behind the observed relationship between obesity and asthma.79, 90 This analysis 
demonstrated a relationship between CRP levels and asthma, and we therefore examined 
whether CRP could be on the pathway between obesity and asthma. It is inappropriate to 
control for such an intermediate variable as a confounder,162 and mediation models and 
other models that attempt to partition effects into direct and indirect effects rely on 
assumptions that are unlikely to hold in our data (e.g. no unmeasured common causes of 
CRP levels and asthma).170, 171 The relationship of CRP to asthma in non-atopic children, 
and the confounding of this relationship by BMI, suggests that overweight may indeed lead 
to systemic inflammation that in turn leads to an increased risk of asthma in non-atopic 
individuals. There was no evidence of a relationship with systemic inflammation among 
atopic youths. 
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One potential limitation of these findings is that the measure of obesity used, BMI, is 
not a direct measure of adiposity and cannot differentiate between lean and fat mass. As an 
index of obesity, it may perform better for one sex than for another. A male at the same BMI 
as a female, even at a BMI of 30 which indicates obesity, may have more muscle mass and 
less body fat.5 Nevertheless the AMA recommends the use of the CDC 2000 BMI-for-age 
percentiles as used in these analyses, considering them to have good sensitivity and 
specificity for identifying the children at greatest health risk.154  
The asthma and wheeze outcome measures come from self-report rather than an 
objective medical diagnosis. However, previous studies have found strong correlations with 
more objective measures of asthma status. Senthilselvan et al. found self-report of asthma 
to be significantly related to concurrently measured pulmonary function tests.172 Tisnado et 
al. found self-reported history of asthma to be in 91% agreement with medical record 
data.173 
Another limitation is that the IgE data were only available for subjects surveyed in 
NHANES2005-2006.  Thus the effect estimates for the analysis stratified by atopy are less 
precise than for the unstratified analysis. Some of the outcomes, such as emergency 
department visit for asthma, were so uncommon that reliable estimates could not be 
obtained.  
It has been suggested that lack of physical activity may be the underlying cause of 
both obesity and asthma.111 This analysis, however, did not show physical activity to be 
related to asthma. Physical activity is difficult to measure, especially in children, and the 
survey measures available in NHANES are not ideal. Better measurement of physical 
activity might result in different findings.  
Because these NHANES data come from a cross-sectional survey it is not possible 
to assign causality to these associations. Confounding of the CRP-asthma relationship by 
BMI could represent systemic inflammation on the causal pathway to asthma, or could 
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indicate that obesity is a proximate cause of both inflammation and asthma. In order to 
understand the true causal pathways that may underlie the relationships between adiposity 
and the development and manifestation of atopy and asthma, it will be necessary to look at 
these relationships prospectively.  
The NHANES is a large national dataset that uses standardized data collection 
procedures, contains an abundance of information regarding every study subject, and is 
generalizable to the U.S. population. Using an objective measure of atopy, we found that 
excess weight in children appears to be associated with higher rates of asthma in children, 
especially asthma that is not accompanied by allergic disease . Current efforts to decrease 
overweight and obesity among U.S. children could potentially have the added benefit of 
decreasing asthma as well. 
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Table 10.  Odds ratios by age group, ethnicity, sex and atopic status for the association between BMI and asthma, overall and stratified 
by sex. NHANES 1999-2006, children and young adults age 2-19. 
 
Stratum Overall P-value* Males P-value* Females P-value* 
       
All subjects  --  --  -- 
Overweight  1.37 (1.13-1.65)   1.34 (1.08-1.67)   1.40 (1.03-1.89)  
Obese  1.66 (1.33-2.06)   1.60 (1.18-2.17)   1.72 (1.28-2.30)  
       
Age        
Overweight vs. normal  0.44  0.22  1.00 
2-5  1.89 (1.19-3.01)   2.32 (1.43-3.75)   1.41 (0.64-3.15)  
6-10  1.25 (0.84-1.85)   1.15 (0.70-1.91)   1.44 (0.70-2.96)  
11-14  1.36 (0.99-1.86)   1.42 (0.93-2.18)   1.30 (0.81-2.06)  
15-19  1.22 (0.89-1.67)   1.03 (0.58-1.85)    1.37 (0.86-2.18)  
Obese vs. normal  0.97  0.65  0.57 
2-5  1.78 (1.19-2.65)   2.02 (1.20-3.40)    1.45 (0.73-2.90)  
6-10  1.65 (1.01-2.68)   1.32 (0.67-2.59)    2.24 (1.32-3.80)  
11-14  1.63 (1.14-2.33)   1.58 (0.99-2.50)    1.69 (0.95-3.00)  
15-19  1.57 (1.13-2.18)   1.85 (1.16-2.96)    1.37 (0.86-2.19)  
       
Race Ethnicity       
Overweight vs. normal  0.45  0.26  0.97 
Non-Hispanic White  1.45 (1.09-1.92)   1.44 (1.03-2.01)   1.46 (0.93-2.27)  
Non-Hispanic Black  1.35 (1.12-1.62)   1.39 (1.05-1.82)   1.36 (1.04-1.76)  
Mexican American  1.65 (1.25-2.18)   1.88 (1.32-2.67)   1.42 (0.87-2.33)  
Other  0.94 (0.48-1.86)   0.74 (0.28-1.93)   1.17 (0.53-2.60)  
Obese vs. normal  0.51  0.26  0.28 
Non-Hispanic White  1.75 (1.18-2.59)   1.69 (1.01-2.83)   1.80 (1.10-2.93)  
Non-Hispanic Black  1.42 (1.17-1.72)   1.50 (1.14-1.98)   1.41 (1.06-1.89)  
Mexican American  1.76 (1.32-2.35)   2.25 (1.56-3.23)   1.14 (0.79-1.65)  
Other  1.65 (0.99-2.76)   1.25 (0.62-2.52)   2.22 (1.01-4.87)  
       
Atopic Status       
Overweight vs. normal  0.25  0.72  0.26 
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Stratum Overall P-value* Males P-value* Females P-value* 
       
Non-Atopic  1.54 (0.80-2.99)   0.80 (0.21-3.03)   2.29 (1.03-5.09)  
Atopic  1.03 (0.71-1.50)   0.97 (0.50-1.88)   1.14 (0.39-3.37)  
Obese vs. normal  0.05  0.03  0.50 
Non-Atopic  2.21 (1.12-4.35)   2.22 (1.21-4.07)   2.19 (0.76-6.28)  
Atopic  1.22 (0.67-2.22)   0.96 (0.49-1.89)   0.66 (0.76-3.61)  
       
Sex       
Overweight vs. normal  0.82     
Males  1.34 (1.08-1.67)      
Females  1.40 (1.03-1.89)      
Obese vs. normal  0.74     
Males  1.60 (1.18-2.17)      
Females  1.72 (1.28-2.31)      
       
 
* P-value testing that the association between weight category and outcome (atopy or allergy symptoms) differs across categories 
 83 
Table 11. Current asthma and medical visits for wheezing by population characteristics, NHANES 1999-2006, children and young 
adults age 2-19.  
 
 
Subject Characteristics N % 
Current asthma 
(%, SE) OR (95% CI) 
Any medical visits 
for wheezing  
(%, SE) OR (95% CI) 
     
Overall 16074 9.6    (0.4)  7.0    (0.3)  
Survey Round     
1999-2000 3924 22.4 9.6    (1.1) 1.00 5.9    (0.6) 1.00 
2001-2002 4124 26.3 9.1    (0.6) 0.94 (0.71-1.25) 6.3    (0.4) 1.07 (0.82-1.40) 
2003-2004 3884 25.4 9.0    (0.7) 0.94 (0.70-1.26) 7.6    (0.4) 1.31 (1.01-1.69) 
2005-2006 4112 25.5 10.7    (0.5) 1.13 (0.86-1.47) 7.8    (0.7) 1.34 (1.00-1.81) 
Age      
2-5 3166 20.5 8.9    (0.7) 0.92 (0.74-1.15) 11.3    (0.8) 1.67 (1.26-2.21) 
6-10 3467 28.6 9.6    (0.8) 1.00 7.1    (0.7) 1.00 
11-14 4064 22.9 10.6    (0.6) 1.12 (0.88-1.43) 5.7    (0.5) 0.80 (0.60-1.07) 
15-19 5377 28.0 9.3    (0.5) 0.92 (0.74-1.15) 4.7    (0.5) 0.65 (0.47-0.90) 
Sex      
Male 7978 50.6 10.3    (0.6) 1.18 (1.02-1.38) 7.5    (0.4) 1.20 (1.02-1.42) 
Female 8096 49.4 8.8    (0.4) 1.00 6.4    (0.4) 1.00 
Race-ethnicity      
Non-Hispanic white 4244 59.9 9.3    (0.5) 1.00 7.3    (0.4) 1.00 
Non-Hispanic black 5032 14.7 13.5    (0.7) 1.52 (1.28-1.80) 8.0    (0.5) 1.11 (0.93-1.31) 
Mexican American 5396 12.5 6.4    (0.4) 0.67 (0.56-0.80) 4.3    (0.3) 0.57 (0.46-0.70) 
Other 1402 12.9 9.5    (1.0) 1.03 (0.78-1.34) 6.6    (1.0) 0.89 (0.64-1.25) 
Poverty Index (quartiles)      
1st 5332 23.6 9.7    (0.7) 0.98 (0.80-1.21) 7.2    (0.5) 1.07 (0.83-1.37) 
2nd 4098 23.4 10.9    (0.9) 1.13 (0.94-1.36) 7.6    (0.7) 1.14 (0.86-1.51) 
3rd 3007 23.7 8.3    (0.8) 0.83 (0.64-1.08) 6.7    (0.7) 0.99 (0.73-1.35) 
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Subject Characteristics N % 
Current asthma 
(%, SE) OR (95% CI) 
Any medical visits 
for wheezing  
(%, SE) OR (95% CI) 
     
4th 2443 23.6 9.8    (0.7) 1.00 6.7    (0.6) 1.00 
Missing/unknown 1194 5.7 8.0    (1.0)  5.3    (0.9)  
Any smokers in household      
Yes 3273 21.9 8.8    (0.6) 0.88 (0.75-1.03) 7.6    (0.7) 1.13 (0.90-1.40) 
No 12609 78.1 9.9    (0.4) 1.00 6.8    (0.3) 1.00 
Mother smoked during pregnancy*      
Yes  1721 18.9 10.0    (0.9) 1.07 (0.86-1.32) 9.9    (0.7) 1.43 (1.16-1.78) 
No 9887 81.1 9.5    (0.5) 1.00 7.1    (0.4) 1.00 
Birthweight*      
<2500 g 1004 7.4 12.5    (1.3) 1.38 (1.08-1.75) 9.1    (1.4) 1.24 (0.87-1.75) 
≥2500 g 10410 92.6 9.4    (0.4) 1.00 7.5    (0.4) 1.00 
Physical Activity      
 0-3 times/wk  6109 34.4 9.1    (0.5) 0.83 (0.68-1.02) 5.4    (0.4) 0.74 (0.58-0.94) 
 4-6 times/wk 2768 18.1  9.7    (0.6) 0.89 (0.72-1.11) 7.5    (0.6) 1.05 (0.76-1.45) 
 7 times/wk 4043 29.2  9.3    (0.7) 0.85 (0.68-1.06) 8.6    (0.5) 1.22 (0.93-1.60) 
 8+ times/wk 2865 18.3  10.7    (0.9) 1.00 7.1    (0.8) 1.00 
Average hours of TV/videos†      
 0 hours/day 1696 14.1  9.3    (1.0) 1.00 7.3    (0.7) 1.00 
 1-2 hours/day 6364 50.1  9.4    (0.5) 1.01 (0.80-1.28) 6.6    (0.5) 1.10 (0.86-1.41) 
 3+ hours/day 5583 35.8  10.1    (0.7) 1.10 (0.87-1.40) 5.9    (0.6) 0.89 (0.68-1.17) 
Average hours of computer†      
 0 hours/day 4370 35.8  9.0    (0.5) 1.00 7.8    (0.6) 1.00 
 1-2 hours/day 3859 28.9  10.8    (0.7) 1.22 (1.04-1.45) 6.4    (0.5) 0.81 (0.66-1.00) 
 3+ hours/day 5409 35.3 9.4    (0.7) 1.06 (0.86-1.30) 7.6    (0.5) 0.97 (0.77-1.21) 
C-reactive protein‡      
Not detectable 3472 24.3  8.7    (0.7) 1.00 5.9    (0.4) 1.00 
0.02 – 0.04 mg/dL 3294 20.1  9.9    (0.7) 1.17 (0.91-1.50) 6.4    (0.6) 1.08 (0.83-1.41) 
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Subject Characteristics N % 
Current asthma 
(%, SE) OR (95% CI) 
Any medical visits 
for wheezing  
(%, SE) OR (95% CI) 
     
0.04 – 0.14 mg/dL 3213 18.7  9.7    (0.8) 1.13 (0.88-1.46) 6.9    (0.7) 1.18 (0.89-1.57) 
>0.14 mg/dL 3466 18.7  11.1    (0.6) 1.32 (1.09-1.58) 7.3    (0.7) 1.25 (0.97-1.60) 
Missing/unknown 2629 9.6  8.8    (0.9)  8.7    (0.9)  
      
 
* Only available for subjects up to age 15. 
† Only available for subjects up to age 15 in years 1999-2002. 
‡ Values represent tertiles above detection. 
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Table 12. Distribution of overweight by population characteristics, NHANES 1999-2006, children and young adults age 2-19. 
 
Subject Characteristics N 
Percent (SE) 
overweight  OR (95% CI) 
Percent (SE) 
obese OR (95% CI) 
      
Overall 16074 15.0   (0.4)  16.2    (0.6)  
Survey Round     
1999-2000 3924 14.2   (0.7) 1.00 15.2   (0.9) 1.00 
2001-2002 4124 14.7   (0.5) 1.05 (0.89-1.23) 15.7   (1.0) 1.04 (0.84-1.30) 
2003-2004 3884 17.0   (0.7) 1.29 (1.07-1.56) 17.4   (1.3) 1.23 (0.96-1.57) 
2005-2006 4112 14.2   (1.0) 1.02 (0.83-1.26) 16.5   (1.3) 1.11 (0.86-1.42) 
Age     
2-5 3166 10.6    (0.7) 0.56 (0.46-0.70) 10.6    (0.8) 0.54 (0.44-0.67) 
6-10 3467 16.0    (1.0) 1.00 16.8    (0.9) 1.00 
11-14 4064 16.8    (0.7) 1.10 (0.86-1.40) 18.9    (1.2) 1.18 (1.01-1.38) 
15-18 5377 15.9    (0.8) 1.01 (0.84-1.21) 17.6    (0.8) 1.06 (0.90-1.25) 
Sex     
Male 7978 14.9    (0.5) 1.00 (0.90-1.12) 17.1    (0.7) 1.13 (1.02-1.26) 
Female 8096 15.2    (0.5) 1.00 15.4    (0.7) 1.00 
Race-ethnicity     
Non-Hispanic white 4244 14.7    (0.6) 1.00 14.3    (0.8) 1.00 
Non-Hispanic black 5032 15.1    (0.5) 1.12 (0.97-1.30) 20.3    (0.6) 1.55 (1.32-1.83) 
Mexican American 5396 17.2    (0.5) 1.34 (1.17-1.54) 21.0    (0.8) 1.68 (1.43-1.98) 
Other 1402 14.3    (1.1) 0.99 (0.79-1.24) 16.0    (1.3) 1.14 (0.90-1.43) 
Poverty Index (quartiles)     
1st 5332 15.5    (0.7) 1.29 (1.08-1.53) 18.4    (0.9) 1.60 (1.34-1.90) 
2nd 4098 15.4    (1.0) 1.25 (1.02-1.54) 17.6    (0.9) 1.51 (1.21-1.89) 
3rd 3007 15.5    (1.0) 1.24 (1.02-1.51) 16.1    (1.0) 1.35 (1.09-1.67) 
4th 2443 13.5    (0.7) 1.00 12.8    (1.0) 1.00 
Missing/unknown 1194 15.9    (1.8)  17.0    (1.8)  
Any smokers in household     
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Subject Characteristics N 
Percent (SE) 
overweight  OR (95% CI) 
Percent (SE) 
obese OR (95% CI) 
      
Yes 3273 15.6    (1.0) 1.12 (0.95-1.32) 19.4    (1.1) 1.35 (1.17-1.57) 
No 12609 15.0    (0.4) 1.00 15.3    (0.6) 1.00 
Mother smoked during pregnancy*     
Yes 1721 17.2    (1.2) 1.33 (1.09-1.62) 18.5    (1.3) 1.34 (1.13-1.59) 
No 9887 14.3    (0.5) 1.00 15.1    (0.6) 1.00 
Birthweight*     
<2500 g 1004 12.6    (1.6) 0.77 (0.58-1.01) 13.0    (1.5) 0.74 (0.57-0.97) 
≥2500 g 10410 15.1    (0.4) 1.00 16.1    (0.7) 1.00 
Physical Activity     
 0-3 times/wk 6109 14.9    (0.7) 0.95 (0.80-1.12) 19.2    (0.8) 1.50 (1.22-1.86) 
 4-6 times/wk 2768 15.3    (0.9) 0.93 (0.74-1.16) 15.3    (1.1) 1.14 (0.95-1.38) 
 7 times/wk 4043 13.9    (0.9) 0.82 (0.65-1.03) 15.0    (0.8) 1.09 (0.86-1.38) 
 8+ times/wk 2865 16.7    (1.1) 1.00 13.5    (1.2) 1.00 
Average hours of TV/videos†     
 0 hours/day 1696 13.8    (1.2) 1.00 9.6    (1.0) 1.00 
 1-2 hours/day 6364 14.7    (0.6) 1.15 (0.92-1.45) 15.1    (0.8) 1.71 (1.34-2.19) 
 3+ hours/day 5583 15.8    (0.6) 1.36 (1.08-1.72) 20.1    (1.0) 2.50 (1.91-3.25) 
Average hours of computer†     
 0 hours/day 4370 14.8    (0.7) 1.00 15.4    (0.9) 1.00 
 1-2 hours/day 3859 16.0    (0.8) 1.12 (0.94-1.34) 16.7    (0.9) 1.12 (0.94-1.34) 
 3+ hours/day 5409 14.2    (0.6) 0.97 (0.83-1.13) 16.5    (0.7) 1.08 (0.94-1.23) 
C-reactive protein‡     
Not detectable 3472 8.0    (0.7) 1.00 2.3    (0.3) 1.00 
0.02 – 0.04 mg/dL 3294 15.7    (0.7) 2.37 (1.88-2.99) 9.8    (0.8) 5.10 (3.90-6.68) 
0.04 – 0.13 mg/dL 3213 22.3    (1.0) 4.53 (3.63-5.66) 22.1    (1.0) 15.4 (11.8-20.0) 
>0.13 mg/dL 3466 19.0    (1.1) 5.07 (3.93-6.54) 38.7    (1.6) 35.4 (26.6-47.1) 
Missing/unknown 2629 12.1    (0.9)  12.8    (1.0)  
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* Only available for subjects up to age 15. 
† Only available for subjects up to age 15 in years 1999-2002. 
‡ Values represent tertiles above detection. 
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Table 13. Asthma and wheeze outcomes by weight category (BMI percentile for age), NHANES 1999-2006, children and young 
adults age 2-19, N=16,074. 
 
Allergy Outcome 
Number with 
outcome/ 
Total in weight 
category 
Percent  
(SE) 
with 
Outcome 
Odds Ratio  
(95% CI) 
Unadjusted Model*
Odds Ratio  
 (95% CI) 
Adjusted Model† 
     
Current asthma    
Normal weight 922/10,529 8.4    (0.4) 1.00 1.00 
Overweight 293/2,520 11.1    (1.0) 1.36 (1.13-1.65) 1.32 (1.08-1.60) 
Obese 381/3,025 13.2    (1.1) 1.65 (1.33-2.05) 1.68 (1.33-2.12) 
Asthma attack in past year     
Normal weight 515/10,529 5.0    (0.3) 1.00 1.00 
Overweight 168/2,519 6.8    (0.8) 1.44 (1.15-1.80) 1.41 (1.11-1.78) 
Obese 225/3,025 8.7    (0.7) 1.87 (1.57-2.22) 1.97 (1.66-2.34) 
ED visit for asthma in past year     
Normal weight 203/10,529 1.5    (0.2) 1.00 1.00 
Overweight 57/2,519 2.0    (0.3) 1.38 (0.84-2.27) 1.38 (0.94-2.04) 
Obese 72/3,025 2.4    (0.4) 1.46 (0.93-2.29) 1.68 (1.17-2.40) 
Wheeze in past year     
Normal weight 1,174/10,516 11.7    (0.5) 1.00 1.00 
Overweight 321/2,518 14.2    (1.0) 1.25 (1.05-1.49) 1.25 (1.05-1.50) 
Obese 451/3,022 17.4    (1.4) 1.60 (1.32-1.94) 1.63 (1.33-2.00) 
Medical visit for wheeze in past year     
Normal weight 610/10,369 6.1    (0.3) 1.00 1.00 
Overweight 171/2,483 8.0    (0.7) 1.43 (1.15-1.78) 1.40 (1.11-1.75) 
Obese 226/2,962 8.9    (0.8) 1.64 (1.29-2.07) 1.64 (1.28-2.09) 
Miss school/work due to wheezing     
Normal weight 289/10,048 3.0    (0.2) 1.00 1.00 
Overweight 100/2,420 4.9    (0.7) 1.65 (1.18-2.31) 1.56 (1.10-2.22) 
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Allergy Outcome 
Number with 
outcome/ 
Total in weight 
category 
Percent  
(SE) 
with 
Outcome 
Odds Ratio  
(95% CI) 
Unadjusted Model*
Odds Ratio  
 (95% CI) 
Adjusted Model† 
     
Obese 151/2,903 6.1    (0.7) 2.10 (1.53-2.88) 2.10 (1.50-2.96) 
 
* Model adjusted for age only. 
 
† Model adjusted for age, survey round, race/ethnicity, sex, poverty income ratio, household smoking, and level of physical activity. 
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Table 14. Asthma and wheeze outcomes by weight category (BMI percentile for age) and gender, NHANES 1999-2006, children and 
young adults age 2-19. 
 
 Boys (N=7,978) Girls (N=8,096)  
Allergy Outcome Percent  (SE) 
Odds Ratio  
(95% CI) 
Unadjusted 
Model*
Odds Ratio  
 (95% CI) 
Adjusted Model† 
Percent 
 (SE) 
Odds Ratio  
 (95% CI) 
Unadjusted 
Model*
Odds Ratio  
 (95% CI) 
Adjusted Model† 
Interaction 
p-value 
        
Current asthma        
Normal weight 9.1    (0.6) 1.00 1.00 7.7    (0.4) 1.00 1.00 0.93 
Overweight 11.8    (1.2) 1.38 (1.10-1.73) 1.39 (1.08-1.78) 10.4    (1.4) 1.35 (1.00-1.83) 1.25 (0.92-1.69)  
Obese 13.8    (1.7) 1.65 (1.21-2.26) 1.72 (1.24-2.40) 12.5    (1.3) 1.65 (1.22-2.22) 1.68 (1.23-2.29)  
Asthma attack in past year        
Normal weight 5.3    (0.4) 1.00 1.00 4.6    (0.4) 1.00 1.00 0.26 
Overweight 8.1    (1.1) 1.66 (1.28-2.15) 1.64 (1.24-2.16) 5.6    (1.0) 1.21 (0.83-1.76) 1.16 (0.78-1.74)  
Obese 8.5    (1.0) 1.77 (1.36-2.31) 1.88 (1.44-2.45) 8.9    (1.0) 1.99 (1.45-2.72) 2.16 (1.59-2.93)  
ED visit for asthma  
in past year      
  
Normal weight 2.0    (0.3) 1.00 1.00 1.0    (0.1) 1.00 1.00 0.38 
Overweight 2.5    (0.5) 1.38 (0.84-2.27) 1.38 (0.82-2.30) 1.4    (0.4) 1.47 (0.81-2.67) 1.38 (0.71-2.69)  
Obese 2.6    (0.5) 1.46 (0.93-2.29) 1.43 (0.89-2.29) 2.2    (0.5) 2.32 (1.30-4.13) 2.21 (1.20-4.05)  
Wheeze in past year        
Normal weight 12.1    (0.6) 1.00 1.00 11.3    (0.6) 1.00 1.00 0.67 
Overweight 15.5    (1.3) 1.37 (1.10-1.72) 1.41 (1.11-1.79) 12.8    (1.5) 1.13 (0.86-1.49) 1.10 (0.83-1.46)  
Obese 18.6    (2.2) 1.72 (1.26-2.33) 1.77 (1.29-2.42) 16.0    (1.3) 1.47 (1.16-1.86) 1.52 (1.20-1.92)  
Medical visit for wheeze 
in past year      
  
Normal weight 6.8    (0.5) 1.00 1.00 5.4    (0.4) 1.00 1.00 0.04 
Overweight 9.1    (1.2) 1.52 (1.09-2.12) 1.46 (1.03-2.08) 6.9    (0.9) 1.35 (0.97-1.86) 1.31 (0.93-1.83)  
Obese 8.0    (1.1) 1.33 (0.94-1.90) 1.34 (0.94-1.92) 10.0    (1.0) 2.04 (1.53-2.72) 2.05 (1.51-2.78)  
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 Boys (N=7,978) Girls (N=8,096)  
Allergy Outcome Percent  (SE) 
Odds Ratio  
(95% CI) 
Unadjusted 
Model*
Odds Ratio  
 (95% CI) 
Adjusted Model† 
Percent 
 (SE) 
Odds Ratio  
 (95% CI) 
Unadjusted 
Model*
Odds Ratio  
 (95% CI) 
Adjusted Model† 
Interaction 
p-value 
        
Miss school/work due to 
wheezing      
  
Normal weight 3.4    (0.4) 1.00 1.00 2.5    (0.3) 
7)
1.00 1.00 0.74 
Overweight 5.5    (0.9) 1.66 (1.14-2.42) 1.55 (1.04-2.32) 4.3    (0.8) 1.64 (1.05-2.58) 1.60 (0.99-2.59)  
Obese 6.4    (1.1) 1.95 (1.30-2.92) 1.91 (1.24-2.94) 5.9    (0.9) 2.29 (1.51-3.47) 2.45 (1.60-3.74)  
        
        
 
* Model adjusted for age only. 
 
† Model adjusted for age, survey round, race/ethnicity, sex, poverty income ratio, household smoking, and level of physical activity. 
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Table 15. Asthma and wheeze outcomes by weight category (BMI percentile for age) and atopic status, NHANES 2005-06, children 
and young adults age 2-19, N=3,387.  
 
 Non-Atopic (N=1,640) Atopic (N=1,737)  
Asthma Outcome 
Number  
with  
outcome/ 
Total in  
weight  
category 
Percent 
 (SE) 
with  
Outcome 
Odds Ratio  
(95% CI) 
Unadjusted  
Model* 
Odds Ratio  
 (95% CI) 
Adjusted  
Model† 
Number 
with 
outcome/ 
Total in 
weight 
category 
Percent 
 (SE) 
with  
Outcome 
Odds Ratio  
 (95% CI) 
Unadjusted  
Model* 
Odds Ratio  
 (95% CI) 
Adjusted  
Model† 
Inter-
action 
p-value 
          
Current asthma          
Normal weight 61/1,092 5.3   (0.6) 1.00 1.00 148/1,063 15.3  (1.5) 1.00 1.00 0.09 
Overweight 19/247 7.9   (2.1) 1.51 (0.78-2.89) 1.29 (0.65-2.53) 39/276 15.6  (2.1) 1.03 (0.71-1.51) 1.05 (0.76-1.45)  
Obese 23/301 10.9   (3.6) 2.16 (1.10-4.22) 2.46 (1.21-5.02) 59/398 18.0  (3.5) 1.23 (0.68-2.22) 1.34 (0.70-2.57)  
Asthma attack in 
past year          
Normal weight 29/1,063 3.3   (0.7) 1.00 1.00 79/1,063 9.0  (1.3) 1.00 1.00 0.42 
Overweight 11/236 5.4   (2.1) 1.68 (0.70-4.03) 1.35 (0.53-3.42) 30/276 13.0  (2.5) 1.57 (0.98-2.52) 1.64 (1.10-2.43)  
Obese 13/301 6.6   (1.9) 2.07 (1.24-3.44) 2.45 (1.31-4.58) 29/398 11.0  (2.5) 1.29 (0.68-2.44) 1.47 (0.74-2.92)  
Wheeze in past year          
Normal weight 80/1,094 7.3  (1.0) 1.00 1.00 165/1,065 18.2  (2.0) 1.00 1.00 0.07 
Overweight 16/247 10.3  (2.4) 1.50 (0.80-2.81) 1.52 (0.77-2.98) 45/277 18.1  (2.0) 0.98 (0.68-1.43) 0.97 (0.69-1.38)  
Obese 31/301 14.2  (3.6) 2.16 (1.10-4.23) 2.20 (1.15-4.22) 61/401 16.6  (2.3) 0.88 (0.57-1.37) 0.85 (0.54-1.36)  
Medical visit for 
wheeze in past year          
Normal weight 48/1,094 4.0  (0.8) 1.00 1.00 90/1,065 10.3  (1.4) 1.00 1.00 0.40 
Overweight 10/247 5.3  (1.5) 1.53 (0.74-3.16) 1.68 (0.86-3.27) 22/277 8.5  (2.3) 0.86 (0.49-1.50) 0.85 (0.49-1.48)  
Obese 16/301 6.9  (2.5) 2.04 (1.02-4.10) 2.14 (0.95-4.78) 28/401 10.2  (2.4) 1.04 (0.60-1.81) 1.10 (0.60-2.00)  
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 Non-Atopic (N=1,640) Atopic (N=1,737)  
Asthma Outcome 
Number  
with  
outcome/ 
Total in  
weight  
category 
Percent 
 (SE) 
with  
Outcome 
Odds Ratio  
(95% CI) 
Unadjusted  
Model* 
Odds Ratio  
 (95% CI) 
Adjusted  
Model† 
Number 
with 
outcome/ 
Total in 
weight 
category 
Percent 
 (SE) 
with  
Outcome 
Odds Ratio  
 (95% CI) 
Unadjusted  
Model* 
Odds Ratio  
 (95% CI) 
Adjusted  
Model† 
Inter-
action 
p-value 
          
Miss school/work 
due to wheezing          
Normal weight 22/1,065 2.4  (0.6) 1.00 1.00 50/1,036 5.6  (1.2) 1.00 1.00 0.04 
Overweight 6/245 3.4  (1.7) 1.46 (0.47-4.50) 1.54 (0.57-4.18) 15/269 7.5  (2.5) 1.36 (0.56-3.31) 1.41 (0.56-3.55)  
Obese 11/299 4.8  (1.8) 2.09 (0.86-5.08) 2.17 (1.00-4.71) 18/392 4.3  (1.3) 0.76 (0.36-1.61) 0.77 (0.35-1.69)  
        
 
* Model adjusted for age only. 
 
† Model adjusted for age, survey round, race/ethnicity, sex, poverty income ratio, household smoking, and level of physical activity. 
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Figure 5.  Probability of current asthma by BMI percentile-for-age and atopy, NHANES 2005-2006, children and young adults age 2-
19. The shaded region represents the 95% confidence limits of the data. The black lines represent observations and show where the 
data lie on the on the BMI distribution. The x axis is plotted as the z-score for BMI-for-age and labeled with the transformation of z-
scores to percentiles.  
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 C.  Manuscript 3:  Does Obesity or Atopy Modify the Effect of Breastfeeding on 
Asthma? 
 
C.1.  Introduction 
 
Both obesity and asthma have been increasing over the last several decades,1, 159 
and studies over the last fifteen years have suggested that obesity is related to asthma.3-5 
Atopy is a strong risk factor for asthma. A factor that may protect against obesity, atopy, and 
asthma is breastfeeding. Breastfeeding could exert its protective effect against asthma by 
reducing obesity or by preventing atopy. 
Much research has been done over the past several decades on the effect of 
breastfeeding on allergic diseases and asthma, and it has largely shown that breastfeeding 
reduces the risk of developing these diseases.138 However, conflicting findings have also 
been reported.139, 140 The general consensus in the medical community is that breastfeeding 
reduces the risk of allergic disease, and some have put forth breastfeeding promotion as a 
method of primary asthma prevention.141, 142  
Previous research on National Health and Nutrition Examination Survey (NHANES) 
III data showed a protective effect of breastfeeding on asthma and recurrent wheeze that 
disappeared after adjustment for confounding for sex, age, race/ethnicity, birth weight, 
parental education, daycare attendance, parental asthma or hay fever, household smoke 
exposure, and whether the mother smoked during pregnancy.174 Another analysis of 
NHANES III data found a reduced risk of being overweight (≥ 85th percentile of BMI for age) 
at age 5 for children who were ever breastfed compared to those not breastfed (OR=0.63, 
95% CI: 0.41, 0.96), but no significant protection against obesity ≥ 95th percentile of BMI for 
age).137  
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In two research studies that specifically examined the interaction of overweight and 
breastfeeding on the development of asthma, one found an interaction,145 but the other did 
not.146  
This analysis uses NHANES data from 1999-2006 to examine the associations 
between breastfeeding, obesity, atopy, and asthma, to investigate the possibility of a 
pathway to asthma from breastfeeding through atopy and through obesity, and to explore 
modification of the effect of breastfeeding on asthma by weight status and by atopy.  
C.2.  Methods 
C.2.1.  Study Population 
The NHANES is a nationally representative survey conducted periodically to assess 
the health and nutritional status of adults and children in the United States.163 Details about 
the NHANES may be found online at http://www.cdc.gov/nchs/nhanes.htm.     
The target population of NHANES is the civilian, non-institutionalized population of 
the U.S. The NHANES uses a stratified, multi-stage probability sampling design with 
oversampling of persons believed to be at increased health risk. Weights are supplied with 
the public use dataset so that estimates can be produced that reflect the US population 
distribution and can be considered to be nationally representative. Of the 5,576 children age 
1-6 in the combined 1999-2006 NHANES, 5,245 (94%) had complete information on height, 
weight, asthma status and breastfeeding.  
C.2.2  Breastfeeding Measures 
A proxy interviewee for all participants aged 0-6 years responded to questions 
regarding infant feeding. Information is available for whether the child had ever been 
breastfed (yes/no), the duration of total breastfeeding, and the duration of exclusive 
breastfeeding (anything to eat or drink other than breastmilk or water). For this analysis, 
these duration variables were categorized into two groups: < 4 months and ≥ 4 months, with 
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no breastfeeding serving as the reference group. Four months was chosen to allow 
comparison with previous work.174  
C.2.3.  Asthma Outcome 
All caregivers of children age 1 and above were asked whether a doctor or other 
health professional had ever said their child had asthma. The primary outcome for these 
analyses was a report of ever having an asthma diagnosis (yes/no). 
C.2.4.  Atopy 
Children aged 1 to 5 years were tested for allergen-specific IgE to dust mite (D. 
farinae and D.  pteronyssinus), cat, dog, cockroach, alternaria, peanut, egg, and milk. A 
detailed description of the laboratory method can be found at NHANES 2005-2006 web 
page (http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/al_ige_d.pdf). Atopy has been 
defined in these analyses as a positive IgE response (≥ 0.35 kU/L) to at least one of the 
allergens tested. In order to be included in the atopy analyses, the child had to have 
information for the full panel of 9 allergens. Six-year old children were tested for a larger 
panel of allergens, but atopy was defined for this analysis based on the smaller panel for 1-5 
year olds. Atopy information was available for 982 children in the 2005-2006 survey age 1-6 
who also had information on breastfeeding, obesity, and asthma. 
C.2.5.  Weight Measurements 
Weight and height measurements taken during the medical examination were used 
to calculate weight-for-length or body mass index (BMI; weight in kilograms divided by 
height in meters squared). Percentiles for both weight-for-length and percentile-for-age were 
calculated separately for boys and girls, using the Centers for Disease Control and 
Prevention 2000 reference standards.153 Weight-for-length percentiles were used for 
children ages 1-2, and BMI percentile-for-age was used for children ages 3-6 to define 
obesity. Children at or above the 95th percentile were considered obese.154 
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C.2.6.  Other Measures 
Covariates included in modeling to adjust for factors suspected a priori to confound 
the measured associations were the age, sex, and race/ethnicity of the child, maternal 
smoking during pregnancy (yes/no), birthweight (low birthweight vs. not), the poverty income 
ratio (the relationship of family income to the family’s appropriate poverty threshold based 
on family size and composition),164 and survey year (except in models for atopy).  
C.2.7.  Statistical Analyses 
The effects of breastfeeding on obesity, asthma and atopy were examined in 
unadjusted and adjusted models using logistic regression.  
In order to examine whether there is any evidence that breastfeeding might operate 
through obesity or through atopy to affect asthma development, models were constructed to 
assess the effect on asthma of the hypothesized intermediate variables – obesity and atopy 
– while adjusting for each of the breastfeeding variables separately (any breastfeeding, 
duration of breastfeeding, and duration of exclusive breastfeeding) in addition to the other 
covariates. If, for example, breastfeeding were a primary determinant of obesity, and obesity 
were a primary determinant of asthma, without many other factors influencing these 
relationships, we would expect to see the obesity-asthma relationship significantly 
attenuated when adjusting for breastfeeding. 
In addition, potential modification of the effect of breastfeeding on asthma was 
examined for both obesity and atopy in adjusted models. A p-value for the interaction term < 
0.15 was considered evidence of interaction.  
All analyses were performed using the survey sampling weights and SAS survey 
sampling procedures to adjust for the NHANES complex sampling design (Version 9.1.3, 
Cary, NC).  
100 
C.3.  Results 
Table 16 shows the prevalence of breastfeeding, obesity, asthma, and atopy by the 
model covariates. Overall, 65.2% of children had ever been breastfed, 10.5% were 
classified as obese at the time of the survey, 11.7% had received a diagnosis of asthma at 
some time in their lives, and 37.8% had at least one positive allergen-specific IgE test.  
Table 17 shows that breastfeeding protected against asthma in this population of 
children, and that the protection did not differ for a longer duration of any breastfeeding or 
exclusive breastfeeding. Breastfeeding also protected against obesity, and in this case, the 
effect was seen most strongly among those exclusively breastfed at least 4 months. There 
was some evidence for a protective effect against atopy for those exclusively breastfed for 4 
months or longer. Because the sample for the atopy analysis was smaller, the estimates 
were less precise.  
Children who were obese at the time of the survey were more likely to report a 
diagnosis of asthma (OR 1.61, 95% CI: 1.13-2.30; Table 18). This effect estimate did not 
change when the model was adjusted for ever being breastfed, the duration of 
breastfeeding, or the duration of exclusive breastfeeding. 
Atopy was shown to be a very strong risk factor for asthma (OR 3.08, 95% CI: 1.97-
4.80; Table 18). This effect estimate was also unchanged when adjusting for the 
breastfeeding variables.  
In models stratified by obesity (Table 19), breastfeeding was shown to be protective 
against asthma among those not obese at the time of the survey (OR 0.65, 95% CI: 0.51-
0.84), but not among obese children (OR 1.04, 95% CI: 0.54-1.99). The p-value for this 
interaction effect was 0.19, which did not quite meet the pre-specified criterion for important 
effect modification. When stratified by atopic status, the relationship between breastfeeding 
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and asthma was similar for atopic (OR 0.54, 95% CI: 0.22-1.31) and non-atopic (OR 0.47, 
95% CI: 0.17-1.27) children. 
C.4.  Discussion 
This analysis reports findings from a representative survey of U.S. children and 
shows that breastfeeding is protective against both childhood obesity and asthma. These 
findings differ from those using NHANES III data, where an effect for breastfeeding on 
asthma was not observed after adjustment for confounders.174 Longer duration of 
breastfeeding and longer duration of exclusive breastfeeding appear to offer somewhat 
greater benefit against obesity, but not asthma. Evidence for an effect of breastfeeding on 
atopy was less strong and imprecise, which was likely because of the smaller sample size 
for this analysis. Still, among children exclusively breastfed for at least 4 months, the OR for 
atopy was 0.75, which is in the expected direction, given the weight of evidence in the 
literature on breastfeeding and allergic disease.  
If breastfeeding were a common determinant of obesity, atopy, and asthma, or 
protected against asthma by protecting against obesity and/or atopy, we would expect 
breastfeeding to act as a confounder in models of the effect of obesity on asthma and of 
atopy on asthma. This was found not to be the case in these data, suggesting that 
breastfeeding, obesity, and atopy have largely independent effects on the development of 
asthma in children.  
In stratified models, we found the inverse association between breastfeeding and 
asthma to be present among non-obese children, but absent or masked among obese 
children. Similar models showed that breastfeeding did not differentially affect the risk of 
asthma among atopic and non-atopic children. However, the power to assess this effect 
modification was limited by sample size, since only the 2005-2006 survey assayed IgE 
levels.  
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These NHANES data come from a cross-sectional survey making it impossible to 
assign causality to these associations. There are undoubtedly many influences on the 
development of obesity, atopy, and asthma in children. While breastfeeding may make an 
important contribution early in life, it is possible that those effects can be countered or 
overridden by later exposures and/or genetic influences which were not measured here. A 
recent analysis of a large birth cohort with objective outcomes for atopy and bronchial 
hyperresponsiveness found that breastfeeding was protective against wheeze in early 
childhood, but the protective effect was not evident against atopy or asthma in older 
children.144 This study also found that maternal allergy was an important confounder of the 
relationship between breastfeeding and atopy. Unfortunately, data on maternal allergy or 
asthma history are not available in the public use NHANES data since 1999.  
This analysis does not provide evidence to support hypotheses that breastfeeding 
influences the risk of asthma by preventing obesity or atopy in children. However, 
breastfeeding was shown to protect against both obesity and asthma, and the association 
between breastfeeding and asthma was only remarkable among non-obese children. 
Pediatricians should continue to encourage breastfeeding according to the 
recommendations of the American Academy of Pediatrics.175  
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Table 16. Distribution of breastfeeding, obesity, asthma, and atopy by population characteristics, NHANES 1999-2006,  
children age 1-6.  
 
Subject Characteristics N % 
Ever 
BF 
(%) 
OR (95% CI) Obese (%) OR (95% CI) 
Ever  
asthma 
(%) 
OR (95% CI) N* Atopy
† 
 (%) OR (95% CI) 
          
Overall 5258  65.2  10.5  11.7  982 37.8  
Survey round       
1999-2000 1149 23.4 62.0 1.00 9.7 1.00 13.9 1.00  
2001-2002 1264 23.7 63.9 1.08 (0.70-1.66) 9.6 0.99 (0.68-1.45) 10.6 0.74 (0.48-1.13)  
2003-2004 1330 26.2 63.6 1.07 (0.70-1.64) 11.9 1.26 (0.88-1.82) 10.1 0.69 (0.48-1.00)  
2005-2006 1515 26.7 70.8 1.49 (1.02-2.17) 10.5 1.09 (0.75-1.59) 12.1 0.85 (0.54-1.35) 982 37.8  
Age       
1-3 3017 49.0 65.5 1.02 (0.90-1.16) 7.4 0.51 (0.41-0.63) 9.3 0.63 (0.51-0.78) 531 33.6 0.72 (0.50-1.02) 
4-6 2241 51.0 65.0 1.00 13.5 1.00 13.9 1.00 451 41.5 1.00 
Sex       
Male 2648 50.6  65.3 1.00 (0.90-1.12) 11.2 1.16 (0.92-1.46) 14.4 1.73 (1.43-2.10) 483 38.7 1.09 (0.76-1.56) 
Female 2610 49.4  65.2 1.00 9.8 1.00 8.9 1.00 499 36.7 1.00 
Race-ethnicity       
Non-Hispanic  white 1535 58.8 67.4 1.00 9.5 1.00 10.5 1.00 280 31.7 1.00 
Non-Hispanic  black 1472 13.9 43.2 0.37 (0.28-0.48) 11.0 1.19 (0.92-1.54) 18.2 1.88 (1.43-2.47) 233 50.7 2.21 (1.62-3.03) 
Mexican American 1697 14.5 73.0 1.31 (0.97-1.77) 14.0 1.56 (1.19-2.04) 8.0 0.74 (0.53-1.02) 359 42.7 1.60 (1.20-2.14) 
Other 554 12.8 70.5 1.16 (0.88-1.52) 10.4 1.12 (0.74-1.68) 13.9 1.37 (0.97-1.95) 110 46.4 1.87 (1.18-2.96) 
Poverty Income Ratio 
(quartiles)       
1st 1766 23.4 52.8 0.28 (0.21-0.36) 11.1 1.25 (0.90-1.74) 12.9 1.18 (0.84-1.65) 297 40.7 1.15 (0.81-1.63) 
2nd 1379 23.8 59.4 0.36 (0.27-0.48) 11.4 1.28 (0.86-1.92) 13.1 1.20 (0.88-1.63) 289 36.0 0.94 (0.62-1.41) 
3rd 968 23.6 70.3 0.58 (0.42-0.80) 10.0 1.11 (0.73-1.70) 9.7 0.85 (0.54-1.33) 202 35.4 0.92 (0.68-1.24) 
4th 786 23.6 80.3 1.00 9.1 1.00 11.2 1.00 148 37.4 1.00 
Missing/unknown 359 5.6 57.2 -- 11.2 -- 10.7 -- 46 54.0 -- 
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Subject Characteristics N % 
Ever 
BF 
(%) 
OR (95% CI) Obese (%) OR (95% CI) 
Ever  
asthma 
(%) 
OR (95% CI) N* Atopy
† 
 (%) OR (95% CI) 
Mother smoked during 
pregnancy       
Yes 748 17.6 45.0 0.35 (0.29-0.43) 13.3 1.41 (1.06-1.86) 13.0 1.17 (0.90-1.53) 136 31.6 0.72 (0.51-1.01) 
No 4492 82.4 69.9 1.00 9.8 1.00 11.4 1.00 844 39.1 1.00 
Birthweight       
<2500 g 491 8.5 51.7 0.54 (0.38-0.76) 8.4 0.76 (0.49-1.19) 20.5 2.11 (1.53-2.92) 88 30.8 0.72 (0.41-1.26) 
≥2500 g 4672 91.5 66.6 1.00 10.7 1.00 10.9 1.00 878 38.2 1.00 
 
* Atopy information only available in the 2005-2006 survey. 
† Atopy defined as at least one positive allergen-specific IgE result to egg, milk, peanut, dust mite (D. farinae and D. pteronyssinus), 
cat, dog, cockroach, or alternaria. 
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Table 17. Asthma, obesity, and atopy by breastfeeding status, NHANES 1999-2006, children 
age 1-6. 
 
Outcome n/N Percent (SE) 
Unadjusted 
Odds Ratio  
(95% CI) 
Adjusted* 
Odds Ratio 
(95% CI) 
     
Ever had asthma    
Breastfed 333/3245 10.0   (0.8) 0.64 (0.53-0.78) 0.74 (0.58-0.95)
Not breastfed 314/2013 14.8   (1.1) 1.00 1.00 
Ever had asthma    
Breastfed ≥ 4 months 202/2038 10.0   (1.0) 0.64 (0.51-0.80) 0.71 (0.52-0.96)
Breastfed < 4 months 136/1188 10.1   (1.2) 0.65 (0.48-0.87) 0.77 (0.57-1.04)
Not breastfed 314/2013 14.8   (1.1) 1.00 1.00 
Ever had asthma    
Exclusively breastfed ≥ 4 134/1417 9.7   (1.1) 0.62 (0.49-0.78) 0.72 (0.54-0.96)
Exclusively breastfed < 4 204/1816 10.3   (1.1) 0.66 (0.52-0.85) 0.76 (0.57-1.02)
Not breastfed 314/2013 14.8   (1.1) 1.00 1.00 
    
Obese (≥ 95th percentile)    
Breastfed 347/3245 9.7  (0.7) 0.80 (0.63-1.01) 0.84 (0.62-1.15)
Not breastfed 244/2013 11.9  (1.1) 1.00 1.00 
Obese (≥ 95th percentile)    
Breastfed ≥ 4 months 199/2038 8.6   (0.8) 0.70 (0.54-0.92) 0.73 (0.52-1.03)
Breastfed < 4 months 146/1188 11.7   (1.2) 0.98 (0.72-1.33) 1.03 (0.73-1.44)
Not breastfed 244/2013 11.9   (1.1) 1.00 1.00 
Obese (≥ 95th percentile)    
Exclusively breastfed ≥ 4 124/1417 7.8   (0.8) 0.63 (0.47-0.83) 0.63 (0.45-0.90)
Exclusively breastfed < 4 220/1816 11.2   (0.9) 0.94 (0.71-1.23) 1.01 (0.73-1.39)
Not breastfed 244/2013 11.9   (1.1) 1.00 1.00 
    
Atopy (at least 1 positive skin test) 
†
   
Breastfed 269/675 37.6   (2.3) 0.98 (0.75-1.29) 0.90 (0.67-1.22)
Not breastfed 132/307 38.0   (2.4) 1.00 1.00 
Atopy (at least 1 positive skin test)    
Breastfed ≥ 4 months 176/442 37.2   (3.1) 0.96 (0.68-1.36) 0.89 (0.61-1.29)
Breastfed < 4 months 92/228 39.1   (4.3) 1.05 (0.72-1.52) 0.98 (0.68-1.41)
Not breastfed 132/307 38.0   (2.4) 1.00 1.00 
Atopy (at least 1 positive skin test)    
Exclusively breastfed ≥ 4 117/312 33.9   (3.4) 0.84 (0.60-1.16) 0.75 (0.51-1.09)
Exclusively breastfed < 4 151/361 41.2   (3.1) 1.14 (0.81-1.59) 1.08 (0.76-1.52)
Not breastfed 132/307 38.0   (2.4) 1.00 1.00 
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*Adjusted for age, race/ethnicity, birthweight, sex, poverty income ratio, smoking during 
pregnancy, and survey round (except in atopy models). 
†Atopy available in 2005-06 data only. 
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Table 18. Association of obesity and of atopy with asthma, adjusted for breastfeeding, NHANES 1999-2006, children age 1-6. 
  
Outcome Odds Ratio* (95% CI) 
Odds Ratio 
Adjusted for Any 
Breastfeeding 
(95% CI) 
Odds Ratio 
Adjusted for 
Breastfeeding 
Duration 
(95% CI) 
Odds Ratio 
Adjusted for 
Exclusive 
Breastfeeding 
Duration 
(95% CI) 
     
Ever had asthma     
Obese 1.61 (1.13-2.30) 1.60 (1.11-2.30) 1.61 (1.11-2.33) 1.61 (1.11-2.32) 
Not obese 1.00 1.00 1.00 1.00 
Ever had asthma     
Atopic 3.08 (1.97-4.80) 3.06 (1.98-4.74) 3.03 (1.95-4.69) 3.04 (1.99-4.64) 
Not atopic 1.00 1.00 1.00 1.00 
     
 
*All odds ratios are adjusted for age, race/ethnicity, birthweight, sex, poverty income ratio, and smoking during pregnancy. The 
obesity models are further adjusted for survey year. 
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 Table 19. Association of breastfeeding wtih asthma, stratified by obesity and by atopy, NHANES 1999-2006, children age 1-6. 
 
Outcome 
Odds Ratio 
for Any 
Breastfeeding 
(95% CI) 
Interaction  
p-value 
Odds Ratio for 
Breastfeeding 
Duration 
(95% CI) 
Interaction 
p-value 
Odds Ratio for 
Exclusive 
Breastfeeding 
Duration 
(95% CI) 
Interaction   
p-value 
       
Obese  0.19  0.06  0.22 
Breastfed ≥ 4 months/Any breastfeeding 1.04 (0.54-1.99)  1.38 (0.69-2.76)  0.78 (0.33-1.86)  
Breastfed < 4 months   0.67 (0.29-1.56)  1.22 (0.62-2.40)  
Not breastfed 1.00  1.00  1.00  
Not Obese       
Breastfed ≥ 4 months/Any breastfeeding 0.65 (0.51-0.84)  0.66 (0.48-0.89)  0.66 (0.49-0.90)  
Breastfed < 4 months   0.66 (0.48-0.89)  0.65 (0.47-0.89)  
Not breastfed 1.00  1.00  1.00  
       
Atopic  0.99  0.38  0.80 
Breastfed ≥ 4 months/Any breastfeeding 0.54 (0.22-1.31)  0.63 (0.27-1.47)  0.59 (0.23-1.52)  
Breastfed < 4 months   0.39 (0.11-1.41)  0.50 (0.18-1.44)  
Not breastfed 1.00  1.00  1.00  
Not Atopic       
Breastfed ≥ 4 months/Any breastfeeding 0.47 (0.17-1.27)  0.36 (0.12-1.11)  0.36 (0.11-1.18)  
Breastfed < 4 months   0.73 (0.26-2.02)  0.61 (0.23-1.65)  
Not breastfed 1.00  1.00  1.00  
       
 
 
  
 
CHAPTER VI:  DISCUSSION 
A.  Findings and Strengths 
 
These studies used cross-sectional survey data from a large representative survey of 
the U.S. population to examine the relationships among obesity, infant feeding, allergic 
disease, and asthma. The large size and representativeness of the NHANES sample 
provide a wonderful opportunity to examine these relationships in U.S. children in the 21st 
century. This dataset is the largest dataset of serum IgE levels ever collected, providing an 
objective assessment of allergic disease in the U.S. population. 
In the first analysis, it was shown that overweight and obesity were related to total 
IgE levels and to atopy, defined as at least one positive allergen-specific IgE result, but not 
to allergy symptoms and hay fever. The relationship between weight and atopy has not been 
examined often in children, and never, to my knowledge, using total and allergen-specific 
IgE tests.  
Previous work using the NHANES III dataset115 did not find a significant relationship 
between overweight and atopy in children age 4-17. Apart from the different age range, the 
major difference between the studies was that the earlier work used quartiles of BMI rather 
than percentiles of BMI-for-age. In order to relate the present findings more directly to this 
previous work and to examine why the findings were different, a separate analysis was run 
using quartiles of BMI in the 2005-2006 data. A dose-response effect for total IgE was still 
found across these quartiles (see Table A1 in the Appendix), lending credence to the finding 
of a continuous relationship as pictured in Figure 3. No relationship was found with atopy in 
this analysis, however. These analyses used quartiles of “raw” BMI, and while the models 
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were adjusted for age and sex, the method differs substantially from the recommended 
transformation of BMI to a percentile based on the CDC sex-specific growth curves of BMI-
for-age. The implication is that the CDC percentiles and categories of overweight and obese 
for children are more informative than simple BMI for children, and that perhaps, had the 
NHANES III data been analyzed in this manner, the findings might have been more like 
those presented in Chapter IV. 
The relationship between obesity and atopy did not differ by gender, although the 
correlation between BMI and total IgE was stronger for girls than it was for boys. These 
analyses using the IgE data were surprisingly consistent across weight categories and 
between males and females. The finding that BMI was associated in a continuous fashion 
with total IgE has never been shown before and demonstrates that overweight may increase 
allergic predisposition. There were some interesting findings regarding race and gender, 
particularly that there was no relationship in Mexican-American girls, but at this level of 
stratification the estimates become somewhat imprecise, and it is probably prudent not to 
make too much of this finding.  
In the second analysis, overweight and obesity were found to be related to asthma. 
This finding is not new; however, there have been inconsistencies in the literature about this 
relationship in children. Because the main analysis of the obesity/asthma relationship was 
done on such a large dataset (more than 16,000 U.S. children and young adults) and the 
findings were so consistent across categories of weight and various asthma and wheeze 
outcomes, we can feel confident that this relationship is real. It is also interesting, perhaps 
even reassuring, that the findings were consistent for males and females. A number of 
previous studies have found gender differences, but Chinn noted in a recent review that 
evidence was very weak for gender differences in children or adolescents.67 This is an 
important contribution to the literature, if not a definitive statement about the relationship 
between obesity and asthma in U.S. children. 
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In both studies a dose response effect was seen for the weight categories on atopy 
and on asthma, in that the effect was typically stronger for the obese category than the 
overweight category. In addition, BMI as a continuous variable was found to be related to 
total IgE and to the probability of current asthma in a linear fashion. This suggests that there 
is nothing magic about the clinical cut-offs for overweight and obesity in children, but that 
increasing weight at any level is associated with increasing risk for allergic disease and 
asthma. 
Other previous work in this area has found that the effect of weight on asthma is 
stronger or only exists among persons without atopy or allergic disease. This study found 
essentially the same thing. The odds ratio for non-atopic children was 2.46 (95% CI: 1.21, 
5.02), while that for atopic children was 1.34 (95% CI: 0.70, 2.57). These confidence 
intervals don’t quite exclude the estimates for the other group, but the p-value for the 
interaction test is 0.09, so it seems reasonable to claim that there is effect modification here 
by atopic status.  
Given the weak or non-existent relationship between BMI and atopic asthma, 
researchers have focused on systemic inflammation as a mechanism whereby overweight 
could lead to an increased of asthma. CRP is a marker for such inflammation and is strongly 
related to weight. Although it cannot be proved in this cross-sectional data, it is generally 
accepted in the medical community that this inflammation is caused by the excess weight. 
Certain hormones with inflammatory properties, such as leptin, are produced by adipose 
tissue. In these studies, CRP was also shown to be related to total IgE/atopy and to asthma. 
The relationship was stronger for asthma than for atopy.  
The idea most commonly expressed in the literature is that obesity leads to systemic 
inflammation and that this generalized inflammatory state causes deficits in lung function 
(asthma symptoms being a result of inflammatory processes in the lung). Because of the 
cross-sectional nature of the NHANES dataset, this sequence of events could not be tested 
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directly. I was able to examine the association between CRP levels and atopy/asthma and 
to test whether BMI operated as a confounder in those models. If it did, that could be taken 
as a piece of evidence that some of the effect of obesity on atopy/asthma might operate 
through the effect of excess weight on CRP/inflammation. 
In both analyses, the effect of CRP on atopy/asthma was shown to be confounded 
by obesity. Although not strictly causal evidence, this does suggest that some of the effect of 
CRP/inflammation could be caused by increasing weight being responsible for that 
inflammation. The effect on inflammation on atopy was especially interesting in this regard. 
A number of researchers have suggested that, since obesity seems to result in more asthma 
mainly among non-atopic children, obesity might operate through an inflammatory 
mechanism separate from the atopic mechanism. My findings show that an inflammatory 
mechanism might be associated with an increased risk for atopy as well. To my knowledge, 
this has not been examined before among children. 
The findings of the first two papers seem contradictory, in that obesity was found to 
be associated with atopy, but not with atopic asthma. However, there was at least some 
evidence of an elevation of risk associated with obesity in the atopic children (OR=1.34). 
This may mean that obesity is indeed a risk factor for atopy, but once a child has become 
atopic, the atopy overshadows the effect of weight. Again, because these data come from a 
cross-sectional survey, it is not possible to test this possible time sequence in this dataset.  
Finally, it was shown in the third analysis that infant feeding was related to the 
development of obesity and asthma, but not atopy. The protective effect of breastfeeding 
against obesity and asthma has been shown previously in other work, and this analysis 
confirms those findings in a rather large sample of U.S. children. The atopy model was 
underpowered, unfortunately, and while there was no association observed, the observed 
effect was protective (OR=0.75), and it is possible that an effect could have been detected in 
a larger dataset.  
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I wanted to examine the question of whether breastfeeding might result in less 
asthma because it led to less obesity and/or less atopy. In models examining the effects of 
the intermediates – obesity and atopy – on the development of asthma, breastfeeding did 
not act as a confounder. This would suggest that any correlation between breastfeeding and 
obesity (my analyses did not show a correlation between breastfeeding and atopy) is not the 
driving force behind asthma being less common in breastfed children. The effect of 
breastfeeding on asthma was stronger among children not obese at the time of the survey 
than among obese children, but evidence for this being a true case of effect modification 
was modest. Thus, I was not able to demonstrate that breastfeeding protected against 
asthma because it protected against obesity or against atopy. There are certainly other 
ways that breastfeeding could operate to protect against asthma. Probably the most 
important would be through reduction of respiratory infections in early childhood.  
B.  Limitations 
 
The time sequence of events cannot be determined in cross-sectional data, which 
limits one’s ability to draw conclusions regarding causality. It is plausible, for example, that 
asthma could lead to obesity if asthmatic children were more sedentary than non-asthmatic 
children. Other researchers, however, have investigated this possibility in longitudinal 
datasets and concluded that obesity typically precedes the development of asthma rather 
than the other way around. The NHANES datasets may not be entirely appropriate for a 
study on the causal mechanisms of obesity and inflammation on development of atopy and 
asthma, but because they come from such a large sample and are generalizable to the U.S. 
population, it is well worth examining the associations that exist as springboards for further 
exploration in mechanistic research studies. 
Another potential limitation of these analyses was the use of BMI as the measure of 
adiposity. The obvious advantage of using BMI in obesity research is that height and weight 
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measurements are easy to obtain and are available in most datasets pertaining to children’s 
health. It is not a direct measure of fatness, however, and may misclassify some children. 
Children grow at different rates, will have growth spurts at different ages, and reach sexual 
maturity at different times. Thus, an individual child whose growth or sexual maturity level is 
in the vanguard or lagging behind others of the same age may fall into the outer reaches of 
the percentile scale, but still be a reasonable weight for their height and own growth 
trajectory.  BMI has also been shown to misclassify individuals, particularly adolescent 
males, who are heavier than average due to a larger bone structure or more muscle 
mass.165  
Nevertheless, BMI has been shown to correlate quite well with other measures of 
adiposity. Mei et al. compared BMI to DXA in a pooled dataset of 3 studies in children and 
found correlations that ranged from 0.78 to 0.88, and that the area under the receiving 
operating characteristics curve was 0.952.166 In other research examining obesity and 
asthma symptoms among inner-city children (Kattan, personal communication), DXA 
measures were found not to add to the ability to predict asthma morbidity once BMI had 
been accounted for. 
Although the NHANES datasets are large (more than 16,000 children age 2-19 
across the 1999-2006 rounds of the survey), in certain subsets of my analyses sample size 
was an issue. This was particularly important for analyses that included the IgE/allergy 
symptom variables, since these were only available for the most recent 2005-2006 round of 
data collection (N=3,387 children 2-19 at normal weight and above). I looked at effect 
modification by sex, age, and ethnicity, and by age group and ethnicity separately for boys 
and girls. At this level of stratification, imprecision started to become a problem. While I did 
show the varying rates for atopy among girls of different ethnicities in the first paper, I felt it 
was better not to make too much of this finding. Because of the sample weighting, when cell 
sizes become small, a single observation can sometimes have undue influence. This is also 
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why analysis of individual allergen-specific IgE tests was relegated to the online supplement. 
For a number of the allergens, there were only a few positive tests, and it is difficult to draw 
conclusions from those findings. Other researchers in our working group are looking into 
interrelationships among these allergen-specific IgE results, a task well beyond the scope of 
the present work. 
A set of these analyses used serum IgE levels, an objective measure of atopy; 
however, other outcomes included asthma and allergy symptom outcome data that were 
collected by self-report, rather than via an objective medical diagnosis. With respect to self-
report of asthma, previous studies have found strong correlations with more objective 
measures of asthma status. Senthilselvan et al. found self-report of asthma to be 
significantly related to concurrently measured pulmonary function tests.172 Tisnado et al. 
found self-reported history of asthma to be in 91% agreement with medical record data.173 
On the other hand, it is interesting that with respect to allergy/atopy, obesity was related to 
the objective measures of allergic tendency, but not to self-report of symptoms. Other efforts 
in the NHANES working group (Hoppin, personal communication) have shown that the 
questions asked regarding allergic symptoms do not predict atopy as measured by total or 
specific IgE with any degree of confidence. 
C.  Changes from Originally Proposed Analyses 
 
One of the pieces of my original proposal was to compare my findings using BMI to 
findings using percent body fat from DXA. DXA was developed to measure bone density for 
clinical assessment of osteoporosis, but recent software and hardware developments allow 
the direct measurement of body composition in terms of bone mass, lean mass, and body 
fat. The DXA machine scans the body with a very weak, but focused, x-ray that can 
differentiate between these different types of tissue.152 Each compartment is measured in 
grams, and the entire body mass can be decomposed into percents by dividing the mass of 
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each compartment by the body weight. Because DXA is a direct measure of fat mass, it has 
become the standard for body fat measurement in recent decades.  
There were a number of challenges to the use of DXA in this analysis, and it was 
determined that it was not really central or necessary, and might be too large a distraction. 
The DXA datasets for 1999-2004 did become available early in 2008. It should be noted that 
the available DXA data do not at this time overlap with the 2005-2006 IgE/allergy data. In 
addition, DXA is only available for participants age 8 and above. More significantly perhaps, 
there are no agreed-upon clinical cut-offs for what percent body fat indicates overweight and 
obesity in children, making a comparable analysis to that for BMI less than straightfoward.154 
There are a number of interesting research questions that could be answered using the 
NHANES DXA data and comparing them to BMI, but these were considered to be beyond 
the scope of the present work.  
Another analysis I had proposed was to examine confounding by a number of dietary 
components, notably anti-oxidants and specific vitamins (A, C, D, E, and carotenoids) that 
are available in laboratory files from NHANES. Again, these variables were not available for 
the 2005-2006 data (except Vitamin D which recently became available), and complications 
surrounding only being able to look at this confounding for certain subsets of the population 
dissuaded me from including these variables in my primary analyses. I have, however, 
included in Table A2 of the Appendix an analysis of differences in these serum markers of 
diet by weight status, current asthma, and atopy. A number of these dietary components are 
related to weight status, but none were related to asthma. The only one showing any 
relationship to atopy was Vitamin D. Since Vitamin D is a suspected risk factor for allergic 
disease, I ran a set of adjusted models including this variable, but found it did not act as a 
confounder in the obesity-atopy relationship. Questions regarding specific effects of Vitamin 
D may be addressed by other researchers in our working group, so I did not attempt to 
examine effect modification or do further analyses with this variable.  
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Both obesity and atopy are risk factors for asthma. Thus, additivity of the effects is 
may demonstrate a biological interaction.162 A test for additive interaction revealed an 
interaction contrast ratio of 0.89 (95% CI: 0.31, 2.54). This implies that there is no actual 
biological synergy between atopy and obesity in the development of asthma. Indeed, effect 
modification was shown to exist by atopic status for the association between obesity and 
asthma, with a p-value for the interaction test of 0.09. Obesity was found to be associated 
with asthma in non-atopic children, but not in atopic children, rather than there being a 
synergistic effect.  
D.  Clinical and Public Health Significance 
 
While obesity and asthma have been shown to be related in a number of studies, it is 
still not understood why this is the case. Although both obesity and asthma are medical 
conditions characterized by inflammation, a direct link to airway inflammation in obese 
individuals has not been established. The recent NHANES datasets provide valuable 
information regarding relationships between C-reactive protein (a marker of systemic 
inflammation) and obesity, atopy, and asthma. The new allergy module of the 2005-2006 
survey also contains total and allergen-specific IgE levels for examination of whether an 
allergic mechanism may be involved in the association between obesity and asthma.  
Asthma is large and growing problem in the U.S. and around the world. A number of 
exposures have been shown to be related to asthma development in children, but none 
have been shown to entirely explain the increases over the past several decades. The 
cause of asthma appears to be multi-factorial, and indeed, there are those that suggest that 
asthma may be more than a single disease. Understanding some of the relationships 
between exposures and mechanisms of disease development could lead to strategies to 
prevent and treat allergic diseases and asthma among certain at-risk children. Reducing 
overweight in children may be one such strategy. 
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Childhood obesity may be the most important health issue facing U.S. children today. 
Recent reports discuss children as young as 2 having significant obesity, setting them up for 
a lifetime of medical problems.176 The public health community has begun to address the 
problem of childhood obesity, and numerous efforts are underway. Messages about healthy 
nutrition and physical activity are being increasingly incorporated into regular health 
education.177 Various school-based programs have been successful in increasing physical 
activity among children, improving diet, and reducing overweight, using approaches such as 
interactive computer media,178 hands-on educational activities,179 or simply providing game 
equipment to increase physical activity at recess.180   
An increased risk of allergic disease and asthma may not be the most consequential 
health risk faced by overweight children. Nonetheless, it provides additional motivation for 
undertaking the difficult challenge to reduce childhood obesity. 
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APPENDIX 
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Table A1. Comparison of NHANES 2005-2006 with NHANES III published data using 
quartiles of BMI, children age 4-17. 
 
Allergy Outcome 
NHANES 2005-2006† 
(N=2610) 
NHANES III‡ 
(N=7505) 
   
Atopy    
1st quartile 1.00 1.00 
2nd quartile 1.11 (0.86-1.44) 1.07 (0.91-1.27) 
3rd quartile 1.05 (0.80-1.38) 1.20 (1.01-1.43) 
4th quartile 0.82 (0.62-1.07) 1.14 (0.96-1.35) 
Total IgE (geometric mean kU/L)   
1st quartile 1.00  
2nd quartile 1.17 (0.91-1.52)  
3rd quartile 1.30 (1.05-1.62)  
4th quartile 1.49 (1.18-1.89)  
   
 NHANES 2005-2006 NHANES III 
Atopy (using same quartile 
definitions)   
1st quartile 1.00 1.00 
2nd quartile 0.98 (0.66-1.46) 1.07 (0.91-1.27) 
3rd quartile 1.14 (0.83-1.55) 1.20 (1.01-1.43) 
4th quartile 0.97 (0.66-1.42) 1.14 (0.96-1.35) 
   
 
* Models in current paper for ages 2-19 adjusted for race, age, sex, poverty income ratio, and 
household smoking. 
 
†Model using NHANES 2005-2006 data ages 4-17 adjusted for race, age, sex, household 
size, and household smoking. Quartiles: First 11.7-16.5; Second 16.6-19.4; Third 19.5-23.5; 
Fourth 23.6-62.1. 
 
‡Model from von Mutius paper ages 4-17 adjusted for race, age, sex, household size, study 
area and passive smoke exposure. Quartiles: First 7.3-15.4; Second 15.5-17.1; Third 17.2-
20.4; Fourth 20.5-37.2. 
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Table A2. Distribution of dietary micronutrients by weight category, current asthma, and 
atopy, NHANES 1999-2006, children age 2-19.  
 
Subject Characteristics N % 
Geometric mean 
total IgE (SE) 
p-value* 
test for trend 
    
Vitamin A    
   
Weight category 9378   
Normal 5988 66.7  41.9    (0.3) <0.0001 
Overweight 1567 16.2  43.7    (0.5)  
Obese 1823 17.1  44.7    (0.4)  
   
Current Asthma 9340   
No 5467 90.6  42.7    (0.3) 0.72 
Yes 496 9.4  42.4    (0.6)  
   
Atopy 0   
No 0   
Yes 0   
   
Vitamin C   
   
Weight category 2736   
Normal 1677 62.4 1.2    (0.03) <0.0001 
Overweight 501 18.5  1.1    (0.03)  
Obese 558 19.0  1.0    (0.04)  
   
Current Asthma 2724   
No 2436 90.9 1.1    (0.02) 0.57 
Yes 288 9.1  1.1    (0.06)  
   
Atopy 0   
No 0   
Yes 0   
   
Vitamin D    
   
Weight category 9889   
Normal 6337 66.6  26.2    (0.4) <0.0001 
Overweight 1617 16.0  24.7    (0.5)  
Obese 1935 17.4  22.3    (0.4)  
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Subject Characteristics N % 
Geometric mean 
total IgE (SE) 
p-value* 
test for trend 
    
Current Asthma 9848   
No 8840 90.1  25.3    (0.4) 0.58 
Yes 1008 9.9  24.6    (0.5)  
   
Atopy   3375   
No 1636 53.6 24.4    (0.5) 0.06 
Yes 1739 46.4 23.0    (0.6)  
   
Vitamin E   
   
Weight category 6652   
Normal 4306 68.4  801.7    (6.3) 0.50 
Overweight 1066 15.2  788.2   (11.5)  
Obese 1280 16.5  795.5   (11.2)  
   
Current Asthma 6627   
No 3938 90.5  800.3    (6.8) 0.28 
Yes 352 9.5  784.3   (13.1)  
   
Atopy   3375   
No 0   
Yes 0   
   
Total b-carotene   
   
Weight category 2712   
Normal 1671 62.8  11.7    (0.3) <0.0001 
Overweight 499 18.6  9.1    (0.3)  
Obese 542 18.6   7.4    (0.3)  
   
Current Asthma 2699   
No 2413 90.9  10.3    (0.3) 0.47 
Yes 286 9.1  10.4    (0.5)  
   
Atopy 0   
No 0   
Yes 0   
    
 
*Test for asthma and atopy among normal weight only. 
 
 
 123
REFERENCES 
 
1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence 
of overweight and obesity in the United States, 1999-2004. JAMA 2006;295(13):1549-55. 
2. Akinbami L. The state of childhood asthma, United States, 1980-2005. Adv Data 
2006(381):1-24. 
3. Chinn S. Obesity and asthma: evidence for and against a causal relation. J Asthma 
2003;40(1):1-16. 
4. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 
2005;115(5):897-909; quiz 10. 
5. Shore SA, Johnston RA. Obesity and asthma. Pharmacol Ther 2006;110(1):83-102. 
6. Arbes SJ, Jr., Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test 
responses to 10 common allergens in the US population: results from the third National 
Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116(2):377-83. 
7. Law M, Morris JK, Wald N, Luczynska C, Burney P. Changes in atopy over a quarter 
of a century, based on cross sectional data at three time periods. BMJ 
2005;330(7501):1187-8. 
8. Schernhammer ES, Vutuc C, Waldhor T, Haidinger G. Time trends of the prevalence 
of asthma and allergic disease in Austrian children. Pediatr Allergy Immunol 2008;19(2):125-
31. 
9. von Mutius E. The rising trends in asthma and allergic disease. Clin Exp Allergy 
1998;28 Suppl 5:45-9; discussion 50-1. 
10. Huang SL, Shiao G, Chou P. Association between body mass index and allergy in 
teenage girls in Taiwan. Clin Exp Allergy 1999;29(3):323-9. 
11. Schachter LM, Peat JK, Salome CM. Asthma and atopy in overweight children. 
Thorax 2003;58(12):1031-5. 
12. Xu B, Jarvelin MR, Pekkanen J. Body build and atopy. J Allergy Clin Immunol 
2000;105(2 Pt 1):393-4. 
13. Jarvis D, Chinn S, Potts J, Burney P. Association of body mass index with respiratory 
symptoms and atopy: results from the European Community Respiratory Health Survey. Clin 
Exp Allergy 2002;32(6):831-7. 
14. Tantisira KG, Litonjua AA, Weiss ST, Fuhlbrigge AL. Association of body mass with 
pulmonary function in the Childhood Asthma Management Program (CAMP). Thorax 
2003;58(12):1036-41. 
15. Chen Y, Dales R, Jiang Y. The association between obesity and asthma is stronger 
in nonallergic than allergic adults. Chest 2006;130(3):890-5. 
 124
16. Arbes SJ, Jr., Gergen PJ, Vaughn B, Zeldin DC. Asthma cases attributable to atopy: 
results from the Third National Health and Nutrition Examination Survey. J Allergy Clin 
Immunol 2007;120(5):1139-45. 
17. Ownby DR, Joseph CL. Should nonatopic asthma get equal attention? J Allergy Clin 
Immunol 2007;120(5):1018-20. 
18. Healthy People 2010: Understanding and Improving Health U.S. Department of 
Health and Human Services, 2000. (Accessed 12/26/07, 2007, at 
http://www.healthypeople.gov/Document/HTML/uih/uih_4.htm.) 
19. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-
sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 
2001;357(9255):505-8. 
20. Welsh JA, Cogswell ME, Rogers S, Rockett H, Mei Z, Grummer-Strawn LM. 
Overweight among low-income preschool children associated with the consumption of sweet 
drinks: Missouri, 1999-2002. Pediatrics 2005;115(2):e223-9. 
21. Jahns L, Siega-Riz AM, Popkin BM. The increasing prevalence of snacking among 
US children from 1977 to 1996. J Pediatr 2001;138(4):493-8. 
22. Lowry R, Brener N, Lee S, Epping J, Fulton J, Eaton D. Participation in high school 
physical education -- United States, 1991-2003. MMWR 2004;53(36):844-7. 
23. Eaton DK, Kann L, Kinchen S, et al. Youth Risk Behavior Surveillance -- United 
States, 2005. MMWR 2006;55(SS-5). 
24. Must A, Bandini LG, Tybor DJ, Phillips SM, Naumova EN, Dietz WH. Activity, 
inactivity, and screen time in relation to weight and fatness over adolescence in girls. 
Obesity (Silver Spring) 2007;15(7):1774-81. 
25. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007;29:1-
5. 
26. Dietz WH. Overweight in childhood and adolescence. N Engl J Med 
2004;350(9):855-7. 
27. Salmon J, Booth ML, Phongsavan P, Murphy N, Timperio A. Promoting physical 
activity participation among children and adolescents. Epidemiol Rev 2007;29:144-59. 
28. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young 
adulthood from childhood and parental obesity. N Engl J Med 1997;337(13):869-73. 
29. Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese 
children become obese adults? A review of the literature. Prev Med 1993;22(2):167-77. 
30. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to 
cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. 
Pediatrics 1999;103(6 Pt 1):1175-82. 
 125
31. Fagot-Campagna A, Narayan KM, Imperatore G. Type 2 diabetes in children. BMJ 
2001;322(7283):377-8. 
32. Steinberger J, Moran A, Hong CP, Jacobs DR, Jr., Sinaiko AR. Adiposity in 
childhood predicts obesity and insulin resistance in young adulthood. J Pediatr 
2001;138(4):469-73. 
33. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among 
children and adolescents with marked obesity. N Engl J Med 2002;346(11):802-10. 
34. Wabitsch M, Hauner H, Hertrampf M, et al. Type II diabetes mellitus and impaired 
glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int 
J Obes Relat Metab Disord 2004;28(2):307-13. 
35. Total Prevalence of Diabetes and Pre-diabetes. American Diabetes Association. 
(Accessed 12/26/07, 2007, at http://www.diabetes.org/diabetes-statistics/prevalence.jsp.) 
36. Must A, Anderson SE. Effects of obesity on morbidity in children and adolescents. 
Nutr Clin Care 2003;6(1):4-12. 
37. Braet C, Mervielde I, Vandereycken W. Psychological aspects of childhood obesity: a 
controlled study in a clinical and nonclinical sample. J Pediatr Psychol 1997;22(1):59-71. 
38. Neumark-Sztainer D, Story M, Resnick MD, Blum RW. Psychosocial concerns and 
weight control behaviors among overweight and nonoverweight Native American 
adolescents. J Am Diet Assoc 1997;97(6):598-604. 
39. Tinkelman D, Schwartz A. School-based asthma disease management. J Asthma 
2004;41(4):455-62. 
40. Dey AN, Schiller JS, Tai DA. Summary Health Statistics for U.S. Children: National 
Health Interview Survey, 2002. Vital and Health Statistics Series 10: Data from the National 
Health Survey 2004(221). 
41. Weiss KB, Gergen PJ, Wagener DK. Breathing better or wheezing worse? The 
changing epidemiology of asthma morbidity and mortality. Annu Rev Public Health 
1993;14:491-513. 
42. Bush A. Diagnosis of asthma in children under five. Prim Care Respir J 2007;16(1):7-
15. 
43. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson 
Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 2003;111(4):661-75; 
quiz 76. 
44. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma 
and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J 
Med 1995;332(3):133-8. 
 126
45. Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, Schoeters G. 
The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol 
Lett 2007;113(1):6-18. 
46. Ly NP, Gold DR, Tzianabos AO, Weiss ST, Celedon JC. Cytokines, allergy, and 
asthma. Curr Opin Allergy Clin Immunol 2005;5:161-6. 
47. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J 
Allergy Clin Immunol 2004;113(3):395-400. 
48. Umetsu DT, Dekruyff RH. Immune dysregulation in asthma. Curr Opin Immunol 
2006;18(6):727-32. 
49. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human 
immune system to environmental allergens: universal skewing of initial T cell responses 
toward the Th2 cytokine profile. J Immunol 1998;160(10):4730-7. 
50. Prescott SL, Macaubas C, Smallacombe T, et al. Reciprocal age-related patterns of 
allergen-specific T-cell immunity in normal vs. atopic infants. Clin Exp Allergy 1998;28 Suppl 
5:39-44; discussion 50-1. 
51. Miles EA, Warner JA, Jones AC, Colwell BM, Bryant TN, Warner JO. Peripheral 
blood mononuclear cell proliferative responses in the first year of life in babies born to 
allergic parents. Clin Exp Allergy 1996;26(7):780-8. 
52. Neaville WA, Tisler C, Bhattacharya A, et al. Developmental cytokine response 
profiles and the clinical and immunologic expression of atopy during the first year of life. J 
Allergy Clin Immunol 2003;112(4):740-6. 
53. Holt PG. Development of T-cell memory against inhalant allergens: risks for the 
future. Clin Exp Allergy 1999;29 Suppl 2:8-13. 
54. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development 
of allergen-specific T-cell memory in atopic and normal children. Lancet 
1999;353(9148):196-200. 
55. Macaubas C, de Klerk NH, Holt BJ, et al. Association between antenatal cytokine 
production and the development of atopy and asthma at age 6 years. Lancet 
2003;362(9391):1192-7. 
56. Contreras JP, Ly NP, Gold DR, et al. Allergen-induced cytokine production, atopic 
disease, IgE, and wheeze in children. J Allergy Clin Immunol 2003;112(6):1072-7. 
57. Rowe J, Heaton T, Kusel M, et al. High IFN-gamma production by CD8+ T cells and 
early sensitization among infants at high risk of atopy. J Allergy Clin Immunol 
2004;113(4):710-6. 
58. Schwartz J, Gold D, Dockery DW, Weiss ST, Speizer FE. Predictors of asthma and 
persistent wheeze in a national sample of children in the United States. Association with 
social class, perinatal events, and race. Am Rev Respir Dis 1990;142(3):555-62. 
 127
59. Fergusson DM, Crane J, Beasley R, Horwood LJ. Perinatal factors and atopic 
disease in childhood. Clin Exp Allergy 1997;27(12):1394-401. 
60. Gregory A, Doull I, Pearce N, et al. The relationship between anthropometric 
measurements at birth: asthma and atopy in childhood. Clin Exp Allergy 1999;29(3):330-3. 
61. Leadbitter P, Pearce N, Cheng S, et al. Relationship between fetal growth and the 
development of asthma and atopy in childhood. Thorax 1999;54(10):905-10. 
62. Shaheen SO, Sterne JA, Montgomery SM, Azima H. Birth weight, body mass index 
and asthma in young adults. Thorax 1999;54(5):396-402. 
63. Negri E, Pagano R, Decarli A, La Vecchia C. Body weight and the prevalence of 
chronic diseases. J Epidemiol Community Health 1988;42(1):24-9. 
64. Chen Y, Dales R, Krewski D, Breithaupt K. Increased effects of smoking and obesity 
on asthma among female Canadians: the National Population Health Survey, 1994-1995. 
Am J Epidemiol 1999;150(3):255-62. 
65. Young SY, Gunzenhauser JD, Malone KE, McTiernan A. Body mass index and 
asthma in the military population of the northwestern United States. Arch Intern Med 
2001;161(13):1605-11. 
66. Camargo CA, Jr., Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective study of 
body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 
1999;159(21):2582-8. 
67. Chinn S. Obesity and asthma. Paediatr Respir Rev 2006;7(3):223-8. 
68. Chen Y, Rennie D, Cormier Y, Dosman J. Sex specificity of asthma associated with 
objectively measured body mass index and waist circumference: the Humboldt study. Chest 
2005;128(4):3048-54. 
69. Guerra S, Sherrill DL, Bobadilla A, Martinez FD, Barbee RA. The relation of body 
mass index to asthma, chronic bronchitis, and emphysema. Chest 2002;122(4):1256-63. 
70. Ford ES, Mannino DM, Redd SC, Mokdad AH, Mott JA. Body mass index and 
asthma incidence among USA adults. Eur Respir J 2004;24(5):740-4. 
71. Chinn S, Rona RJ. Can the increase in body mass index explain the rising trend in 
asthma in children? Thorax 2001;56(11):845-50. 
72. Gilliland FD, Berhane K, Islam T, et al. Obesity and the risk of newly diagnosed 
asthma in school-age children. Am J Epidemiol 2003;158(5):406-15. 
73. Gold DR, Damokosh AI, Dockery DW, Berkey CS. Body-mass index as a predictor of 
incident asthma in a prospective cohort of children. Pediatr Pulmonol 2003;36(6):514-21. 
74. Castro-Rodriguez JA, Holberg CJ, Morgan WJ, Wright AL, Martinez FD. Increased 
incidence of asthmalike symptoms in girls who become overweight or obese during the 
school years. Am J Respir Crit Care Med 2001;163(6):1344-9. 
 128
75. Flaherman V, Rutherford GW. A meta-analysis of the effect of high weight on 
asthma. Arch Dis Child 2006;91(4):334-9. 
76. Huovinen E, Kaprio J, Koskenvuo M. Factors associated to lifestyle and risk of adult 
onset asthma. Respir Med 2003;97(3):273-80. 
77. Varraso R, Siroux V, Maccario J, Pin I, Kauffmann F. Asthma severity is associated 
with body mass index and early menarche in women. Am J Respir Crit Care Med 
2005;171(4):334-9. 
78. Mai XM, Bottcher MF, Leijon I. Leptin and asthma in overweight children at 12 years 
of age. Pediatr Allergy Immunol 2004;15(6):523-30. 
79. Retnakaran R, Hanley AJ, Connelly PW, Harris SB, Zinman B. Elevated C-reactive 
protein in Native Canadian children: an ominous early complication of childhood obesity. 
Diabetes Obes Metab 2006;8(5):483-91. 
80. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin 
concentrations in normal-weight and obese humans. N Engl J Med 1996;334(5):292-5. 
81. Friedman JM. Leptin, leptin receptors, and the control of body weight. Nutr Rev 
1998;56(2 Pt 2):s38-46; discussion s54-75. 
82. Faggioni R, Jones-Carson J, Reed DA, et al. Leptin-deficient (ob/ob) mice are 
protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. 
Proc Natl Acad Sci U S A 2000;97(5):2367-72. 
83. Mohamed-Ali V, Pinkney JH, Panahloo A, Goodrick S, Coppack SW, Yudkin JS. 
Relationships between plasma leptin and insulin concentrations, but not insulin resistance, 
in non-insulin-dependent (type 2) diabetes mellitus. Diabet Med 1997;14(5):376-80. 
84. Palacio A, Lopez M, Perez-Bravo F, Monkeberg F, Schlesinger L. Leptin levels are 
associated with immune response in malnourished infants. J Clin Endocrinol Metab 
2002;87(7):3040-6. 
85. Visser M. Higher levels of inflammation in obese children. Nutrition 2001;17(6):480-1. 
86. Singhal A, Farooqi IS, Cole TJ, et al. Influence of leptin on arterial distensibility: a 
novel link between obesity and cardiovascular disease? Circulation 2002;106(15):1919-24. 
87. Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of 
sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma 
Immunol 2002;89(4):381-5. 
88. Matsuda K, Nishi Y, Okamatsu Y, Kojima M, Matsuishi T. Ghrelin and leptin: a link 
between obesity and allergy? J Allergy Clin Immunol 2006;117(3):705-6. 
89. Hancox RJ, Poulton R, Greene JM, et al. Systemic inflammation and lung function in 
young adults. Thorax 2007;62(12):1064-8. 
 129
90. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein 
and body mass index in children: findings from the Third National Health and Nutrition 
Examination Survey, 1988-1994. J Pediatr 2001;138(4):486-92. 
91. Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J 
Asthma 2003;40(7):733-9. 
92. Butland BK, Strachan DP, Rudnicka AR. C-reactive protein, obesity, atopy and 
asthma symptoms in middle-aged British adults. Eur Respir J 2008;32(1):77-84. 
93. Wong GW, Liu EK, Leung TF, et al. High levels and gender difference of exhaled 
nitric oxide in Chinese schoolchildren. Clin Exp Allergy 2005;35(7):889-93. 
94. Buchvald F, Baraldi E, Carraro S, et al. Measurements of exhaled nitric oxide in 
healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005;115(6):1130-6. 
95. Leung TF, Li CY, Lam CW, et al. The relation between obesity and asthmatic airway 
inflammation. Pediatr Allergy Immunol 2004;15(4):344-50. 
96. Santamaria F, Montella S, De Stefano S, et al. Asthma, atopy, and airway 
inflammation in obese children. J Allergy Clin Immunol 2007;120(4):965-7. 
97. Barros R, Moreira A, Fonseca J, et al. Obesity and airway inflammation in asthma. J 
Allergy Clin Immunol 2006;117(6):1501-2. 
98. McLachlan CR, Poulton R, Car G, et al. Adiposity, asthma, and airway inflammation. 
J Allergy Clin Immunol 2007;119(3):634-9. 
99. Todd DC, Armstrong S, D'Silva L, Allen CJ, Hargreave FE, Parameswaran K. Effect 
of obesity on airway inflammation: a cross-sectional analysis of body mass index and 
sputum cell counts. Clin Exp Allergy 2007;37(7):1049-54. 
100. Lazarus R, Colditz G, Berkey CS, Speizer FE. Effects of body fat on ventilatory 
function in children and adolescents: cross-sectional findings from a random population 
sample of school children. Pediatr Pulmonol 1997;24(3):187-94. 
101. Li AM, Chan D, Wong E, Yin J, Nelson EA, Fok TF. The effects of obesity on 
pulmonary function. Arch Dis Child 2003;88(4):361-3. 
102. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care 
Med 2006;174(2):112-9. 
103. Collins LC, Hoberty PD, Walker JF, Fletcher EC, Peiris AN. The effect of body fat 
distribution on pulmonary function tests. Chest 1995;107(5):1298-302. 
104. Plumb J, Brawer R, Brisbon N. The interplay of obesity and asthma. Curr Allergy 
Asthma Rep 2007;7(5):385-9. 
105. de Marco R, Locatelli F, Sunyer J, Burney P. Differences in incidence of reported 
asthma related to age in men and women. A retrospective analysis of the data of the 
European Respiratory Health Survey. Am J Respir Crit Care Med 2000;162(1):68-74. 
 130
106. Firrincieli V, Keller A, Ehrensberger R, et al. Decreased physical activity among 
Head Start children with a history of wheezing: use of an accelerometer to measure activity. 
Pediatr Pulmonol 2005;40(1):57-63. 
107. Epstein LH, Wu YW, Paluch RA, Cerny FJ, Dorn JP. Asthma and maternal body 
mass index are related to pediatric body mass index and obesity: results from the Third 
National Health and Nutrition Examination Survey. Obes Res 2000;8(8):575-81. 
108. Beckett WS, Jacobs DR, Jr., Yu X, Iribarren C, Williams OD. Asthma is associated 
with weight gain in females but not males, independent of physical activity. Am J Respir Crit 
Care Med 2001;164(11):2045-50. 
109. Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A. Body mass index in relation 
to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol 
2004;160(10):969-76. 
110. Fredberg JJ, Inouye DS, Mijailovich SM, Butler JP. Perturbed equilibrium of myosin 
binding in airway smooth muscle and its implications in bronchospasm. Am J Respir Crit 
Care Med 1999;159(3):959-67. 
111. Lucas SR, Platts-Mills TA. Paediatric asthma and obesity. Paediatr Respir Rev 
2006;7(4):233-8. 
112. Fitch KD, Godfrey S. Asthma and athletic performance. JAMA 1976;236(2):152-7. 
113. Orenstein DM, Reed ME, Grogan FT, Jr., Crawford LV. Exercise conditioning in 
children with asthma. J Pediatr 1985;106(4):556-60. 
114. Varray AL, Mercier JG, Terral CM, Prefaut CG. Individualized aerobic and high 
intensity training for asthmatic children in an exercise readaptation program. Is training 
always helpful for better adaptation to exercise? Chest 1991;99(3):579-86. 
115. von Mutius E, Schwartz J, Neas LM, Dockery D, Weiss ST. Relation of body mass 
index to asthma and atopy in children: the National Health and Nutrition Examination Study 
III. Thorax 2001;56(11):835-8. 
116. Rasmussen F, Lambrechtsen J, Siersted HC, Hansen HS, Hansen NC. Low physical 
fitness in childhood is associated with the development of asthma in young adulthood: the 
Odense schoolchild study. Eur Respir J 2000;16(5):866-70. 
117. Camargo CA, Jr., Rifas-Shiman SL, Litonjua AA, et al. Maternal intake of vitamin D 
during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 
2007;85(3):788-95. 
118. Devereux G, Litonjua AA, Turner SW, et al. Maternal vitamin D intake during 
pregnancy and early childhood wheezing. Am J Clin Nutr 2007;85(3):853-9. 
119. Kull I, Bergstrom A, Melen E, et al. Early-life supplementation of vitamins A and D, in 
water-soluble form or in peanut oil, and allergic diseases during childhood. J Allergy Clin 
Immunol 2006;118(6):1299-304. 
 131
120. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J 
Allergy Clin Immunol 2007;120(5):1031-5. 
121. Weiss ST, Litonjua AA. Childhood asthma is a fat-soluble vitamin deficiency disease. 
Clin Exp Allergy 2008. 
122. Seaton A, Devereux G. Diet, infection and wheezy illness: lessons from adults. 
Pediatr Allergy Immunol 2000;11 Suppl 13:37-40. 
123. Martindale S, McNeill G, Devereux G, Campbell D, Russell G, Seaton A. Antioxidant 
intake in pregnancy in relation to wheeze and eczema in the first two years of life. Am J 
Respir Crit Care Med 2005;171(2):121-8. 
124. Litonjua AA, Rifas-Shiman SL, Ly NP, et al. Maternal antioxidant intake in pregnancy 
and wheezing illnesses in children at 2 y of age. Am J Clin Nutr 2006;84(4):903-11. 
125. Dunstan JA, Prescott SL. Does fish oil supplementation in pregnancy reduce the risk 
of allergic disease in infants? Current opinion in allergy and clinical immunology 
2005;5(3):215-21. 
126. Mihrshahi S, Peat JK, Marks GB, et al. Eighteen-month outcomes of house dust mite 
avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study 
(CAPS). J Allergy Clin Immunol 2003;111(1):162-8. 
127. Barden AE, Mori TA, Dunstan JA, et al. Fish oil supplementation in pregnancy lowers 
F2-isoprostanes in neonates at high risk of atopy. Free Radic Res 2004;38(3):233-9. 
128. Almqvist C, Garden F, Xuan W, et al. Omega-3 and omega-6 fatty acid exposure 
from early life does not affect atopy and asthma at age 5 years. J Allergy Clin Immunol 
2007;119(6):1438-44. 
129. Johnson JB, Summer W, Cutler RG, et al. Alternate day calorie restriction improves 
clinical findings and reduces markers of oxidative stress and inflammation in overweight 
adults with moderate asthma. Free Radic Biol Med 2007;42(5):665-74. 
130. Ahroni JH, Montgomery KF, Watkins BM. Laparoscopic adjustable gastric banding: 
weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg 
2005;15(5):641-7. 
131. Simard B, Turcotte H, Marceau P, et al. Asthma and sleep apnea in patients with 
morbid obesity: outcome after bariatric surgery. Obes Surg 2004;14(10):1381-8. 
132. Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-
related illness in 500 U.S. patients following laparoscopic adjustable gastric banding 
procedure. Am J Surg 2005;189(1):27-32. 
133. Goldner WS, Stoner JA, Thompson J, et al. Prevalence of Vitamin D Insufficiency 
and Deficiency in Morbidly Obese Patients: A Comparison with Non-Obese Controls. Obes 
Surg 2008. 
 132
134. Bodnar LM, Catov JM, Roberts JM, Simhan HN. Prepregnancy obesity predicts poor 
vitamin D status in mothers and their neonates. J Nutr 2007;137(11):2437-42. 
135. Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S. 
Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr 
Endocrinol Metab 2007;20(7):817-23. 
136. Gillman MW, Rifas-Shiman SL, Camargo CA, Jr., et al. Risk of overweight among 
adolescents who were breastfed as infants. JAMA 2001;285(19):2461-7. 
137. Hediger ML, Overpeck MD, Kuczmarski RJ, Ruan WJ. Association between infant 
breastfeeding and overweight in young children. JAMA 2001;285(19):2453-60. 
138. van Odijk J, Kull I, Borres MP, et al. Breastfeeding and allergic disease: a 
multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy 
and its impact on later atopic manifestations. Allergy 2003;58(9):833-43. 
139. Sears MR, Greene JM, Willan AR, et al. Long-term relation between breastfeeding 
and development of atopy and asthma in children and young adults: a longitudinal study. 
Lancet 2002;360(9337):901-7. 
140. Wright AL, Holberg CJ, Taussig LM, Martinez FD. Factors influencing the relation of 
infant feeding to asthma and recurrent wheeze in childhood. Thorax 2001;56(3):192-7. 
141. Friedman NJ, Zeiger RS. The role of breast-feeding in the development of allergies 
and asthma. J Allergy Clin Immunol 2005;115(6):1238-48. 
142. Kull I, Almqvist C, Lilja G, Pershagen G, Wickman M. Breast-feeding reduces the risk 
of asthma during the first 4 years of life. J Allergy Clin Immunol 2004;114(4):755-60. 
143. Snijders BE, Thijs C, Kummeling I, Penders J, van den Brandt PA. Breastfeeding 
and infant eczema in the first year of life in the KOALA birth cohort study: a risk period-
specific analysis. Pediatrics 2007;119(1):e137-41. 
144. Elliott L, Henderson J, Northstone K, Chiu GY, Dunson D, London SJ. Prospective 
study of breast-feeding in relation to wheeze, atopy, and bronchial hyperresponsiveness in 
the Avon Longitudinal Study of Parents and Children (ALSPAC). J Allergy Clin Immunol 
2008;122(1):49-54,  e1-3. 
145. Mai XM, Becker AB, Sellers EA, Liem JJ, Kozyrskyj AL. The relationship of breast-
feeding, overweight, and asthma in preadolescents. J Allergy Clin Immunol 
2007;120(3):551-6. 
146. Oddy WH, Sherriff JL, de Klerk NH, Kendall GE. Breastfeeding, body mass index, 
and asthma and atopy in children. Adv Exp Med Biol 2004;554:387-90. 
147. Guler N, Kirerleri E, Ones U, Tamay Z, Salmayenli N, Darendeliler F. Leptin: does it 
have any role in childhood asthma? J Allergy Clin Immunol 2004;114(2):254-9. 
 133
148. Appleton SL, Adams RJ, Wilson DH, Taylor AW, Ruffin RE. Central obesity is 
associated with nonatopic but not atopic asthma in a representative population sample. J 
Allergy Clin Immunol 2006;118(6):1284-91. 
149. Arshad SH, Tariq SM, Matthews S, Hakim E. Sensitization to common allergens and 
its association with allergic disorders at age 4 years: a whole population birth cohort study. 
Pediatrics 2001;108(2):E33. 
150. Asthma Risk Factors. WebMD, LLC, 2007. (Accessed May 13, 2008, at 
http://www.webmd.com/asthma/guide/asthma-risk-factors.) 
151. Dorland WAN. Dorland's Medical Dictionary. 29th Rev ed. Philadelphia: W.B. 
Saunders Company; 2000. 
152. Eisenmann JC, Heelan KA, Welk GJ. Assessing body composition among 3- to 8-
year-old children: anthropometry, BIA, and DXA. Obes Res 2004;12(10):1633-40. 
153. Clinical Growth Charts. National Center for Health Statistics, 2007. (Accessed 
October 31, 2007, at 
http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/clinical_charts.htm.) 
154. Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D. Assessment of 
child and adolescent overweight and obesity. Pediatrics 2007;120 Suppl 4:S193-228. 
155. Li R, Scanlon KS, Serdula MK. The validity and reliability of maternal recall of 
breastfeeding practice. Nutr Rev 2005;63(4):103-10. 
156. Bland RM, Rollins NC, Solarsh G, Van den Broeck J, Coovadia HM. Maternal recall 
of exclusive breast feeding duration. Arch Dis Child 2003;88(9):778-83. 
157. Elia M, Betts P, Jackson DM, Mulligan J. Fetal programming of body dimensions and 
percentage body fat measured in prepubertal children with a 4-component model of body 
composition, dual-energy X-ray absorptiometry, deuterium dilution, densitometry, and 
skinfold thicknesses. Am J Clin Nutr 2007;86(3):618-24. 
158. Kiechl-Kohlendorfer U, Horak E, Mueller W, et al. Neonatal characteristics and risk of 
atopic asthma in schoolchildren: results from a large prospective birth-cohort study. Acta 
Paediatr 2007;96(11):1606-10. 
159. Akinbami L. The state of childhood asthma, United States, 1980-2005. MMWR 
2006(381):1-24. 
160. Braback L, Hjern A, Rasmussen F. Body mass index, asthma and allergic 
rhinoconjunctivitis in Swedish conscripts-a national cohort study over three decades. Respir 
Med 2005;99(8):1010-4. 
161. R: A language and environment for statistical computing. Foundation for Statistical 
Computing, 2008. (Accessed May 16, 2008, at http://www.R-project.org.) 
162. Rothman KJ, Greenland S. Modern Epidemiology. Second ed. Philadelphia: 
Lippincott, Williams and Wilkins; 1998. 
 134
163. National Center for Health Statistics. Let's Improve Our Health: National Health and 
Nutrition Examination Survey, 2007-2008, Overview. Hyattsville, MD: Centers for Disease 
Control and Prevention; 2007 January. 
164. How the Census Bureau Measures Poverty. 2007. (Accessed May 13, 2008, at 
http://www.census.gov/hhes/www/poverty/povdef.html.) 
165. Burkhauser RV, Cawley J. Beyond BMI: The value of more accurate measures of 
fatness and obesity in social science research. J Health Econ 2007. 
166. Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, Dietz WH. Validity 
of body mass index compared with other body-composition screening indexes for the 
assessment of body fatness in children and adolescents. Am J Clin Nutr 2002;75(6):978-85. 
167. Story RE. Asthma and obesity in children. Curr Opin Pediatr 2007;19(6):680-4. 
168. Visness CM, Daniels J, Kaufman JS, et al. Association of obesity with IgE and 
allergy symptoms in children and adolescents: Results from NHANES 2005-2006. TBN. 
169. Kwon HL, Ortiz B, Swaner R, et al. Childhood asthma and extreme values of body 
mass index: the Harlem Children's Zone Asthma Initiative. J Urban Health 2006;83(3):421-
33. 
170. Kaufman JS, Maclehose RF, Kaufman S. A further critique of the analytic strategy of 
adjusting for covariates to identify biologic mediation. Epidemiol Perspect Innov 2004;1(1):4. 
171. Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect 
effects. Epidemiology 1992;3(2):143-55. 
172. Senthilselvan A, Dosman JA, Chen Y. Relationship between pulmonary test 
variables and asthma and wheezing: a validation of self-report of asthma. J Asthma 
1993;30(3):185-93. 
173. Tisnado DM, Adams JL, Liu H, et al. What is the concordance between the medical 
record and patient self-report as data sources for ambulatory care? Med Care 
2006;44(2):132-40. 
174. Chulada PC, Arbes SJ, Jr., Dunson D, Zeldin DC. Breast-feeding and the prevalence 
of asthma and wheeze in children: analyses from the Third National Health and Nutrition 
Examination Survey, 1988-1994. J Allergy Clin Immunol 2003;111(2):328-36. 
175. Gartner LM, Morton J, Lawrence RA, et al. Breastfeeding and the use of human milk. 
Pediatrics 2005;115(2):496-506. 
176. Obesity Epidemic Spreads to Toddlers: Parents Monitor Children's Weight to Prevent 
Health Complications. ABC News, 2008. (Accessed August 24, 2008, at 
http://abcnews.go.com/Health/story?id=5602922&page=1.) 
177. Secondary school health education related to nutrition and physical activity -- 
selected sites, United States, 2004. MMWR 2006;55(30):821-04. 
 135
178. Frenn M, Malin S, Brown RL, et al. Changing the tide: an Internet/video exercise and 
low-fat diet intervention with middle-school students. Appl Nurs Res 2005;18(1):13-21. 
179. Fitzgibbon ML, Stolley MR, Schiffer L, Van Horn L, KauferChristoffel K, Dyer A. Two-
year follow-up results for Hip-Hop to Health Jr.: a randomized controlled trial for overweight 
prevention in preschool minority children. J Pediatr 2005;146(5):618-25. 
180. Verstraete SJ, Cardon GM, De Clercq DL, De Bourdeaudhuij IM. Increasing 
children's physical activity levels during recess periods in elementary schools: the effects of 
providing game equipment. Eur J Public Health 2006;16(4):415-9. 
 
 
 
